Processing 00000000.tx.1: Degradation of the Alzheimer's Amyloid Peptide by Endothelin-converting Enzyme* Elizabeth A. 

Phrase: "Degradation of the Alzheimer's Amyloid Peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1523817:peptide degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "by Endothelin-converting Enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "* Elizabeth A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.2: Eckman, Dana Kim Reed, and Christopher B. 

Phrase: "Eckman,"

Phrase: "Dana Kim Reed,"

Phrase: "and"

Phrase: "Christopher B."
Processing 00000000.tx.3: Eckman From the Mayo Clinic Jacksonville, Jacksonville, Florida 32224 Received for publication, August 19,2000, and in revised form, May 2,2001  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Deposition of -amyloid (A) peptides in the brain is an early and invariant feature of all forms of Alzheimer's disease. 

Phrase: "Eckman From the Mayo Clinic Jacksonville,"

Phrase: "Jacksonville,"

Phrase: "Florida 32224"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016253:Florida [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "August 19,"

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "May 2,"

Phrase: "2001  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Deposition of -amyloid (A) peptides in the brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   774   C1705760:Amyloid Deposition [Finding]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "an early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "invariant feature of all"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1521970:Feature [Qualitative Concept]
   770   C1706388:Feature [Conceptual Entity]
   770   C2346469:Feature [Qualitative Concept]
   770   C2348519:Feature [Qualitative Concept]

Phrase: "forms of Alzheimer's disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.4: As with any secreted protein, the extracellular concentration of A is determined not only by its production but also by its catabolism. 

Phrase: "As with any secreted protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1327616:Secreted [Cell Function]

Phrase: "the extracellular concentration of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "is"

Phrase: "determined"

Phrase: "not only by its production"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033268:production [Occupational Activity]
   760   C0205171:Only [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also by its catabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0543484:catabolism [Functional Concept]
   770   C0699900:Catabolism [Organism Function]
   770   C1516314:Catabolism [Physiologic Function]
Processing 00000000.tx.5: A major focus of Alzheimer's research has been the elucidation of the mechanisms responsible for the generation of A. 

Phrase: "A major focus of Alzheimer's research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205234:Focus [Spatial Concept]
   753   C1285542:focus [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "the elucidation of the mechanisms"

Phrase: "responsible for the generation of A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]
Processing 00000000.tx.6: Much less, however, is known about the mechanisms responsible for A removal in the brain. 

Phrase: "Much less,"

Phrase: "however,"

Phrase: "is"

Phrase: "known about the mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205309:Known [Qualitative Concept]
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for A removal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.7: In this report, we describe the identification of endothelin-converting enzyme-1 (ECE-1) as a novel A-degrading enzyme. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "describe"

Phrase: "the identification of endothelin-converting enzyme-1 (ECE-1)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "as a novel A-degrading enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.8: We show that treatment of endogenous ECE-expressing cell lines with the metalloprotease inhibitor phosphoramidon causes a 2-3-fold elevation in extracellular A concentration that appears to be due to inhibition of intracellular A degradation. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that treatment of endogenous ECE-expressing cell lines"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "with the metalloprotease inhibitor phosphoramidon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734   C1152589:metalloprotease inhibitor [Molecular Function]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a 2-3-fold elevation in extracellular A concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439775:Elevation [Therapeutic or Preventive Procedure]
   742   C0702240:Elevation [Spatial Concept]

Phrase: "that"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be due to inhibition of intracellular A degradation."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0175996:intracellular [Cell Component]
   744   C0178719:Intracellular [Spatial Concept]
   744   C0243125:degradation [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0699900:Degradation [Organism Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]
   744   C3463820:Inhibition [Activity]
Processing 00000000.tx.9: Furthermore, we show that overexpression of ECE-1 in Chinese hamster ovary cells, which lack endogenous ECE activity, reduces extracellular A concentration by up to 90% and that this effect is completely reversed by treatment of the cells with phosphoramidon. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that overexpression of ECE-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "in Chinese hamster ovary cells,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "endogenous ECE activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "reduces"

Phrase: "extracellular A concentration by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "up to 90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "reversed by treatment of the cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0007634:Cells [Cell]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3282337:Cells [Cell]
   753   C3538994:TREATMENT [Research Activity]
   719 E C1269647:Cell [Cell]
   719   C1555029:Reverse [Idea or Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with phosphoramidon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.10: Finally, we show that recombinant soluble ECE-1 is capable of hydrolyzing synthetic A40 and A42 in vitro at multiple sites.  

Phrase: "Finally,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that recombinant soluble ECE-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C1514798:recombinant [Organism]
   812   C1749467:soluble [Cell Component]
   812   C1948047:Soluble [Qualitative Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "capable of hydrolyzing synthetic A40"

Phrase: "and"

Phrase: "A42"

Phrase: "in vitro at multiple sites."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Alzheimer's disease (AD)1 is the most common cause of dementia in the elderly and is characterized pathologically by the accumulation of -amyloid peptides (A) in the brain in the form of senile plaques. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)1"

Phrase: "is"

Phrase: "the most common cause of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "in the elderly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]

Phrase: "and"

Phrase: "is"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "pathologically by the accumulation of -amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")"

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in the form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "of senile plaques."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]
Processing 00000000.tx.12: A is normally produced from the -amyloid precursor protein (APP) through the combined proteolytic actions of - and -secretase and is then secreted into the extracellular milieu (1, 2). 

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "normally"

Phrase: "produced from the -amyloid precursor protein (APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "through the combined proteolytic actions of -"

Phrase: "and -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "is"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "secreted into the extracellular milieu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0521119:Extracellular [Cell Component]
   760   C1327616:Secreted [Cell Function]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: The degree of A accumulation is dependent not only on its production but also on the mechanisms responsible for its removal. 

Phrase: "The degree of A accumulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "is"

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "not only on its production"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033268:production [Occupational Activity]
   760   C0205171:Only [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also on the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for its removal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.14: While considerable effort has been directed at elucidating the enzymes and pathways contributing to the production of A, much less is known regarding A catabolism. 

Phrase: "While"

Phrase: "considerable effort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015264:Effort [Organism Function]

Phrase: "has"

Phrase: "been"

Phrase: "directed at elucidating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "the enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "contributing to the production of A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033268:production [Occupational Activity]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1880177:Contributing [Activity]

Phrase: "much less"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "regarding"

Phrase: "A catabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0543484:catabolism [Functional Concept]
   861   C0699900:Catabolism [Organism Function]
   861   C1516314:Catabolism [Physiologic Function]
Processing 00000000.tx.15: A catabolism is likely to involve proteases at multiple sites, both intracellular and extracellular. 

Phrase: "A catabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0543484:catabolism [Functional Concept]
   861   C0699900:Catabolism [Organism Function]
   861   C1516314:Catabolism [Physiologic Function]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "involve"

Phrase: "proteases at multiple sites,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1947941:Proteases [Enzyme]

Phrase: "both intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "and"

Phrase: "extracellular."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521119:Extracellular [Cell Component]
Processing 00000000.tx.16: Proteases acting at the site of A generation and/or within the secretory pathway may degrade the peptide intracellularly, thus limiting the amount of the peptide available for secretion. 

Phrase: "Proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "acting at the site of A generation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C2945843:Site of [Qualitative Concept]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0079411:Generation [Temporal Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
   748   C3146294:Generation [Activity]
   714   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "and/or within the secretory pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1159342:Secretory Pathway [Cell Function]
   790   C1706528:And/Or [Conceptual Entity]
   753   C1327616:Secretory [Cell Function]
   753   C1515981:And [Idea or Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "may"

Phrase: "degrade"

Phrase: "the peptide intracellularly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "thus"

Phrase: "limiting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439801:limiting [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "the amount of the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "available for secretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]
Processing 00000000.tx.17: The concentration of secreted A may be further regulated by direct degradation by extracellular proteases and by receptor-mediated endocytosis or phagocytosis followed by lysosomal degradation. 

Phrase: "The concentration of secreted A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "regulated by direct degradation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243125:degradation [Functional Concept]
   770   C0439851:Direct [Qualitative Concept]
   770   C0699900:Degradation [Organism Function]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1947931:Direct [Qualitative Concept]

Phrase: "by extracellular proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "and by receptor-mediated endocytosis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0597361:Receptor Mediated Endocytosis [Cell Function]
   760   C0014139:Endocytosis [Cell Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1515981:And [Idea or Concept]
   760   C2984285:Endocytosis [Functional Concept]

Phrase: "or"

Phrase: "phagocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031308:Phagocytosis [Cell Function]

Phrase: "followed by lysosomal degradation."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0243125:degradation [Functional Concept]
   770   C0521450:Lysosomal [Body Location or Region]
   770   C0699900:Degradation [Organism Function]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.18: Catabolism of A peptides at each of these steps would limit the accumulation of extracellular A, and disruption of this catabolism may be a risk factor for AD. 

Phrase: "Catabolism of A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1523817:peptide catabolism [Molecular Function]
   770   C0543484:catabolism [Functional Concept]
   770   C0699900:Catabolism [Organism Function]
   770   C1516314:Catabolism [Physiologic Function]

Phrase: "at each"

Phrase: "of these steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1261552:steps [Conceptual Entity]
   966 E C1704379:Step [Functional Concept]
   966 E C1705117:Step [Quantitative Concept]
   966 E C2825408:Step [Manufactured Object]

Phrase: "would"

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "the accumulation of extracellular A,"

Phrase: "and"

Phrase: "disruption of this catabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "a risk factor for AD."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0035648:Risk factor [Quantitative Concept]
   797   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   797   C0960756:factor A [Organic Chemical]
   760   C0035647:Risk [Qualitative Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.19: Additionally, the identification of enzymes that degrade A intracellularly and extracellularly may lead to development of novel therapeutics aimed at reducing A concentration by enhancing its removal. 

Phrase: "Additionally,"

Phrase: "the identification of enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "that"

Phrase: "degrade"

Phrase: "A intracellularly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "extracellularly"

Phrase: "may"

Phrase: "lead to development of novel therapeutics"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0039796:Therapeutics [Therapeutic or Preventive Procedure]
   753   C0205314:Novel [Temporal Concept]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C0679622:novel [Intellectual Product]
   753   C0723712:therapeutics [Organic Chemical,Pharmacologic Substance]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1527148:Development [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
   748   C1522647:Developmental Therapeutics [Research Activity]

Phrase: "aimed at reducing A concentration"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0086045:Concentration [Mental Process]
   760   C0392756:Reducing [Qualitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1446561:Concentration [Quantitative Concept]
   726   C1947946:Aim [Idea or Concept]
   726   C2948600:Aim [Pharmacologic Substance]
   726   C3540471:AIM [Gene or Genome]
   726   C3540472:AIM [Functional Concept]

Phrase: "by enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "its removal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]
Processing 00000000.tx.20: Recent reports suggest a role for both insulin-degrading enzyme and neprilysin (NEP) in the degradation of extracellular A (3-10). 

Phrase: "Recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role for both insulin-degrading enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "neprilysin (NEP) in the degradation of extracellular A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(3-10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: Matrix metalloproteinase-9, EC 3.4.24.15, and 2-macroglobulin complexes have also been reported to play a role in A degradation (11-13). 

Phrase: "Matrix metalloproteinase-9,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0165519:Matrix Metalloproteinase 9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MATRIX METALLOPROTEINASE 9 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "EC 3.4.24.15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "2-macroglobulin complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in A degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "(11-13"

Phrase: ")."
Processing 00000000.tx.22: In this report, we describe the identification of endothelin-converting enzyme-1 (ECE-1) as a novel A-degrading enzyme. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "describe"

Phrase: "the identification of endothelin-converting enzyme-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "(ECE-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "as a novel A-degrading enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.23: The endothelin converting enzymes are a class of type II integral membrane zinc metalloproteases (active site luminal) named for their ability to hydrolyze a family of biologically inactive intermediates, big endothelins (big ETs), exclusively at a Trp21-Val/Ile22 bond to form the potent vasoconstrictors endothelins (14). 

Phrase: "The endothelin converting enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
   827   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "a class of type II integral membrane zinc metalloproteases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0441886:Class II [Intellectual Product]
   762   C2698968:Class II [Finding]
   742   C0456387:Class [Intellectual Product]
   742   C1705943:Class [Classification]

Phrase: "(active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "luminal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0524462:Luminal [Spatial Concept]
   944 E C0031412:Phenobarbital [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "named for their ability to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0027365:named [Intellectual Product]
   760   C0085732:Ability [Organism Attribute]
   726 E C1547383:Name [Intellectual Product]

Phrase: "hydrolyze"

Phrase: "a family of biologically inactive intermediates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]

Phrase: "big endothelins (big ETs),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0053571:Endothelin, Big [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079284:Endothelins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2984383:Endothelins [Functional Concept]

Phrase: "exclusively at a Trp21-Val/Ile22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0042285:Val [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "bond"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the potent vasoconstrictors endothelins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079284:Endothelins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2984383:Endothelins [Functional Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.24: In addition to this specific cleavage event, ECE-1 has been reported to hydrolyze several biologically active peptides in vitro, including bradykinin, neurotensin, substance P, and oxidized insulin B chain by cleaving on the amino side of hydrophobic residues (15, 16). 

Phrase: "In addition to this specific cleavage event,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441471:Event [Event]

Phrase: "ECE-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "hydrolyze"

Phrase: "several biologically active peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "bradykinin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "neurotensin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "substance P,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038585:Substance P [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1420563:substance P [Gene or Genome]
   861   C0439861:Substance [Substance]

Phrase: "and"

Phrase: "oxidized insulin B chain by cleaving"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0337112:Chain [Manufactured Object]
   753   C1524075:Chain [Idea or Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "on the amino side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "of hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.25: Two different endothelin-converting enzymes have been cloned. 

Phrase: "Two different endothelin-converting enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   851   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0014442:Enzymes [Enzyme,Organic Chemical]
   804   C0014445:enzymes [Functional Concept]
   804   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "cloned."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]
Processing 00000000.tx.26: The first identified, ECE-1, is abundantly expressed in the vascular endothelial cells of all organs and is also widely expressed in nonvascular cells of tissues including lung, pancreas, testis, ovary, and adrenal gland (17-19). 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "ECE-1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "abundantly"

Phrase: "expressed in the vascular endothelial cells of all organs"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   790   C1257792:Vascular Endothelial Cells [Cell]
   764   C0225336:Endothelial Cells [Cell]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0007634:Cells [Cell]
   742   C0014257:Endothelial [Tissue]
   742   C0178784:organs [Body Part, Organ, or Organ Component]
   742   C1558950:VASCULAR [Finding]
   742   C1801960:Vascular [Qualitative Concept]
   742   C3282337:Cells [Cell]
   729   C0014261:Endothelium, Vascular [Tissue]
   712   C0005773:Blood Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   703 E C2328697:Hemal cell [Cell]
   701 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "and"

Phrase: "is"

Phrase: "also widely"

Phrase: "expressed in nonvascular cells of tissues"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C0040300:Tissues [Tissue]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1547928:Tissue [Intellectual Product]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "pancreas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "testis,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: "ovary,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "adrenal gland"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001625:Adrenal gland [Body Part, Organ, or Organ Component]
  1000   C1268989:Adrenal gland [Body Part, Organ, or Organ Component]
  1000   C1515890:GLAND, ADRENAL [Tissue]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "(17-19"

Phrase: ")."
Processing 00000000.tx.27: A comprehensive analysis examining both ECE activity and expression in human brain has not been reported. 

Phrase: "A comprehensive analysis examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332128:examining [Finding]
   812   C2004054:Examining [Activity]

Phrase: "both ECE activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "expression in human brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.28: Studies have, however, detected human ECE-1 immunoreactivity in fibers within the glial limitans and neuronal processes and cell bodies of the cerebral cortex (18). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: ","

Phrase: "however,"

Phrase: "detected human ECE-1 immunoreactivity in fibers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "within the glial limitans"

Phrase: "and"

Phrase: "neuronal processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   947   C0085103:neuron process [Cell Component]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "cell bodies of the cerebral cortex"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   783   C0599444:bodies cell [Cell Component]
   783   C1166657:cell cortex [Cell Component]
   756 E C2752549:cell body [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0242821:bodies [Human]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C1995017:Bodies [Cell Component]
   719 E C0460148:Body [Anatomical Structure]
   719 E C1268086:Body [Anatomical Structure]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.29: In rats, ECE-1 immunoreactivity has been detected in pyramidal cells of the hippocampus and in cultured primary astrocytes (20). 

Phrase: "In rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "ECE-1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "detected in pyramidal cells of the hippocampus"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   778   C0206441:Pyramidal Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   748   C0442726:Detected [Finding]
   748   C0949582:Hippocampus [Fish]
   748   C1029104:Hippocampus [Fish]
   748   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C3282337:Cells [Cell]
   745 E C2334588:Pyramidal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and in cultured primary astrocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004112:Astrocytes [Cell]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1515981:And [Idea or Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.30: Four isoforms of human ECE-1 differing only in the cytoplasmic tail are produced by a single gene located on chromosome 1(1p36) through the use of alternate promoters (17, 21-25). 

Phrase: "Four isoforms of human ECE-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "differing"

Phrase: "only in the cytoplasmic tail"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1511625:Cytoplasmic Tail [Cell Component]
   760   C0010834:Cytoplasmic [Cell Component]
   760   C0039259:Tail [Body Part, Organ, or Organ Component]
   760   C0205171:Only [Quantitative Concept]
   760   C0521449:Cytoplasmic [Body Location or Region]
   760   C1720467:Only [Intellectual Product]

Phrase: "are"

Phrase: "produced by a single gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017337:Gene [Gene or Genome]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]

Phrase: "located on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008651:Chromosome 1 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "(1p36"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520972:1p36 [Cell Component]

Phrase: ")"

Phrase: "through the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of alternate promoters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(17,"

Phrase: "21-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450347:21/25 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.31: The four isoforms cleave big ETs with equal efficiency but differ primarily in their subcellular localization and tissue distribution (24, 25). 

Phrase: "The four isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "cleave"

Phrase: "big ETs with equal efficiency"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0053571:Endothelin, Big [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0079284:Endothelins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2984383:Endothelins [Functional Concept]

Phrase: "but"

Phrase: "differ"

Phrase: "primarily in their subcellular localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "tissue distribution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040287:Tissue Distribution [Quantitative Concept]
  1000   C0220927:tissue distribution [Functional Concept]
   861   C0040300:Tissue [Tissue]
   861   C0520511:distribution [Idea or Concept]
   861   C1547928:Tissue [Intellectual Product]
   861   C1704711:Distribution [Functional Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.32: Human ECE-1a is localized predominantly to the plasma membrane (24, 25). 

Phrase: "Human ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "is"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "predominantly to the plasma membrane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.33: Human ECE-1c and ECE-1d have also been reported to be localized predominantly to the plasma membrane with additional intracellular expression detected (24, 25). 

Phrase: "Human ECE-1c"

Phrase: "and"

Phrase: "ECE-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "1d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "predominantly to the plasma membrane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "with additional intracellular expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.34: In contrast, human ECE-1b appears to be localized exclusively intracellularly. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "human ECE-1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450345:1B [Intellectual Product]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "exclusively intracellularly."
Processing 00000000.tx.35: Co-immunolocalization studies performed by Schweizer et al. 

Phrase: "Co-immunolocalization studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "performed by Schweizer et al."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1550369:Performed By [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.36: (24) on human ECE-1b-transfected CHO cells indicate the presence of this isoform in the trans-Golgi network (TGN). 

Phrase: "(24"

Phrase: ")"

Phrase: "on human ECE-1b-transfected CHO cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   895   C0427861:Human cells [Laboratory or Test Result]
   827   C0085080:CHO Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "indicate"

Phrase: "the presence of this isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the trans-Golgi network (TGN)."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]
Processing 00000000.tx.37: Azarani et al. similarly demonstrated that human ECE-1b was located in an intracellular compartment when expressed in Madin-Darby canine kidney cells (26), and Cailler et al. 

Phrase: "Azarani et al. similarly"

Phrase: "demonstrated"

Phrase: "that human ECE-1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450345:1B [Intellectual Product]

Phrase: "was"

Phrase: "located in an intracellular compartment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "when"

Phrase: "expressed in Madin-Darby canine kidney cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   897   C0598829:Madin Darby Canine Kidney Cells [Cell]
   774   C0553257:cells kidney [Cell]
   748   C0007634:Cells [Cell]
   748   C0012984:Canine, NOS [Mammal]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1280551:Canine [Mammal]
   748   C1514845:KIDNEY [Tissue]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Cailler et al."
Processing 00000000.tx.38: (27) demonstrated that a dileucine motif in the cytosolic tail of ECE-1b was probably responsible for its intracellular localization. 

Phrase: "(27"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "a dileucine motif in the cytosolic tail of ECE-1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1514562:Motif [Amino Acid Sequence]

Phrase: "was"

Phrase: "probably responsible for its intracellular localization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]
Processing 00000000.tx.39: In an endogenous ECE-1b- and ECE-1c-expressing cell line, ECV304, ECE-1 immunoreactivity was detected in intracellular Golgi-like structures as well as at the cell surface (24). 

Phrase: "In an endogenous ECE-1b-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "ECE-1c-expressing cell line,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "ECV304,"

Phrase: "ECE-1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "detected in intracellular Golgi-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0018042:Golgi [Cell Component]
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "as well as at the cell surface"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0699040:Cell surface [Cell Component]
   748   C0007634:Cell [Cell]
   748   C0205148:Surface [Spatial Concept]
   748   C0205170:Well [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3146287:Well [Manufactured Object]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.40: Bovine ECE-1b, which corresponds to human ECE-1c, is also localized predominantly on the plasma membrane (28). 

Phrase: "Bovine ECE-1b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450345:1B [Intellectual Product]

Phrase: "which"

Phrase: "corresponds to human ECE-1c,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086418:Human [Human]
   760   C1414244:ECE [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "predominantly on the plasma membrane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.41: However, in contrast to human ECE-1a, bovine ECE-1a has convincingly been shown to be constitutively targeted to the lysosome (28). 

Phrase: "However,"

Phrase: "in contrast to human ECE-1a,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "bovine ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "has"

Phrase: "convincingly"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "constitutively"

Phrase: "targeted to the lysosome"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0024369:Lysosome [Cell Component]
   770   C1521840:Targeted [Functional Concept]
   770   C2984253:Lysosome [Functional Concept]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.42: This difference between the localization of human and bovine ECE-1a may be due to the fact that the isoform-specific N-terminal region of ECE-1a is poorly conserved between the species. 

Phrase: "This difference between the localization of human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "bovine ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "may"

Phrase: "be due to the fact"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0678226:Due to [Functional Concept]
           due
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "that"

Phrase: "the isoform-specific N-terminal region of ECE-1a"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0017446:Region [Geographic Area]
   742   C0205088:Terminal [Temporal Concept]
   742   C0205147:Region [Spatial Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]

Phrase: "is"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "conserved between the species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.43: In fact, Emoto et al. 

Phrase: "In fact,"

Phrase: "Emoto et al."
Processing 00000000.tx.44: (28) identified lysosome-targeting signals in the N-terminal tail of bovine ECE-1a that are not conserved in human ECE-1a. 

Phrase: "(28"

Phrase: ")"

Phrase: "identified lysosome-targeting signals in the N-terminal tail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1710082:Signal [Phenomenon or Process]

Phrase: "of bovine ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "that"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "conserved in human ECE-1a."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086418:Human [Human]
   760   C0450344:1A [Intellectual Product]
   760   C1414244:ECE [Gene or Genome]
   760   C1553633:1a [Medical Device]
Processing 00000000.tx.45: ECE-2 is a homologous enzyme with catalytic activity similar to that of ECE-1. 

Phrase: "ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "is"

Phrase: "a homologous enzyme with catalytic activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0243102:enzyme activity [Molecular Function]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "similar to that of ECE-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.46: Bovine ECE-2 has been cloned and is encoded by a separate gene from ECE-1 (29). 

Phrase: "Bovine ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1414244:ECE [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "is"

Phrase: "encoded by a separate gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017337:Gene [Gene or Genome]
   760   C0443299:Separate [Spatial Concept]
   760   C0679058:encoded [Mental Process]
   760   C2700640:Encoded [Activity]

Phrase: "from ECE-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.47: The sequence and chromosomal location of the human ECE-2 gene have not been reported. 

Phrase: "The sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "chromosomal location of the human ECE-2 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0450429:Location [Spatial Concept]
   744   C1515974:Location [Body Location or Region]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.48: However, Nagase et al. 

Phrase: "However,"

Phrase: "Nagase et al."
Processing 00000000.tx.49: (30) recently reported the cloning of an unidentified human brain cDNA, KIAA0604, that shares 93% identity with the bovine ECE-2 gene and is located on human chromosome 3.

Phrase: "(30"

Phrase: ")"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "the cloning of an unidentified human brain cDNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0525049:Human Cloning [Research Activity]
   744   C0009015:Cloning [Research Activity]

Phrase: "KIAA0604,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421917:KIAA0604 [Gene or Genome]

Phrase: "that"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "93% identity with the bovine ECE-2 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0424215:Identity [Mental Process]
   744   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "is"

Phrase: "located on human chromosome 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0008643:Human Chromosome [Cell Component]
   806   C0008666:Chromosome 3 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C0086418:Human [Human]
Processing 00000000.tx.50: Given the similarity to bovine ECE-2, this cDNA probably represents human ECE-2. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the similarity to bovine ECE-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similarity [Qualitative Concept]

Phrase: "this cDNA probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "human ECE-2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1414244:ECE [Gene or Genome]
Processing 00000000.tx.51: ECE-2 is localized intracellularly and has an acidic pH optimum (29). 

Phrase: "ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "is"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "intracellularly"

Phrase: "and"

Phrase: "has"

Phrase: "an acidic pH optimum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2698651:Optimum [Qualitative Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.52: Immunocytochemical analysis of endogenous ECE-2 in HUVECs revealed a punctate pattern of staining consistent with expression of ECE-2 in acidic intracellular vesicles of the constitutive secretory pathway (31). 

Phrase: "Immunocytochemical analysis of endogenous ECE-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in HUVECs"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a punctate pattern of staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C0449778:Pattern of staining [Spatial Concept]
   760   C0449774:Pattern [Spatial Concept]

Phrase: "consistent with expression of ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in acidic intracellular vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "of the constitutive secretory pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159343:constitutive secretory pathway [Cell Function]
   901   C1159342:Secretory Pathway [Cell Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.53: Northern blot analysis of bovine tissues revealed that ECE-2 is most abundantly expressed in neural tissues including cerebral cortex, cerebellum, and adrenal medulla, with low level expression detected in many other tissues (29). 

Phrase: "Northern blot analysis of bovine tissues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005861:Northern blot analysis [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "is"

Phrase: "most abundantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "expressed in neural tissues"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   833   C0027757:neural tissues [Tissue]
       E   NERVE
   816 E C1762608:Neural tissue [Tissue]
   770   C0040300:Tissues [Tissue]
   770   C0599851:Neural [Functional Concept]
   737 E C1547928:Tissue [Intellectual Product]
   715 E C0027740:Nerve [Tissue]
   715 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "and"

Phrase: "adrenal medulla,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001629:Adrenal Medulla [Body Part, Organ, or Organ Component]
   861   C0025148:medulla [Body Part, Organ, or Organ Component]
   861   C1269575:Medulla [Body Part, Organ, or Organ Component]
   861   C1305694:Medulla [Body Part, Organ, or Organ Component]
   861   C2698825:Medulla [Plant]

Phrase: "with low level expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "detected in many"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "other tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.54: In mouse brain, ECE-2 is expressed in heterogeneous populations of neurons in the thalamus, hypothalamus, amygdala, dentate gyrus, and CA3 (32). 

Phrase: "In mouse brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "is"

Phrase: "expressed in heterogeneous populations of neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0019409:Heterogeneous [Qualitative Concept]
   753   C0027882:Neurons [Cell]
   753   C0032659:Population [Quantitative Concept]
   753   C1257890:Population [Population Group]
   748   C0086833:Population Heterogeneity [Group Attribute]

Phrase: "in the thalamus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039729:Thalamus [Body Part, Organ, or Organ Component]
  1000   C1269896:Thalamus [Body Part, Organ, or Organ Component]

Phrase: "hypothalamus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
  1000   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "amygdala,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002708:Amygdala [Body Part, Organ, or Organ Component]

Phrase: "dentate gyrus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0152314:Dentate Gyrus [Body Part, Organ, or Organ Component]
  1000   C1281026:Dentate gyrus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "CA3"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.55: Like ECE-1, ECE-2 cleaves big ET-1 most efficiently among the three big ETs (24, 29). 

Phrase: "Like ECE-1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "cleaves"

Phrase: "big ET-1 most efficiently among the three big ETs"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0053571:Big Endothelin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Endothelin, Big
   760   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Endothelin-1
   757   C1413561:BIG-1 [Gene or Genome]
   741   C1414260:ENDOTHELIN 1 [Gene or Genome]
   739   C0079284:Endothelins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205449:Three [Quantitative Concept]
   739   C0549177:Big [Quantitative Concept]
   739   C2984383:Endothelins [Functional Concept]

Phrase: "(24,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.56: Another member of the ECE family, ECE-3, has recently been purified from bovine iris microsomes and is highly specific for the conversion of big ET-3 (33). 

Phrase: "Another member of the ECE family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0086282:Family member [Family Group]
   783   C1611821:Family Member [Intellectual Product]
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "ECE-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1414244:ECE [Gene or Genome]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "purified from bovine iris microsomes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007452:Bovine [Mammal]
   760   C0022077:Iris [Body Part, Organ, or Organ Component]
   760   C0026029:Microsomes [Cell Component]
   760   C1001362:Iris [Plant]
   760   C1140701:bovine [Mammal]
   760   C1278891:Iris [Body Part, Organ, or Organ Component]
   760   C1998793:Purified [Functional Concept]
   760   C2314880:Iris [Eukaryote]

Phrase: "and"

Phrase: "is"

Phrase: "highly specific for the conversion of big ET-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205369:Specific [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.57: The enzyme responsible for this activity has not yet been cloned. 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for this activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "cloned."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]
Processing 00000000.tx.58: The role that ECE may play in Alzheimer's disease has not been previously explored. 

Phrase: "The role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "that ECE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "may"

Phrase: "play in Alzheimer's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0032214:Play [Daily or Recreational Activity]
   770   C0600138:play [Finding]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "previously"

Phrase: "explored."
Processing 00000000.tx.59: Here we present both pharmacological and biochemical evidence that ECE-1 can hydrolyze A both in vitro and in vivo. 

Phrase: "Here"

Phrase: "we"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "both pharmacological"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacological [Biomedical Occupation or Discipline]
  1000   C0205464:pharmacological [Functional Concept]
   928 E C1524059:pharmacology [Functional Concept]

Phrase: "and"

Phrase: "biochemical evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that ECE-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "can"

Phrase: "hydrolyze"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.60: These data indicate a potential role for this enzyme family in A catabolism.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "a potential role for this enzyme family"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0680074:family role [Social Behavior]
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in A catabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0543484:catabolism [Functional Concept]
   861   C0699900:Catabolism [Organism Function]
   861   C1516314:Catabolism [Physiologic Function]
Processing 00000000.tx.61: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Analysis of A Concentration by Sandwich ELISA-- Human A was measured by sandwich ELISA as previously described (34), using the BAN50/BA27 and BAN50/BC05 antibody systems (Takeda) to detect A40 and A42, respectively. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Analysis of A Concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "by Sandwich ELISA-- Human A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "measured by sandwich ELISA"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0014441:ELISA [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BAN50/BA27"

Phrase: "and"

Phrase: "BAN50/BC05 antibody systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "(Takeda"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "A40"

Phrase: "and"

Phrase: "A42,"

Phrase: "respectively."
Processing 00000000.tx.62: Hamster A derived from CHO cells was measured using the BNT77/BA27 and BNT77/BC05 antibody systems. 

Phrase: "Hamster A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "derived from CHO cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BNT77/BA27"

Phrase: "and"

Phrase: "BNT77/BC05 antibody systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.63: The BNT77 antibody (Takeda) was raised against amino acids 11-28 and thus may recognize amino-terminally modified or truncated peptides (35). 

Phrase: "The BNT77 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Takeda"

Phrase: ")"

Phrase: "was"

Phrase: "raised against amino acids 11-28"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C0442818:Raised [Quantitative Concept]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "thus"

Phrase: "may"

Phrase: "recognize"

Phrase: "amino-terminally"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "or"

Phrase: "truncated peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.64: A concentration was determined by comparing values obtained for samples with those obtained for synthetic A40 and A42 standards (Bachem). 

Phrase: "A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined by comparing values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]
   737   C1707455:Compare [Activity]

Phrase: "obtained for samples"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   841   C1277697:Sample obtained [Finding]
   790   C1301820:Obtained [Functional Concept]
   756   C0370003:Sample [Substance]
   756 E C1706701:Obtain [Activity]
   756   C2347026:Sample [Conceptual Entity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with those"

Phrase: "obtained for synthetic A40"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   770   C1883254:synthetic [Activity]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "A42 standards"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0038137:standards [Intellectual Product]
   861   C0175675:Standards [Qualitative Concept]
   827 E C1442989:Standard [Qualitative Concept]
   827 E C2828392:Standard [Intellectual Product]

Phrase: "(Bachem"

Phrase: ")."
Processing 00000000.tx.65: Cloning of Human ECE-1a and ECE-1b-- ECE-1a and ECE-1b were cloned by reverse transcription-polymerase chain reaction in two fragments (joined by a unique PvuII site) from human umbilical vein endothelial cell (HUVEC, ATCC) RNA using the following primers (restriction sites underlined): 1) ECE-1a forward, 5'-CAGGAATTCGCCACCATGCCTCTCCAGGGCCTGGGCCTGC-3'; 

Phrase: "Cloning of Human ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0525049:Human Cloning [Research Activity]
   760   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "ECE-1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "--"

Phrase: "ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "ECE-1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "were"

Phrase: "cloned by reverse transcription-polymerase chain reaction"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   897   C0814037:reverse transcription polymerase chain reaction [Genetic Function]
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0035380:Reverse Transcription [Genetic Function]
   748   C0009013:cloned [Cell]
   748   C0040649:Transcription [Genetic Function]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524075:Chain [Idea or Concept]
   748   C1555029:Reverse [Idea or Concept]
   714 E C1522642:Clone [Tissue]

Phrase: "in two fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "joined by a unique PvuII site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1710548:Unique [Qualitative Concept]
   753   C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "from human umbilical vein endothelial cell"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   897   C0427861:human cell [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial cell [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cell [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1269647:Cell [Cell]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "(HUVEC,"

Phrase: "ATCC) RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(restriction sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   966   C1882940:Restriction Site [Nucleotide Sequence]
   861   C0205145:Sites [Spatial Concept]
   861   C0443288:Restriction [Functional Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "underlined"

Phrase: ")"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "ECE-1a forward, 5'-CAGGAATTCGCCACCATGCCTCTCCAGGGCCTGGGCCTGC-3'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0439780:Forward [Spatial Concept]
   799   C0450344:1A [Intellectual Product]
   799   C1414244:ECE [Gene or Genome]
   799   C1553633:1a [Medical Device]

Phrase: ";"
Processing 00000000.tx.66: 2) ECE-1b forward, 5'-CAGGAATTCGCCACCATGCGGGGCGTGTGGCCGCCC-3'; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "ECE-1b forward, 5'-CAGGAATTCGCCACCATGCGGGGCGTGTGGCCGCCC-3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0439780:Forward [Spatial Concept]
   799   C0450345:1B [Intellectual Product]
   799   C1414244:ECE [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.67: 3) ECE-1 PvuII reverse, 5'-CAGCAGCTTCCCCAGCTGGACC-3'; 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "ECE-1 PvuII reverse, 5'-CAGCAGCTTCCCCAGCTGGACC-3'"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C1555029:Reverse [Idea or Concept]
   712 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.68: 4) ECE-1 PvuII forward, 5'-GGTCCAGCTGGGGAAGCTGCTG-3'; 

Phrase: "4"

Phrase: ")"

Phrase: "ECE-1 PvuII forward, 5'-GGTCCAGCTGGGGAAGCTGCTG-3'"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0439780:Forward [Spatial Concept]
   712 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.69: and 5) ECE-1 reverse, 5'-GCTCTAGATTACCAGACTTCGCACTTGTGAGGCGGG-3'. 

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "ECE-1 reverse, 5'-GCTCTAGATTACCAGACTTCGCACTTGTGAGGCGGG-3'."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C1555029:Reverse [Idea or Concept]
   716 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.70: RNA was prepared from HUVEC cells using the Qiagen RNeasy miniprep kit and was reverse transcribed using Superscript II reverse transcriptase and an oligo(dT) primer (Roche Molecular Biochemicals). 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared from HUVEC cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C3179121:HUVEC Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Qiagen RNeasy miniprep kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "and"

Phrase: "was"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Superscript II reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1555029:Reverse [Idea or Concept]
   812   C2257077:transcriptase [Genetic Function]

Phrase: "and"

Phrase: "an oligo(dT) primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0069417:oligo (dT) [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")."
Processing 00000000.tx.71: The 5' fragment of ECE-1a was amplified using primers 1and 3.

Phrase: "The 5' fragment of ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 1and 3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.72: The 5' fragment of ECE-1b was amplified using primers 2and 3.

Phrase: "The 5' fragment of ECE-1b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 2and 3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.73: The 3' fragment of ECE-1, which is common to both isoforms, was amplified using primers 4and 5.Pfu polymerase (Stratagene) was used for all amplifications. 

Phrase: "The 3' fragment of ECE-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "common to both isoforms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "was"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 4and 5.Pfu polymerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0136227:Pfu polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "was"

Phrase: "used for all amplifications."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1517480:Amplification [Molecular Biology Research Technique]
   737   C1521871:Amplification [Phenomenon or Process]
   737   C1705759:Amplification [Cell or Molecular Dysfunction]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.74: The 5' and 3' fragments were ligated together at the PvuII site and subcloned into pcDNA3 (Invitrogen) using primer-encoded EcoRI and XbaI sites. 

Phrase: "The 5'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3' fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "ligated"

Phrase: "together at the PvuII site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C1883357:Together [Qualitative Concept]
   760   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "subcloned into pcDNA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C1883178:Subclone [Cell]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primer-encoded EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "XbaI sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.75: The sequences of the constructs were confirmed by dideoxy sequencing by the Mayo Molecular Biology Core Facility. 

Phrase: "The sequences of the constructs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "confirmed by dideoxy sequencing"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0750484:Confirmed [Idea or Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "by the Mayo Molecular Biology Core Facility."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1511521:Core Facility [Health Care Related Organization,Manufactured Object]
   804   C1547538:Facility [Idea or Concept]
Processing 00000000.tx.76: Cell Culture and Transfections-- Unless otherwise noted, cell culture reagents were purchased from Life Technologies, Inc., and cell lines were purchased from ATCC. 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "-"

Phrase: "-"

Phrase: "Unless"

Phrase: "otherwise"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "cell culture reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "purchased from Life Technologies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]
   770   C0869011:purchased [Activity]

Phrase: "Inc.,"

Phrase: "and"

Phrase: "cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "purchased from ATCC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0598079:ATCC [Intellectual Product]
   790   C0869011:purchased [Activity]
Processing 00000000.tx.77: HUVECs were cultured in Kaighn's F12K medium (ATCC) supplemented with 10% fetal bovine serum, 0.1mg/ml heparin, 0.03mg/ml endothelial cell growth supplement (Sigma), 100units/ml penicillin, and 100g/ml streptomycin. 

Phrase: "HUVECs"

Phrase: "were"

Phrase: "cultured in Kaighn's F12K medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   781   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "(ATCC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598079:ATCC [Intellectual Product]

Phrase: "supplemented with 10% fetal bovine serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "0.1mg/ml heparin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "0.03mg/ml endothelial cell growth supplement"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   818   C0007595:Cell Growth [Cell Function]
   818   C0225336:Endothelial cell [Cell]
   795   C0007634:Cell [Cell]
   795   C0014257:Endothelial [Tissue]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0220844:growth [Physiologic Function]
   795   C0242295:Supplement [Food]
   795   C1269647:Cell [Cell]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C1704653:Cell [Medical Device]
   795   C1947943:Supplement [Intellectual Product]
   795   C1948049:Cell [Spatial Concept]
   795   C2348609:Supplement [Functional Concept]
   795   C2911660:Growth [Activity]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "100units/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "100g/ml streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.78: CHO cells were cultured in Ham's F-12 medium (BioWhittaker) supplemented with 10% newborn calf serum, 100units/ml penicillin, and 100g/ml streptomycin. 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in Ham's F-12 medium"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0439133:(f) [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1553038:[f] [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "(BioWhittaker"

Phrase: ")"

Phrase: "supplemented with 10% newborn calf serum,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0021289:Newborn [Age Group]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2239178:Newborn, NOS [Finding]
   753   C2939425:Newborn, NOS [Temporal Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "100units/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "100g/ml streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.79: H4 cells (human neuroglioma origin) were cultured in Opti-MEM supplemented with 10% fetal bovine serum, 100units/ml penicillin, and 100g/ml streptomycin. 

Phrase: "H4 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(human neuroglioma origin"
Meta Candidates (Total=17; Excluded=13; Pruned=0; Remaining=4)
   913   C0086418:Human - origin [Human]
   827   C0079946:origin [Classification]
   827   C0439659:Origin [Temporal Concept]
   827   C1550512:origin [Intellectual Product]
   771 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   771 E C0314603:Genetic [Functional Concept]
   755 E C0205313:Original [Idea or Concept]
   755 E C2347409:Original [Occupational Activity]
   743 E C0005615:Birth [Organism Function]
   743 E C0035150:Reproduction [Organism Function]
   743 E C1550722:birth [Idea or Concept]
   743 E C3245487:birth [Intellectual Product]
   727 E C0454729:Natal [Geographic Area]
   727 E C0559522:Genital [Body System]
   727 E C0598240:originality [Mental Process]
   727 E C1546649:Genital [Intellectual Product]
   727 E C1550642:Genital [Body Substance]

Phrase: ")"

Phrase: "were"

Phrase: "cultured in Opti-MEM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with 10% fetal bovine serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "100units/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "100g/ml streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.80: For passaging of cells prior to experiments in which ECE activity was to be measured, a highly purified trypsin (Sigma T-7418) solution was used (17). 

Phrase: "For passaging"

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "prior to experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "in which ECE activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "a highly purified trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(Sigma T-7418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.81: CHO cells were transfected with FuGENE 6(Roche Molecular Biochemicals) according to the directions of the manufacturer. 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with FuGENE 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0916399:FuGene 6 [Lipid]
           FuGene

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "according to the directions"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0439755:Directions [Spatial Concept]
   966 E C0449738:Direction [Spatial Concept]
   893 E C1707761:Directionality [Functional Concept]
   893 E C3274524:Directionality [Functional Concept]

Phrase: "of the manufacturer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0947322:Manufacturer [Intellectual Product]
  1000   C1705426:Manufacturer [Population Group]
Processing 00000000.tx.82: Stable lines were generated by selecting pcDNA3-transfected cells (ECE-1a and ECE-1b) with 1mg/ml Geneticin and pSecTag-transfected cells (solECE-1) with 0.8mg/ml Zeocin (Invitrogen). 

Phrase: "Stable lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "generated by selecting pcDNA3-transfected cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C3146294:Generated [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719   C1707391:Select [Activity]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "ECE-1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "with 1mg/ml Geneticin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0119053:Geneticin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "pSecTag-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(solECE-1"

Phrase: ")"

Phrase: "with 0.8mg/ml Zeocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0537913:Zeocin [Amino Acid, Peptide, or Protein]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.83: Measurement of ECE Activity in Cell Membrane Fractions-- Cell membrane fractions were prepared as described by Xu et al. 

Phrase: "Measurement of ECE Activity in Cell Membrane Fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0242485:Measurement [Functional Concept]

Phrase: "--"

Phrase: "Cell membrane fractions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0805525:Cell fractions [Cell Component]
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
   734   C0007603:Cell Membrane [Cell Component]
   734   C3161472:Cell Membrane [Cell Component]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described by Xu et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.84: (17). 

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.85: Protein concentration was determined by BCA assay (Pierce) in membranes resuspended in buffer B (20mM Tris-HCl, pH 7.4,containing 250mM sucrose) or in membranes solubilized in buffer B containing 2.5% C12E10 (polyoxyethylene-10-lauryl ether, Sigma). 

Phrase: "Protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined by BCA assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1332420:bca [Gene or Genome]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "in membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "resuspended in buffer B (20mM Tris-HCl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "250mM sucrose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "or in membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "solubilized in buffer B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2.5% C12E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1313055:C12E10 [Organic Chemical]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "(polyoxyethylene-10-lauryl ether,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0137840:polyoxyethylene lauryl ether [Organic Chemical,Pharmacologic Substance]
   902   C0770623:POLYOXYETHYLENE ETHER [Organic Chemical,Pharmacologic Substance]
   812   C0014994:Ether [Organic Chemical,Pharmacologic Substance]
   812   C0014996:Ether, NOS [Organic Chemical,Pharmacologic Substance]
   812   C1161324:ether [Organic Chemical,Pharmacologic Substance]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.86: For measurement of ECE activity, membrane fractions (10-50 g of protein) were incubated for 30min at 37C with 0.1M big ET-1 (1-38) (American Peptide Co.) in 0.1M sodium phosphate buffer (pH 6.8) containing 0.5M NaCl, 1mM phenylmethylsulfonyl fluoride (PMSF), 100M leupeptin, and 20M pepstatin. 

Phrase: "For measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of ECE activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "membrane fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "(10-50 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "incubated for 30min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "with 0.1M big ET-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C1413561:BIG-1 [Gene or Genome]
   840   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0549177:Big [Quantitative Concept]

Phrase: "(1-38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(American Peptide Co.) in 0.1M sodium phosphate buffer"

Phrase: "(pH 6.8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM phenylmethylsulfonyl fluoride (PMSF),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "20M pepstatin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.87: Duplicate reactions were carried out in the presence of phosphoramidon (100M). 

Phrase: "Duplicate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205173:Duplicate [Functional Concept]
  1000   C3539942:Duplicate [Intellectual Product]

Phrase: "reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in the presence of phosphoramidon"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   791   C0442722:Present + out of +++ [Finding]
   791   C0442723:Present ++ out of +++ [Finding]
   791   C0442724:Present +++ out of +++ [Finding]
   791   C0442725:Present ++++ out of ++++ [Finding]
   791   C2724205:Present +++ out of ++++ [Finding]
   791   C2724207:Present + out of ++++ [Finding]
   791   C2724208:Present ++ out of ++++ [Finding]
   753   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]

Phrase: "(100M"

Phrase: ")."
Processing 00000000.tx.88: Reactions were stopped by the addition of EDTA (5mM), and mature ET-1-(1-21) peptide was quantitated by sandwich ELISA (Amersham Pharmacia Biotech). 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped by the addition of EDTA (5mM"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   748   C1272691:stopped [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   714 E C1947925:Stop [Activity]
   714 E C2746065:Stop [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mature ET-1-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "quantitated by sandwich ELISA (Amersham Pharmacia Biotech"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0014441:ELISA [Laboratory Procedure]
   748   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.89: Treatment of Cells with Metalloprotease Inhibitors-- Cells were passaged into six-well plates 1day prior to treatment and were utilized at confluence. 

Phrase: "Treatment of Cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with Metalloprotease Inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1152589:metalloprotease inhibitor [Molecular Function]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "passaged into six-well"

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "1day prior to treatment"

Phrase: "and"

Phrase: "were"

Phrase: "utilized at confluence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205200:Confluent [Qualitative Concept]
Processing 00000000.tx.90: Triplicate wells were washed twice with Hanks' balanced salt solution and then incubated for 17-24 h with 1ml of growth medium containing phosphoramidon (Roche Molecular Biochemicals), thiorphan (Sigma), or captopril (Sigma) at the indicated concentrations. 

Phrase: "Triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with Hanks' balanced salt solution"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   833   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0205415:Balanced [Functional Concept]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]
   719   C1423529:HANK [Gene or Genome]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 17-24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 1ml"

Phrase: "of growth medium containing phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "thiorphan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "captopril"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "at the indicated concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.91: Control cells were incubated in growth medium containing an equal concentration of vehicle (phosphate-buffered saline). 

Phrase: "Control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in growth medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an equal concentration of vehicle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "(phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.92: After treatment, the culture medium was harvested and spun at 14,000g, and the supernatant was analyzed for A40 and A42 by sandwich ELISA as described and for secreted APP by Western blot. 

Phrase: "After treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "spun at 14,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1446863:Spun [Laboratory Procedure]
   756 E C1415347:SPIN [Gene or Genome]
   756 E C1823107:SPIN [Gene or Genome]

Phrase: "000g,"

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "analyzed for A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "A42 by sandwich ELISA"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "and for secreted APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1327616:Secreted [Cell Function]
   753   C1515981:And [Idea or Concept]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "by Western blot."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.93: To assess cellular toxicity of the compounds, MTS assays (CellTiter 96, Promega), which measure the conversion of MTS to formazan by metabolically active cells, were performed on the cells after the indicated time points. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "cellular toxicity of the compounds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "MTS assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C2986858:MTS Assay [Research Activity]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(CellTiter 96,"

Phrase: "Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the conversion of MTS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439836:Conversion [Functional Concept]

Phrase: "to formazan"

Phrase: "by metabolically active cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "performed on the cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0884358:Performed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "after the indicated time points."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.94: Culture medium was subjected to electrophoresis on 10-20% Tricine gels (Novex) and was subsequently transferred to Immobilon P (Millipore Corp.). 

Phrase: "Culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "subjected to electrophoresis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "on 10-20% Tricine gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: "(Novex"

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "subsequently"

Phrase: "transferred to Immobilon P (Millipore Corp."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0123400:Immobilon P [Organic Chemical]
   753   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   753   C0348011:transferred [Functional Concept]
   753   C0683758:Corp. [Organization]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: ")."
Processing 00000000.tx.95: Western blots on CHO cells were performed using 22C11 antibody (Roche Molecular Biochemicals) to detect secreted APP. 

Phrase: "Western blots on CHO cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "22C11 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "secreted APP."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1327616:Secreted [Cell Function]
   812   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.96: Bound antibody was detected by incubation with the appropriate horseradish peroxidase-linked secondary antibody (Amersham Pharmacia Biotech) followed by ECL Western blotting reagents (Amersham Pharmacia Biotech) and exposure to x-ray film. 

Phrase: "Bound antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "detected by incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with the appropriate horseradish peroxidase-linked secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "followed by ECL Western blotting reagents"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0332283:Followed by [Temporal Concept]
           followed
   773 E C0949466:Western Blot [Laboratory Procedure]
   753   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   753   C1332684:ECL [Gene or Genome]
   753   C1705493:Western [Spatial Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "and"

Phrase: "exposure to x-ray film."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0868115:exposure x ray [Injury or Poisoning]
   806   C0332157:Exposure to [Clinical Attribute]
           Exposure
   760   C0274281:Exposure, NOS [Injury or Poisoning]
Processing 00000000.tx.97: Expression and Purification of Soluble ECE-1-- A construct encoding a soluble form of ECE-1 similar to that described by Ahn et al. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Purification of Soluble ECE-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243114:purification [Functional Concept]
   760   C1998793:Purification [Functional Concept]

Phrase: "--"

Phrase: "A construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a soluble form of ECE-1 similar"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "to that"

Phrase: "described by Ahn et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.98: (36) and Korth et al. 

Phrase: "(36"

Phrase: ")"

Phrase: "and"

Phrase: "Korth et al."
Processing 00000000.tx.99: (37) was generated by amplifying the extracellular domain of ECE-1a using the following primers: SolECE-1 forward, 5'-GAGAGAATTCTCAGTACCAGACAAGATCCCC-3'; 

Phrase: "(37"

Phrase: ")"

Phrase: "was"

Phrase: "generated by amplifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "the extracellular domain of ECE-1a"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1517050:Extracellular Domain [Spatial Concept]
   753   C0521119:Extracellular [Cell Component]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "SolECE-1 forward, 5'-GAGAGAATTCTCAGTACCAGACAAGATCCCC-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439780:Forward [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.100: SolECE-1 reverse, 5'-CGTTTTCCTTTTGCGGCCGCCCAGACTTCGCACTTGTGAGG-3'. 

Phrase: "SolECE-1 reverse, 5'-CGTTTTCCTTTTGCGGCCGCCCAGACTTCGCACTTGTGAGG-3'."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.101: The solECE-1 construct was subcloned using primer-encoded EcoRI and NotI sites into pSecTag2B (Invitrogen), which incorporates a leader sequence onto the N terminus of the protein for secretion by mammalian cells and sequential c-Myc and His6 tags at the C terminus to facilitate detection and purification. 

Phrase: "The solECE-1 construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "subcloned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1883178:Subclone [Cell]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primer-encoded EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "NotI sites into pSecTag2B"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "incorporates"

Phrase: "a leader sequence onto the N terminus of the protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0037081:Leader Sequence [Amino Acid Sequence]
   757   C0002518:Protein Sequence [Amino Acid Sequence]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C1519249:Sequence [Functional Concept]

Phrase: "for secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "by mammalian cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "sequential c-Myc"

Phrase: "and"

Phrase: "His6 tags at the C terminus to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   762   C1505208:his6 tag [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C1139855:tags [Medical Device]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "facilitate"

Phrase: "detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "purification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]
Processing 00000000.tx.102: The sequence of the construct was confirmed by dideoxy sequencing by the Mayo Molecular Biology Core Facility. 

Phrase: "The sequence of the construct"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "confirmed by dideoxy sequencing"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0750484:Confirmed [Idea or Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "by the Mayo Molecular Biology Core Facility."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1511521:Core Facility [Health Care Related Organization,Manufactured Object]
   804   C1547538:Facility [Idea or Concept]
Processing 00000000.tx.103: A stable solECE-1 secreting cell line was generated by transfecting the construct into CHO cells and selecting with Zeocin (0.8mg/ml). 

Phrase: "A stable solECE-1 secreting cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0598091:stable cell line [Cell]
   818   C0007600:Cell Line [Cell]
   795   C0007634:Cell [Cell]
   795   C0205132:Line [Spatial Concept]
   795   C1269647:Cell [Cell]
   795   C1550648:Line [Substance]
   795   C1552960:Line [Quantitative Concept]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "generated by transfecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "the construct into CHO cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "selecting with Zeocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707391:Select [Activity]

Phrase: "(0.8mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.104: At confluence, the cells were washed twice with Hanks' balanced salt solution and then cultured for 48h in serum-free medium (CHO-S-SFM II) containing 1mM sodium butyrate. 

Phrase: "At confluence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205200:Confluent [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with Hanks' balanced salt solution"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   833   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0205415:Balanced [Functional Concept]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]
   719   C1423529:HANK [Gene or Genome]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cultured for 48h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1442464:48H [Temporal Concept]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "in serum-free medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0009458:Medium [Intellectual Product]
   827   C0229671:Serum [Body Substance]
   827   C0332296:free [Functional Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1705217:Medium [Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   827   C3244283:medium [Intellectual Product]

Phrase: "(CHO-S-SFM II"

Phrase: ")"

Phrase: "containing 1mM sodium butyrate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0142812:Sodium Butyrate [Lipid,Pharmacologic Substance]
   812   C0006521:butyrate [Lipid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0220802:butyrate [Lipid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.105: Conditioned medium was filtered through a 0.2-m filter and dialyzed against binding buffer, 0.05M sodium phosphate, pH 8.0,0.3M NaCl, prior to purification via the C-terminal His6 tag using Ni2+-nitrilotriacetic acid-agarose (Qiagen). 

Phrase: "Conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "filtered through a 0.2-m filter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   714   C0180860:Filter [Manufactured Object]
   714   C0581406:Filter [Medical Device]
   714   C1522664:Filter [Intellectual Product]
   714   C1704449:Filter [Conceptual Entity]
   714   C1704684:Filter [Medical Device]
   714   C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "dialyzed against binding buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "0.05M sodium phosphate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.3M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "prior to purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "via the C-terminal His6 tag"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1505208:his6 tag [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   812   C0037293:Tag [Neoplastic Process]
   812   C0181496:Tag [Manufactured Object]
   812   C1710492:TAG [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Ni2+-nitrilotriacetic acid-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036681:Agarose [Carbohydrate]

Phrase: "(Qiagen"

Phrase: ")."
Processing 00000000.tx.106: Bound protein was eluted from the Ni2+-nitrilotriacetic acid-agarose with binding buffer containing 100mM imidazole. 

Phrase: "Bound protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "eluted from the Ni2+-nitrilotriacetic acid-agarose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0028132:Nitrilotriacetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0036681:Agarose [Carbohydrate]
   748   C0202406:Acid [Laboratory Procedure]
   748   C2347351:Ni2+ [Element, Ion, or Isotope]

Phrase: "with binding buffer containing 100mM imidazole."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   804   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.107: The solECE-1 was initially estimated to be 25% pure, as assessed by SDS-polyacrylamide gel electrophoresis and Coomassie staining (data not shown). 

Phrase: "The solECE-1"

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "25% pure,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2247561:PurE [Molecular Function]
   789 E C1882508:Purity [Quantitative Concept]

Phrase: "as"

Phrase: "assessed by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1516048:Assessed [Activity]

Phrase: "and"

Phrase: "Coomassie staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: The concentration of active solECE-1 was further estimated by determining the second order rate of big ET-1 hydrolysis and dividing this rate by the published kcat/Km. 

Phrase: "The concentration of active solECE-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "estimated by determining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750572:Estimated [Quantitative Concept]

Phrase: "the second order rate of big ET-1 hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:dividing [Functional Concept]

Phrase: "this rate by the published kcat/Km."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.109: Specifically, big ET-1 (0.1M) was reacted at 37C with solECE-1 in 50mM MES, pH 6.5,containing 100mM NaCl, 0.05% bovine serum albumin, 1mM PMSF, 100M leupeptin, and 20M pepstatin. 

Phrase: "Specifically,"

Phrase: "big ET-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1413561:BIG-1 [Gene or Genome]
   901   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0549177:Big [Quantitative Concept]

Phrase: "(0.1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "reacted at 37C"

Phrase: "with solECE-1"

Phrase: "in 50mM MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0265215:MES [Congenital Abnormality]
   861   C1417092:MES [Gene or Genome]

Phrase: "pH 6.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.05% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "1mM PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "20M pepstatin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.110: The reactions were stopped by the addition of EDTA (5mM), and mature ET-1 peptide was measured by sandwich ELISA (Amersham Pharmacia Biotech). 

Phrase: "The reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped by the addition of EDTA (5mM"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   748   C1272691:stopped [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   714 E C1947925:Stop [Activity]
   714 E C2746065:Stop [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mature ET-1 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "measured by sandwich ELISA (Amersham Pharmacia Biotech"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0014441:ELISA [Laboratory Procedure]
   748   C0331955:Pharmacia [Health Care Related Organization]
   748   C0444706:Measured [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: ")."
Processing 00000000.tx.111: The second order rate was determined as the apparent rate constant k from Equation 1, where y is the fraction of substrate hydrolyzed and t is the time. 

Phrase: "The second order rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "determined as the apparent rate constant k"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C2986811:Rate Constant [Quantitative Concept]
   748   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0750489:apparent [Idea or Concept]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
   748   C1547014:*Constant [Quantitative Concept]
   748   C1708601:K' [Quantitative Concept]
   748   C1948059:Constant [Qualitative Concept]

Phrase: "from Equation 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:Equation [Conceptual Entity]

Phrase: "where y"

Phrase: "is"

Phrase: "the fraction of substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1264633:Fraction of [Quantitative Concept]
           Fraction
   770   C1554103:Fraction [Idea or Concept]

Phrase: "hydrolyzed"

Phrase: "and"

Phrase: "t"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "is"

Phrase: "the time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.112: Since k=kcat/Km[E], the calculated k was then divided by the reported kcat/Km for big ET-1 hydrolysis by solECE-1 (2.52104 M1 s1 at pH 6.5) (16) to determine the active enzyme concentration. 

Phrase: "Since"

Phrase: "k=kcat/Km[E"

Phrase: "],"

Phrase: "the calculated k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "divided by the reported kcat/Km"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C1709908:Reported By [Group]
   753   C0332849:Divided [Functional Concept]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]

Phrase: "for big ET-1 hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020291:Hydrolysis [Natural Phenomenon or Process]
   708   C1413561:BIG-1 [Gene or Genome]

Phrase: "by solECE-1"

Phrase: "(2.52104 M1 s1 at pH 6.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C1414297:S1-5 [Gene or Genome]

Phrase: ")"

Phrase: "(16"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the active enzyme concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.113: The active enzyme concentration was estimated by this method throughout this report and was ~30-fold lower than that originally estimated from the protein concentration and Coomassie-stained gel, suggesting either that our estimation of purity by Coomassie staining was incorrect or that a majority of the solECE-1 was in an inactive form. 

Phrase: "The active enzyme concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "estimated by this method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0750572:Estimated [Quantitative Concept]
   770   C0871511:METHOD [Intellectual Product]

Phrase: "throughout this report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "was ~"

Phrase: "30-fold lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "that originally"

Phrase: "estimated from the protein concentration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0427716:Protein concentration [Laboratory Procedure]
   806   C1304757:Protein concentration [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086045:Concentration [Mental Process]
   760   C0750572:Estimated [Quantitative Concept]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "Coomassie-stained gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "either"

Phrase: "that"

Phrase: "our estimation of purity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0680844:estimation [Mental Process]
   770   C0681916:Estimation [Quantitative Concept]
   770   C0750572:Estimation [Quantitative Concept]

Phrase: "by Coomassie staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "incorrect"

Phrase: "or"

Phrase: "that"

Phrase: "a majority of the solECE-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "was in an inactive form."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0205254:Inactive [Qualitative Concept]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1421478:WAS [Gene or Genome]
   760   C1522492:Form [Functional Concept]
Processing 00000000.tx.114: To control for the presence of co-purifying native CHO proteins, conditioned serum-free medium from nontransfected CHO cells was purified as above, and the eluted proteins were used in control experiments. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for the presence of"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "co-purifying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1998793:Purifying [Functional Concept]
   768 E C1947930:Cleanse [Activity]

Phrase: "native CHO proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "conditioned serum-free medium from nontransfected CHO cells"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   750   C1183428:Free cell [Cell]
   744   C0009458:Medium [Intellectual Product]
   744   C0229671:Serum [Body Substance]
   744   C0332296:free [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   744   C1705217:Medium [Substance]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
   744   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "purified as above,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "the eluted proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "used in control experiments."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   833   C0009932:control experiments [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.115: ELISA Analysis of solECE-1-mediated A40 and A42 Degradation-- SolECE-1 was preincubated for 15min at room temperature with the ECE inhibitor PD069185 (synthesized according to published methods (38) by the Organic Chemistry Core Facility at the Mayo Clinic Jacksonville) or phosphoramidon (150M) or an equal volume of vehicle (Me2SO and phosphate-buffered saline, respectively), prior to incubation with synthetic A40 or A42 (0.01M) in 50mM MES, pH 6.5,containing 0.01% C12E10, 1mM PMSF, 100M leupeptin, and 20M pepstatin. 

Phrase: "ELISA Analysis of solECE-1-mediated A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "A42 Degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "--"

Phrase: "SolECE-1"

Phrase: "was"

Phrase: "preincubated for 15min"

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with the ECE inhibitor PD069185"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0671712:PD069185 [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "synthesized according to published methods"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0034037:Published [Occupational Activity]
   760   C0449851:Methods [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C1704324:Published [Intellectual Product]
   760   C1883254:Synthesized [Activity]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "(38"

Phrase: ")"

Phrase: "by the Organic Chemistry Core Facility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511521:Core Facility [Health Care Related Organization,Manufactured Object]
   812   C1547538:Facility [Idea or Concept]

Phrase: "at the Mayo Clinic Jacksonville"

Phrase: ")"

Phrase: "or"

Phrase: "phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(150M"

Phrase: ")"

Phrase: "or"

Phrase: "an equal volume of vehicle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0449468:*Volume [Quantitative Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "(Me2SO"

Phrase: "and"

Phrase: "phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "prior to incubation"

Phrase: "with synthetic A40"

Phrase: "or"

Phrase: "A42"

Phrase: "(0.01M"

Phrase: ")"

Phrase: "in 50mM MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0265215:MES [Congenital Abnormality]
   861   C1417092:MES [Gene or Genome]

Phrase: "pH 6.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.01% C12E10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1313055:C12E10 [Organic Chemical]

Phrase: "1mM PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "20M pepstatin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.116: The amount of solECE used in this reaction was estimated to be ~6 nM. 

Phrase: "The amount of solECE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "used in this reaction"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be ~"

Phrase: "6 nM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.117: As a control, A was incubated with Ni2+-nitrilotriacetic acid-purified proteins from nontransfected CHO cells or in reaction buffer alone. 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated with Ni2+-nitrilotriacetic acid-purified proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0028132:Nitrilotriacetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0202406:Acid [Laboratory Procedure]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1998793:Purified [Functional Concept]
   748   C2347351:Ni2+ [Element, Ion, or Isotope]

Phrase: "from nontransfected CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "or in reaction buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.118: Following incubation at 37 C for the indicated time points, the reactions were stopped by the addition of 5mM EDTA. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation at 37 C"

Phrase: "for the indicated time points,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "the reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped by the addition of 5mM EDTA."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   748   C1272691:stopped [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   714 E C1947925:Stop [Activity]
   714 E C2746065:Stop [Temporal Concept]
Processing 00000000.tx.119: A concentration was then analyzed using a highly specific sandwich ELISA, which captures A via binding of antibody BAN50 to the N terminus and detects full-length peptides ending at position 40(BA27) or 42(BC05). 

Phrase: "A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a highly specific sandwich ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014441:ELISA [Laboratory Procedure]

Phrase: "which"

Phrase: "captures"

Phrase: "A via binding of antibody BAN50"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to the N terminus"

Phrase: "and"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "full-length peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "ending at position 40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439509:/40 [Temporal Concept]
   770   C0444930:ending [Spatial Concept]
   770   C0733755:Position [Spatial Concept]
   770   C2746065:Ending [Temporal Concept]

Phrase: "(BA27"

Phrase: ")"

Phrase: "or"

Phrase: "42"

Phrase: "(BC05"

Phrase: ")."
Processing 00000000.tx.120: Thus, A that has been cleaved will not be detected in this assay. 

Phrase: "Thus,"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "will"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "detected in this assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.121: HPLC Analysis of solECE-1-mediated Degradation of 3H-Labeled A40-- To further analyze the degradation of A by solECE-1, the enzyme was incubated as above with 3H-radiomethylated A40 (0.56M, 2104 dpm), a gift from Dr. 

Phrase: "HPLC Analysis of solECE-1-mediated Degradation of 3H-Labeled A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "analyze"

Phrase: "the degradation of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "by solECE-1,"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "incubated as above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 3H-radiomethylated A40"

Phrase: "(0.56M,"

Phrase: "2104 dpm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512024:DPM [Intellectual Product]
   861   C1634619:dpm [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a gift from Dr."
Processing 00000000.tx.122: T.L.

Phrase: "T.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.123: Rosenberry. 

Phrase: "Rosenberry."
Processing 00000000.tx.124: A peptide and fragments were resolved by reversed-phase HPLC on a Vydac C4 column using a linear gradient of 0-100% B in 60min (A buffer=0.1% trifluoroacetic acid in water; B buffer=0.1% trifluoroacetic acid in acetonitrile). 

Phrase: "A peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "resolved by reversed-phase HPLC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]
   726   C1555029:Reverse [Idea or Concept]

Phrase: "on a Vydac C4 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a linear gradient of 0-100% B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]

Phrase: "in 60min"

Phrase: "(A buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "=0.1% trifluoroacetic acid in water"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "; B buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "=0.1% trifluoroacetic acid in acetonitrile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.125: Fractions were collected and counted in a Beckman LS 6500scintillation counter. 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "counted in a Beckman LS 6500scintillation counter."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0677601:Counter [Manufactured Object]
   748   C1705206:Counter [Medical Device]
   714   C0750480:Count [Activity]
   714   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.126: Characterization of A40 Proteolytic Fragments by HPLC, Mass Spectrometry, and Edman Sequencing-- solECE-1 (~20 nM) was incubated as above with synthetic A40 (100M) for 17h at 37C. 

Phrase: "Characterization of A40 Proteolytic Fragments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "by HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "Mass Spectrometry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "Edman Sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "--"

Phrase: "solECE-1"

Phrase: "(~20 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "was"

Phrase: "incubated as above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with synthetic A40"

Phrase: "(100M"

Phrase: ")"

Phrase: "for 17h"

Phrase: "at 37C."
Processing 00000000.tx.127: The digest samples were run on an Applied Biosystems 130A Separation System (Applied Biosystems, Foster City, CA) using a C4 reversed-phase column (Brownlee Aquapore BU-300; 2.1220mm). 

Phrase: "The digest samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "an Applied Biosystems 130A Separation System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a C4 reversed-phase column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]

Phrase: "(Brownlee Aquapore BU-300"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "; 2.1220mm"

Phrase: ")."
Processing 00000000.tx.128: The peptides were eluted with a gradient of 5-80% B over a period of 69min (A buffer=0.1% trifluoroacetic acid; B buffer=80% acetonitrile, 20% water, 0.09% trifluoroacetic acid). 

Phrase: "The peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "eluted with a gradient of 5-80% B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439182:% gradient [Quantitative Concept]
   744   C0812409:Gradient [Quantitative Concept]

Phrase: "over a period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0439531:/period [Temporal Concept]
  1000   C1948053:Period [Temporal Concept]
   928 E C0332182:Periodic [Temporal Concept]
   928 E C1706381:PERIODIC [Intellectual Product]
   900 E C0031084:Periodicities [Temporal Concept]

Phrase: "of 69min"

Phrase: "(A buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "=0.1% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "; B buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "=80% acetonitrile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050456:acetonitrile [Organic Chemical]

Phrase: "20% water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "0.09% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.129: The flow rate was 200l/min, and absorbance was monitored at 215nm. 

Phrase: "The flow rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "200l/min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1268822:Absorbance [Clinical Attribute]
  1000   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "monitored at 215nm."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.130: Half-minute fractions were collected, and peaks were analyzed by mass spectrometry and Edman sequencing. 

Phrase: "Half-minute fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:peaks [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by mass spectrometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C0936012:Analyzed [Research Activity]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "Edman sequencing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.131: The masses of the collected peptides were determined with a PerSeptive Biosystems MALDI-TOF Voyager DE-RP Mass Spectrometer (Framingham, MA) operated in the delayed extraction and reflector mode using -cyano-4-hydroxycinnamic acid. 

Phrase: "The masses of the collected peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0577559:Mass [Finding]
   719   C1306372:*Mass [Quantitative Concept]
   719   C3152252:Mass [Quantitative Concept]

Phrase: "were"

Phrase: "determined with a PerSeptive Biosystems MALDI-TOF Voyager DE-RP Mass Spectrometer"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   753   C0183396:Mass Spectrometer [Medical Device]
   753   C1518101:MALDI-TOF [Research Activity]
   736   C0011198:DE [Geographic Area]
   736   C0017480:DE [Geographic Area]
   736   C0039685:TOF [Congenital Abnormality]
   736   C0183395:Spectrometer [Medical Device]
   736   C0282597:MALDI [Laboratory Procedure]
   736   C0577559:Mass [Finding]
   736   C1306372:*Mass [Quantitative Concept]
   736   C1538326:RP [Gene or Genome]
   736   C1710143:Spectrometer [Manufactured Object]
   736   C1825291:TOF [Gene or Genome]
   736   C2348791:TOF [Quantitative Concept]
   736   C3152252:Mass [Quantitative Concept]
   736   C3541240:DE [Idea or Concept]
   736   C3541325:RP [Idea or Concept]

Phrase: "(Framingham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3166866:Framingham [Intellectual Product]

Phrase: "MA)"

Phrase: "operated in the delayed extraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0205421:Delayed [Temporal Concept]
   760   C0684295:extraction [Laboratory Procedure]
   760   C3272602:Delayed [Qualitative Concept]
   726   C3242339:operate [Functional Concept]

Phrase: "and"

Phrase: "reflector mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1513371:Mode [Functional Concept]
   861   C1705738:Mode [Quantitative Concept]
   861   C2347637:Mode [Quantitative Concept]
   861   C2348146:Mode [Quantitative Concept]

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cyano-4-hydroxycinnamic acid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.132: The first two amino acids of each peptide were determined using an Applied Biosystems Procise 492sequencer. 

Phrase: "The first two amino acids of each peptide"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Applied Biosystems Procise 492sequencer."
Processing 00000000.tx.133: Kinetics of A Hydrolysis by solECE-1-- In an attempt to determine the Km of A40 hydrolysis by solECE-1, we incubated the enzyme (~17 nM) with synthetic A40 (3,10,and 20M) for 0or 6h at 37C in 50mM MES buffer, pH 6.5,containing 0.05% bovine serum albumin, 1mM PMSF, 100M leupeptin, and 20M pepstatin. 

Phrase: "Kinetics of A Hydrolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022702:Kinetics [Natural Phenomenon or Process]
   770   C0220865:kinetics [Functional Concept]
   770   C2825046:Kinetics [Occupation or Discipline]

Phrase: "by solECE-1"

Phrase: "-"

Phrase: "-"

Phrase: "In an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "determine"

Phrase: "the Km of A40 hydrolysis"

Phrase: "by solECE-1,"

Phrase: "we"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(~17 nM) with synthetic A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "10,"

Phrase: "and"

Phrase: "20M"

Phrase: ")"

Phrase: "for 0or 6h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1292428:6H [Temporal Concept]

Phrase: "at 37C"

Phrase: "in 50mM MES buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 6.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.05% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "1mM PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "20M pepstatin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.134: Control reactions were carried out in the absence of enzyme or in the presence of solECE-1 inhibited by phosphoramidon (100M). 

Phrase: "Control reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in the absence of enzyme"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0332197:absence [Quantitative Concept]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "or in the presence of solECE-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "inhibited by phosphoramidon"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "(100M"

Phrase: ")."
Processing 00000000.tx.135: The reactions were stopped by the addition of EDTA (5mM), and A40 concentration was determined by sandwich ELISA using the BAN50/BA27 system. 

Phrase: "The reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped by the addition of EDTA (5mM"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   748   C1272691:stopped [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   714 E C1947925:Stop [Activity]
   714 E C2746065:Stop [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "A40 concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined by sandwich ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0014441:ELISA [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BAN50/BA27 system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.136: The rate of A hydrolysis in these assays was linear with respect to substrate concentration, precluding a determination of Km and Vmax. 

Phrase: "The rate of A hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "in these assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "linear with respect to substrate concentration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205132:Linear [Spatial Concept]

Phrase: "precluding"

Phrase: "a determination of Km"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "Vmax."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710637:Vmax [Phenomenon or Process]
Processing 00000000.tx.137: We next determined the second order rate constant, kcat/Km, for A40 hydrolysis relative to that for big ET-1 hydrolysis by solECE-1. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "determined"

Phrase: "the second order rate constant,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   861   C2986811:Rate Constant [Quantitative Concept]
   812   C0205436:Second [Quantitative Concept]
   812   C0457385:Second [Temporal Concept]
   812   C0565930:/second [Quantitative Concept]
   812   C0871208:Rate [Activity]
   812   C1521828:Rate [Quantitative Concept]
   812   C1547014:*Constant [Quantitative Concept]
   812   C1561503:second [Idea or Concept]
   812   C1705175:Order [Intellectual Product]
   812   C1705176:Order [Qualitative Concept]
   812   C1705177:Order [Classification]
   812   C1705178:Order [Activity]
   812   C1705190:Second [Qualitative Concept]
   812   C1882348:Order [Qualitative Concept]
   812   C1948059:Constant [Qualitative Concept]
   741 E C0027627:secondary [Neoplastic Process]
   741 E C0175668:Secondary [Temporal Concept]

Phrase: "kcat/Km,"

Phrase: "for A40 hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "relative to that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "for big ET-1 hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020291:Hydrolysis [Natural Phenomenon or Process]
   708   C1413561:BIG-1 [Gene or Genome]

Phrase: "by solECE-1."
Processing 00000000.tx.138: The second order rate for hydrolysis of each substrate was determined at substrate concentrations well below Km. 

Phrase: "The second order rate for hydrolysis of each substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "determined at substrate concentrations well"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0205170:Well [Qualitative Concept]
   760   C1710236:Substrate [Manufactured Object]
   760   C3146287:Well [Manufactured Object]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "below Km."
Processing 00000000.tx.139: Specifically, A40 (2.5M) and big ET-1 (0.1M) were incubated in triplicate alone or with solECE-1 (0.3-8.3 nM) at 37C at either pH 6.5or pH 5.6in 50mM MES buffer containing 100mM NaCl, 0.05% bovine serum albumin, 1mM PMSF, 100M leupeptin, and 20M pepstatin. 

Phrase: "Specifically,"

Phrase: "A40"

Phrase: "(2.5M"

Phrase: ")"

Phrase: "and"

Phrase: "big ET-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1413561:BIG-1 [Gene or Genome]
   901   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0549177:Big [Quantitative Concept]

Phrase: "(0.1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "incubated in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or with solECE-1"

Phrase: "(0.3-8.3 nM) at 37C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1328200:NM-3 [Pharmacologic Substance]
   748   C0312860:NM [Cell Function]

Phrase: "at either pH 6.5or pH 5.6in 50mM MES buffer containing 100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   786   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   786   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.05% bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "1mM PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "20M pepstatin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.140: The reactions were stopped by the addition of EDTA (5mM). 

Phrase: "The reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped by the addition of EDTA (5mM"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   748   C1272691:stopped [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   714 E C1947925:Stop [Activity]
   714 E C2746065:Stop [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.141: Remaining full-length A40 was determined by BAN50/BA27 sandwich ELISA, and the amount of ET-1 peptide generated was measured by ET-1 sandwich ELISA (Amersham Pharmacia Biotech). 

Phrase: "Remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527428:Remaining [Qualitative Concept]

Phrase: "full-length A40"

Phrase: "was"

Phrase: "determined by BAN50/BA27 sandwich ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014441:ELISA [Laboratory Procedure]

Phrase: "and"

Phrase: "the amount of ET-1 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "was"

Phrase: "measured by ET-1 sandwich ELISA (Amersham Pharmacia Biotech"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   764   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0014441:ELISA [Laboratory Procedure]
   742   C0331955:Pharmacia [Health Care Related Organization]
   742   C0444706:Measured [Qualitative Concept]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]

Phrase: ")."
Processing 00000000.tx.142: The apparent rate constant k was again determined from Equation 1.

Phrase: "The apparent rate constant k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1708601:K' [Quantitative Concept]

Phrase: "was"

Phrase: "again"

Phrase: "determined from Equation 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0552449:Equation [Conceptual Entity]
Processing 00000000.tx.143: Under these conditions, no detectable ET-1 peptide was generated in the absence of solECE-1. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "no detectable ET-1 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "generated in the absence of solECE-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C3146294:Generated [Activity]
Processing 00000000.tx.144: However, we consistently observed some loss of A40 in the absence of enzyme, presumably due to adsorption to the reaction tube or other nonspecific mechanism. 

Phrase: "However,"

Phrase: "we consistently"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "some loss of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "presumably due to adsorption"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0001674:Adsorption [Laboratory Procedure]
   770   C3146286:Due [Idea or Concept]

Phrase: "to the reaction tube"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0175730:Tube [Medical Device]
   861   C1547937:Tube NOS [Intellectual Product]
   861   C1561954:tube [Conceptual Entity]
   861   C1704730:TUBE [Medical Device]

Phrase: "or"

Phrase: "other nonspecific mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.145: Therefore, the rate of loss in the absence of enzyme was determined and subtracted from the rate determined in the presence of solECE-1. 

Phrase: "Therefore,"

Phrase: "the rate of loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "and"

Phrase: "subtracted from the rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]
   737   C1719767:Subtract [Intellectual Product]
   737   C2348589:Subtract [Phenomenon or Process]

Phrase: "determined in the presence of solECE-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.146: For subsequent calculations the average kS.E. for A40 hydrolysis at each pH was determined from three experiments, with triplicate reactions in each experiment. 

Phrase: "For subsequent calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1441506:Calculation [Activity]

Phrase: "the average kS.E."

Phrase: "for A40 hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "at each pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "determined from three experiments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205449:Three [Quantitative Concept]
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "with triplicate reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "in each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.147: For big ET-1 hydrolysis, the k is an average of two separate experiments, with triplicate reactions in each experiment. 

Phrase: "For big ET-1 hydrolysis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020291:Hydrolysis [Natural Phenomenon or Process]
   708   C1413561:BIG-1 [Gene or Genome]

Phrase: "the k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "is"

Phrase: "an average of two separate experiments,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1510992:Average [Quantitative Concept]
   753   C2825518:AVERAGE [Quantitative Concept]

Phrase: "with triplicate reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "in each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.148: From the enzyme concentration [E] determined from the k for big ET-1 at pH 6.5as outlined under Equation 1,we determined the kcat/Km for A40 hydrolysis at pH 6.5and 5.6and for big ET-1 at pH 5.6with the equation kcat/Km=k/[E].  

Phrase: "From the enzyme concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "[E]"

Phrase: "determined from the k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1708601:K' [Quantitative Concept]

Phrase: "for big ET-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1413561:BIG-1 [Gene or Genome]
   901   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0549177:Big [Quantitative Concept]

Phrase: "at pH 6.5as"

Phrase: "outlined under Equation 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0552449:Equation [Conceptual Entity]

Phrase: "we"

Phrase: "determined"

Phrase: "the kcat/Km for A40 hydrolysis"

Phrase: "at pH 6.5and 5.6and"

Phrase: "for big ET-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1413561:BIG-1 [Gene or Genome]
   901   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0549177:Big [Quantitative Concept]

Phrase: "at pH 5.6with"

Phrase: "the equation kcat/Km=k/[E"

Phrase: "]."
Processing 00000000.tx.149: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Phosphoramidon, but Not Thiorphan or Captopril, Increases A Accumulation by H4 Neuroglioma Cells-- Our group and others have previously shown that treatment with metalloprotease inhibitors, in particular phosphoramidon, results in a rapid 2-3-fold increase in the concentration of A40 and A42 in the conditioned medium of neuronal cell lines without affecting the concentration of secreted APP (sAPP) (39, 40). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "but"

Phrase: "Not Thiorphan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "Captopril,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "Increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "A Accumulation by H4 Neuroglioma Cells"

Phrase: "-"

Phrase: "-"

Phrase: "Our group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that treatment with metalloprotease inhibitors,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "in particular phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "results in a rapid 2-3-fold increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0332462:Fold [Spatial Concept]
   744   C0439831:Rapid [Qualitative Concept]
   744   C0442805:Increase [Functional Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1880834:FOLD [Phenomenon or Process]
   744   C2825142:Result [Finding]

Phrase: "in the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of A40"

Phrase: "and"

Phrase: "A42 in the conditioned medium of neuronal cell lines"

Phrase: "without affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the concentration of secreted APP (APP)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0427716:Protein concentration [Laboratory Procedure]
   774   C1304757:Protein concentration [Laboratory or Test Result]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "(39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.150: Importantly, this increase in A concentration is as large or larger than that seen in cells expressing most AD-causing mutations (2). 

Phrase: "Importantly,"

Phrase: "this increase in A concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "is as large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0549177:Large [Quantitative Concept]

Phrase: "or"

Phrase: "larger than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0443228:larger [Quantitative Concept]
   790   C0549177:Larger [Quantitative Concept]
   790   C1704243:Larger [Quantitative Concept]

Phrase: "seen in cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0205397:Seen [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C0042789:see [Organism Function]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1947903:See [Activity]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "most AD-causing mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.151: The enzyme(s) responsible for the phosphoramidon-induced elevations in A has not previously been reported. 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "("

Phrase: "s)"

Phrase: "responsible for the phosphoramidon-induced elevations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "in A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "not previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.152: Phosphoramidon is known to inhibit several metalloproteases including NEP (IC50=0.034M), angiotensin-converting enzyme (ACE; IC50=78M), ECE-1 (IC50=1-3.5 M), and ECE-2 (IC50=0.004M) (29, 41) but does not inhibit insulin-degrading enzyme (42). 

Phrase: "Phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "several metalloproteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:Metalloproteases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "(IC50=0.034M"

Phrase: ")"

Phrase: ","

Phrase: "angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(ACE"

Phrase: "; IC50=78M"

Phrase: ")"

Phrase: ","

Phrase: "ECE-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(IC50=1-3.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: ","

Phrase: "and"

Phrase: "ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "(IC50=0.004M"

Phrase: ")"

Phrase: "(29,"

Phrase: "41"

Phrase: ")"

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.153: A role for NEP in extracellular A catabolism has been highlighted in a recent report from Iwata and colleagues (9). 

Phrase: "A role for NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in extracellular A catabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0543484:catabolism [Functional Concept]
   827   C0699900:Catabolism [Organism Function]
   827   C1516314:Catabolism [Physiologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "highlighted in a recent report"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332185:Recent [Temporal Concept]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "from Iwata"

Phrase: "and"

Phrase: "colleagues"

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.154: Infusion of the metalloprotease inhibitor thiorphan into the hippocampus of rats resulted in a significant increase in the amount of A and in the deposition of the longer more amyloidogenic form, A42, reportedly through the inhibition of A degradation by NEP. 

Phrase: "Infusion of the metalloprotease inhibitor thiorphan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0574032:Infusion [Therapeutic or Preventive Procedure]
   753   C1827465:Infusion [Functional Concept]

Phrase: "into the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "resulted in a significant increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0237881:significant [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and in the deposition of the longer more amyloidogenic form,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0333562:Deposition [Functional Concept]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1515981:And [Idea or Concept]
   739   C1522492:Form [Functional Concept]
   706   C0205166:Long [Qualitative Concept]
   706   C1706317:Long [Qualitative Concept]

Phrase: "A42,"

Phrase: "reportedly through the inhibition of A degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0699900:Degradation [Organism Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by NEP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]
Processing 00000000.tx.155: NEP and ACE have been reported to reside predominantly on the cell surface, although a soluble form of NEP is also present in serum and cerebral spinal fluid (43-46). 

Phrase: "NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "ACE"

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2982691:Reside [Activity]

Phrase: "predominantly on the cell surface,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "although"

Phrase: "a soluble form of NEP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "present in serum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0150312:Present [Quantitative Concept]
   790   C0229671:Serum [Body Substance]
   790   C0449450:Present [Idea or Concept]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "cerebral spinal fluid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007806:Cerebral Spinal Fluid [Body Substance]
           Spinal fluid
   827   C0005889:FLUID [Body Substance]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C0521329:Spinal [Spatial Concept]
   827   C1704353:Fluid [Substance]

Phrase: "(43-46"

Phrase: ")."
Processing 00000000.tx.156: A recently identified thiorphan-sensitive NEP homologue SEP/NL1/NEPII is expressed both as a membrane-bound and secreted protease (47-49). 

Phrase: "A recently identified thiorphan-sensitive NEP homologue SEP/NL1/NEPII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1826261:NEPII [Gene or Genome]

Phrase: "is"

Phrase: "expressed"

Phrase: "both as a membrane-bound"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0025255:Membrane [Tissue]
   760   C0238767:Both [Spatial Concept]
   760   C0332297:bound [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1706086:Both [Qualitative Concept]
   760   C1706182:Membrane [Manufactured Object]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "secreted protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "(47-49"

Phrase: ")."
Processing 00000000.tx.157: We evaluated a role for NEP and ACE in H4 neuroglioma cells using more selective inhibitors of these enzymes, thiorphan and captopril, respectively. 

Phrase: "We"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "a role for NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "ACE in H4 neuroglioma cells"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "more selective inhibitors of these enzymes,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0014432:enzymes inhibitors [Pharmacologic Substance]
   783   C1152555:enzymes inhibitors [Molecular Function]
   767 E C2756995:Enzyme Inhibitors [Molecular Function]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   750 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "thiorphan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "captopril,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.158: We have not yet been able to similarly analyze ECE, since a more selective inhibitor of ECE is not commercially available. 

Phrase: "We"

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "able to similarly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "analyze"

Phrase: "ECE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "since"

Phrase: "a more selective inhibitor of ECE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "is"

Phrase: "not commercially available."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1548671:Not available [Idea or Concept]
   827   C0470187:Available [Functional Concept]
Processing 00000000.tx.159: Treatment of H4 cells with phosphoramidon (34M) resulted in a greater than 2-fold elevation in A40 accumulation (Fig. 1), with a half-maximal effect occurring at a dose of ~7.5 M (data not shown). 

Phrase: "Treatment of H4 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(34M"

Phrase: ")"

Phrase: "resulted in a greater"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "than 2-fold elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439775:Elevation [Therapeutic or Preventive Procedure]
   827   C0702240:Elevation [Spatial Concept]

Phrase: "in A40 accumulation"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "with a half-maximal effect"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0205289:Maximal [Qualitative Concept]
   827   C0806909:Maximal [Quantitative Concept]
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
   827   C2825407:Half [Quantitative Concept]
   755 E C1552615:maximum [Quantitative Concept]
   755 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "occurring at a dose of ~7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   714   C1709305:Occur [Activity]
   714   C2745955:OCCUR [Temporal Concept]

Phrase: "M ("

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.160: However, treatment with thiorphan or captopril at concentrations greater than 1000times the reported IC50 for the target enzymes in in vitro studies (50, 51), but less than that required to inhibit ECE, failed to result in increases in extracellular A (Fig. 1), indicating that the phosphoramidon-induced effect in H4 cells is not likely to be due to inhibition of NEP or ACE. 

Phrase: "However,"

Phrase: "treatment with thiorphan"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "captopril at concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "greater than 1000times"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "the reported IC50 for the target enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0600495:IC50 [Quantitative Concept]

Phrase: "in in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "(50,"

Phrase: "51"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "less than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0439092:Less Than [Intellectual Product]
           less
   790   C0547044:Less [Qualitative Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ECE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in increases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442805:increases [Functional Concept]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "in extracellular A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the phosphoramidon-induced effect in H4 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "not likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "be due to inhibition of NEP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1366499:NEPRILYSIN [Gene or Genome]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "ACE."
Processing 00000000.tx.161: Similar results were obtained for A42 (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained for A42"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.162: Since NEP and ACE are localized mainly on the cell surface, the membrane permeability of these compounds is not relevant to the inhibition of the known protease, although we cannot rule out the possible presence of an intracellular form of NEP or ACE based on these results. 

Phrase: "Since"

Phrase: "NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "ACE"

Phrase: "are"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "mainly on the cell surface,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "the membrane permeability of these compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007605:membrane permeability [Cell Function]
   753   C0031164:Permeability [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "not relevant to the inhibition of the known protease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2347946:Relevant [Qualitative Concept]

Phrase: "although"

Phrase: "we"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possible presence of an intracellular form of NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "ACE"

Phrase: "based on these results."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1880279:Base [Biomedical or Dental Material]
   737   C2825142:Result [Finding]
Processing 00000000.tx.163: Similarly, we cannot rule out the possibility that the phosphoramidon-induced effect in these cells is due to an as yet unidentified enzyme that is insensitive to treatment with thiorphan and captopril. 

Phrase: "Similarly,"

Phrase: "we"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the phosphoramidon-induced effect in these cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "is due to an as yet unidentified enzyme"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0205427:Unidentified [Qualitative Concept]
   744   C3146286:Due [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "insensitive to treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0237677:Insensitivity [Finding]

Phrase: "with thiorphan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "captopril."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.164: We did, however, find endogenous ECE activity in solubilized membranes of H4 cells using a big ET conversion assay (17, 36) (data not shown). 

Phrase: "We"

Phrase: "did"

Phrase: ","

Phrase: "however,"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "endogenous ECE activity in solubilized membranes of H4 cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   745   C0596897:membrane activity [Cell Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a big ET conversion assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "(17,"

Phrase: "36"

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.165: Collectively, these data led us to investigate ECE more closely. 

Phrase: "Collectively,"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "ECE more closely."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1414244:ECE [Gene or Genome]
Processing 00000000.tx.166: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.167: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.168: Effect of metalloprotease inhibitors on A concentration in the culture medium of H4 cells. 

Phrase: "Effect of metalloprotease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "of H4 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.169: Confluent wells of H4 cells were treated with phosphoramidon, captopril (selective inhibitor of ACE), or thiorphan (selective inhibitor of NEP) for 24h at the indicated concentrations. 

Phrase: "Confluent wells of H4 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C2347578:Cells/well [Quantitative Concept]
   726   C0205170:Well [Qualitative Concept]
   726   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "treated with phosphoramidon,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "captopril"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006938:Captopril [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(selective inhibitor of ACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0003015:ACE inhibitor [Pharmacologic Substance]
   770   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "thiorphan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "(selective inhibitor of NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "at the indicated concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.170: A40 concentration in the conditioned medium was determined using the BAN50/BA27 sandwich ELISA. 

Phrase: "A40 concentration in the conditioned medium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BAN50/BA27 sandwich ELISA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.171: Data are plotted as meanS.E. of triplicate wells. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "plotted as meanS.E. of triplicate wells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0205174:Triplicate [Quantitative Concept]
   748   C1704970:Means [Conceptual Entity]
   714   C0205170:Well [Qualitative Concept]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
   714   C3146287:Well [Manufactured Object]
Processing 00000000.tx.172: MTS cell proliferation assays on the treated cells did not reveal cellular toxicity at any of the doses. 

Phrase: "MTS cell proliferation assays on the treated cells"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0596290:Cell Proliferation [Cell Function]
   750   C2986858:MTS Assay [Research Activity]
   744   C0007634:Cell [Cell]
   744   C0334094:Proliferation [Pathologic Function]
   744   C1269647:Cell [Cell]
   744   C1514485:Proliferation [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711   C1510438:Assay [Laboratory Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "cellular toxicity at any of the doses."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040539:toxicity [Qualitative Concept]
   748   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.173: Overexpression of Endothelin-converting Enzyme-1 Results in a Significant Decrease in Extracellular A Concentration That Is Completely Reversed by Treatment with Phosphoramidon-- Evidence implicating a potential role for ECE in modulating A concentration came further from the casual observation that CHO cells, which have no endogenous ECE activity (17), produce very high levels of A when compared with most other cell types2 and fail to respond to phosphoramidon (see Fig. 2). 

Phrase: "Overexpression of Endothelin-converting Enzyme-1 Results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "in a Significant Decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "in Extracellular A Concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "That"

Phrase: "Is"

Phrase: "Completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "Reversed by Treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756   C1555029:Reverse [Idea or Concept]

Phrase: "with Phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "--"

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "implicating"

Phrase: "a potential role for ECE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in modulating A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "came"

Phrase: "further from the casual observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0302523:Observation [Research Activity]
   760   C0700325:observation [Health Care Activity]
   760   C1517331:Further [Spatial Concept]
   760   C1964257:Observation [Diagnostic Procedure]
   726 E C0205108:far [Spatial Concept]

Phrase: "that CHO cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "have"

Phrase: "no endogenous ECE activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "produce"

Phrase: "very high levels of A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "when"

Phrase: "compared with most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "other cell types2"

Phrase: "and"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "respond to phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.174: Conversely, HUVECs, which have high levels of endogenous ECE (52), accumulate very little A unless treated with high concentrations of phosphoramidon (data not shown). 

Phrase: "Conversely,"

Phrase: "HUVECs,"

Phrase: "which"

Phrase: "have"

Phrase: "high levels of endogenous ECE (52"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "accumulate"

Phrase: "very little A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "unless"

Phrase: "treated with high concentrations of phosphoramidon"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1522326:Treated [Functional Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.175: To further investigate the role of ECE in A accumulation, we cloned and stably transfected CHO cells with human ECE-1b and ECE-1a. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the role of ECE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in A accumulation,"

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "stably transfected CHO cells with human ECE-1b"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0085080:CHO Cells [Cell]
   767   C0427861:Human cells [Laboratory or Test Result]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "ECE-1a."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]
Processing 00000000.tx.176: ECE activity, determined using a big ET-1 conversion assay (17, 36), was confirmed to be present in solubilized membranes from the ECE-1-transfected cells and absent in vector-transfected cells (data not shown). 

Phrase: "ECE activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a big ET-1 conversion assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]

Phrase: "(17,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in solubilized membranes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "from the ECE-1-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "absent in vector-transfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.177: The amount of ECE-1 activity in each of our stable ECE-1 lines was similar. 

Phrase: "The amount of ECE-1 activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "in each"

Phrase: "of our stable ECE-1 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "similar."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.178: Overexpression of either ECE-1a or ECE-1b in CHO cells, which lack endogenous ECE activity, resulted in a striking 75-90% reduction in A40 and a 45-60% reduction in A42 (Fig. 2). 

Phrase: "Overexpression of either ECE-1a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "or"

Phrase: "ECE-1b in CHO cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0450345:1B [Intellectual Product]

Phrase: "which"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "endogenous ECE activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "resulted in a striking 75-90% reduction"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0038452:striking [Occupational Activity]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0439083:>90 [Quantitative Concept]
   748   C0439087:<90 [Quantitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "in A40"

Phrase: "and"

Phrase: "a 45-60% reduction in A42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.179: No significant changes were observed in the amount of sAPP accumulation in ECE-1-transfected cells compared with the vector controls, indicating that the cells were similarly viable and that general secretion is not affected by ECE-1 overexpression. 

Phrase: "No significant changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "observed in the amount of sAPP accumulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1265611:Amount [Quantitative Concept]
   744   C1327616:Secreted [Cell Function]
   744   C1441672:Observed [Functional Concept]
   744   C3538722:APP [Laboratory Procedure]

Phrase: "in ECE-1-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "compared with the vector controls,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   781   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "similarly viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443348:Viable [Qualitative Concept]

Phrase: "and"

Phrase: "that general secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by ECE-1 overexpression."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1514559:Overexpression [Genetic Function]
   726 E C0001721:Affect [Mental Process]
Processing 00000000.tx.180: The reduction in A concentration in ECE-1a- and ECE-1b-transfected cells was completely reversed by treatment with phosphoramidon, indicating that the observed phenotype was probably due to the enzymatic activity of the overexpressed ECE-1. 

Phrase: "The reduction in A concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in ECE-1a-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "ECE-1b-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "reversed by treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756   C1555029:Reverse [Idea or Concept]

Phrase: "with phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "indicating"

Phrase: "that"

Phrase: "the observed phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "was"

Phrase: "probably due to the enzymatic activity of the overexpressed ECE-1."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C0678226:Due to [Functional Concept]
           due
   756   C2267219:Enzymatic Activity [Molecular Function]
   754   C0243102:enzyme activity [Molecular Function]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C0750492:Probably [Idea or Concept]
   738   C1561536:*Activity [Idea or Concept]
   738   C3146286:Due [Idea or Concept]
   704   C1514559:overexpress [Genetic Function]
Processing 00000000.tx.181: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.182: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.183: Overexpression of ECE-1a or ECE-1b in CHO cells reduces extracellular A concentration without affecting secretion of sAPP. 

Phrase: "Overexpression of ECE-1a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "or"

Phrase: "ECE-1b in CHO cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0450345:1B [Intellectual Product]

Phrase: "reduces"

Phrase: "extracellular A concentration without affecting secretion of sAPP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0086045:Concentration [Mental Process]
   742   C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.184: A40 (A) and A42 (B) concentration in the conditioned media of stable ECE-1a- and ECE-1b-transfected CHO cell lines was determined by sandwich ELISA (BNT77/BA27 and BNT77/BC05, respectively) following a 24-h incubation with or without 100M phosphoramidon. 

Phrase: "A40"

Phrase: "(A"

Phrase: ")"

Phrase: "and"

Phrase: "A42"

Phrase: "(B) concentration in the conditioned media of stable ECE-1a-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0086045:Concentration [Mental Process]
   739   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "ECE-1b-transfected CHO cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0007600:Cell lines [Cell]
   799   C0205132:lines [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "determined by sandwich ELISA (BNT77/BA27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014441:ELISA [Laboratory Procedure]

Phrase: "and"

Phrase: "BNT77/BC05,"

Phrase: "respectively"

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a 24-h incubation with"

Phrase: "or without 100M phosphoramidon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.185: Data are plotted as meanS.E. of triplicate wells. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "plotted as meanS.E. of triplicate wells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0205174:Triplicate [Quantitative Concept]
   748   C1704970:Means [Conceptual Entity]
   714   C0205170:Well [Qualitative Concept]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
   714   C3146287:Well [Manufactured Object]
Processing 00000000.tx.186: Western blot analysis (C) was also performed on the conditioned media of cells incubated with or without phosphoramidon (phos), using 22C11 antibody to detect sAPP. 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "performed on the conditioned media of cells"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   778   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   748   C0007634:Cells [Cell]
   748   C0009458:Media [Intellectual Product]
   748   C0009647:Conditioned [Mental Process]
   748   C0162867:Media [Tissue]
   748   C0884358:Performed [Functional Concept]
   748   C1254021:Media [Tissue]
   748   C3282337:Cells [Cell]
   714 E C0439536:Medium [Quantitative Concept]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1705217:Medium [Substance]
   714 E C1948049:Cell [Spatial Concept]
   714 E C2947996:Perform [Pharmacologic Substance]
   714 E C3244283:medium [Intellectual Product]

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "or without phosphoramidon (phos),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "22C11 antibody to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "sAPP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538722:APP [Laboratory Procedure]
Processing 00000000.tx.187: Increased Removal of Exogenous A Is Apparent Only in ECE-1a-transfected Cells-- While the exact mechanism of the phosphoramidon-induced increase in A concentration in neuronal cells was unknown, it has been suggested that it may be the result of inhibition of intracellular degradation of the peptide (40). 

Phrase: "Increased Removal of Exogenous A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "Is"

Phrase: "Apparent Only in ECE-1a-transfected Cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0007634:Cells [Cell]
   748   C0205171:Only [Quantitative Concept]
   748   C0450344:1A [Intellectual Product]
   748   C0750489:apparent [Idea or Concept]
   748   C1414244:ECE [Gene or Genome]
   748   C1553633:1a [Medical Device]
   748   C1720467:Only [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "While"

Phrase: "the exact mechanism of the phosphoramidon-induced increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "in A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "the result of inhibition of intracellular degradation of the peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.188: Consistent with this hypothesis, treatment with phosphoramidon is reported to result in a 2-fold increase in extracellular A concentration and an increase in cell-associated A without affecting sAPP levels in SY5Y cells treated with the compound (40). 

Phrase: "Consistent with this hypothesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "treatment with phosphoramidon"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in a 2-fold increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332462:Fold [Spatial Concept]
   753   C0442805:Increase [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1880834:FOLD [Phenomenon or Process]
   753   C2825142:Result [Finding]

Phrase: "in extracellular A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "an increase in cell-associated A without affecting sAPP levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "treated with the compound"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0205198:Compound [Qualitative Concept]
   770   C1522326:Treated [Functional Concept]
   770   C1706082:Compound [Chemical]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.189: As we have shown, treatment of H4 neuroglioma cells with phosphoramidon also results in a significant increase in extracellular A concentration (see Fig. 1). 

Phrase: "As"

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "treatment of H4 neuroglioma cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with phosphoramidon also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "results in a significant increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0237881:significant [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C2825142:Result [Finding]

Phrase: "in extracellular A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.190: To examine whether the phosphoramidon-induced increases in A were likely to be due to inhibition of a cell-surface or secreted protease, we performed a spike experiment in which exogenous A was added to the medium bathing H4 cells in the absence or presence of phosphoramidon. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "the phosphoramidon-induced increases in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "were"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be due to inhibition of a cell-surface"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   789   C0699040:Surface of cell [Cell Component]
           Cell surface
   770   C0678226:Due to [Functional Concept]
           due
   744   C0007634:Cell [Cell]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0205148:Surface [Spatial Concept]
   744   C1269647:Cell [Cell]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "secreted protease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a spike experiment in which exogenous A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0681814:Experiment [Research Activity]
   748   C1706386:Experiment [Conceptual Entity]

Phrase: "was"

Phrase: "added to the medium bathing H4 cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   748   C0007634:Cells [Cell]
   748   C0009458:Medium [Intellectual Product]
   748   C0150141:Bathing [Therapeutic or Preventive Procedure]
   748   C0439536:Medium [Quantitative Concept]
   748   C0518460:Bathing [Finding]
   748   C0541747:bathing [Therapeutic or Preventive Procedure]
   748   C1524062:Added [Functional Concept]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1883712:Add [Functional Concept]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of phosphoramidon."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]
Processing 00000000.tx.191: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.192: 3, exogenous A42 was removed equally well in the presence or absence of phosphoramidon. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "exogenous A42"

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "equally well in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205170:Well [Qualitative Concept]
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
   760   C3146287:Well [Manufactured Object]

Phrase: "or"

Phrase: "absence of phosphoramidon."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.193: The inset shows the results from a sister set of culture wells where synthetic A was not added, indicating that phosphoramidon was indeed promoting endogenous A accumulation in this experiment. 

Phrase: "The inset"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the results from a sister"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "set of culture wells where synthetic A"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0010453:Culture [Idea or Concept]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0036849:Set [Mental Process]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]
   748   C1883254:synthetic [Activity]
   748   C2242979:Culture [Laboratory Procedure]
   714   C0205170:Well [Qualitative Concept]
   714   C3146287:Well [Manufactured Object]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "indicating"

Phrase: "that phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "indeed"

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "endogenous A accumulation in this experiment."
Processing 00000000.tx.194: Similar data were obtained using synthetic A40 (data not shown). 

Phrase: "Similar data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synthetic A40"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.195: View larger version (11K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.196: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.197: Effect of phosphoramidon on removal of exogenous A by H4 cells. 

Phrase: "Effect of phosphoramidon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of exogenous A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by H4 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.198: Synthetic A42 (150pM) was added to confluent H4 cells in the presence (closed symbols) or absence (open symbols) of 34M phosphoramidon and incubated for 6and 24h. 

Phrase: "Synthetic A42"

Phrase: "(150pM"

Phrase: ")"

Phrase: "was"

Phrase: "added to confluent H4 cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0205200:Confluent [Qualitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1883712:Add [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(closed symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "of 34M phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated for 6and 24h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456696:/24h [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1442770:24H [Temporal Concept]
Processing 00000000.tx.199: A second set of control H4 cells was incubated with or without phosphoramidon for the same time period. 

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "set of control H4 cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   844   C0007634:Set of cells [Cell]
           Cells set
           Cells
   760   C0036849:Set [Mental Process]
   760   C0243148:control [Qualitative Concept]
   760   C1442518:Set [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1705195:Set [Conceptual Entity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "or without phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "for the same time period."
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   901   C0439582:Time period [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   743 E C1632851:Times [Quantitative Concept]
   727 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.200: A42 was measured in both sets at the indicated time points using the BAN50/BA27 sandwich ELISA, and remaining synthetic A concentration was determined by subtracting values obtained from control (endogenous) cells from those obtained from the cells incubated with spiked-in A. 

Phrase: "A42"

Phrase: "was"

Phrase: "measured in both"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "sets at the indicated time points"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C2348792:Time Point [Temporal Concept]
   753   C0036849:Set [Mental Process]
   753   C0040223:Time [Temporal Concept]
   753   C1442518:Set [Functional Concept]
   753   C1444656:Indicated [Finding]
   753   C1705195:Set [Conceptual Entity]
   753   C3541383:Time [Temporal Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BAN50/BA27 sandwich ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014441:ELISA [Laboratory Procedure]

Phrase: "and"

Phrase: "remaining synthetic A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined by subtracting values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]
   737   C1719767:Subtract [Intellectual Product]
   737   C2348589:Subtract [Phenomenon or Process]

Phrase: "obtained from control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(endogenous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205227:Endogenous [Functional Concept]

Phrase: ")"

Phrase: "cells from those"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "obtained from the cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "incubated with spiked-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.201: The inset graph shows the accumulation of endogenous A42 in the conditioned medium of H4 cells after 24h of treatment with phosphoramidon. 

Phrase: "The inset graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681493:Graph [Intellectual Product]
   861   C2698021:Graph [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the accumulation of endogenous A42"

Phrase: "in the conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "of H4 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "after 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "of treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with phosphoramidon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.202: Data are plotted as meanS.E. of triplicate wells. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "plotted as meanS.E. of triplicate wells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0205174:Triplicate [Quantitative Concept]
   748   C1704970:Means [Conceptual Entity]
   714   C0205170:Well [Qualitative Concept]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
   714   C3146287:Well [Manufactured Object]
Processing 00000000.tx.203: To determine whether extracellular A removal could account, at least in part, for the dramatic decrease in extracellular A concentration in the ECE-1-transfected cell lines, we next spiked synthetic A40 into the culture medium in the presence or absence of phosphoramidon and determined the percentage of removal by sandwich ELISA at 6and 24h. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "extracellular A removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015252:Removal [Therapeutic or Preventive Procedure]
   827   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "for the dramatic decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "in extracellular A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in the ECE-1-transfected cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C0007600:Cell lines [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "we next spiked synthetic A40 into the culture medium"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of phosphoramidon"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "determined"

Phrase: "the percentage of removal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "by sandwich ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "at 6and 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456696:/24h [Temporal Concept]
   861   C1442770:24H [Temporal Concept]
Processing 00000000.tx.204: After a 6-h incubation, removal of A was similar in the culture medium of vector- and ECE-1-transfected CHO cells (Fig. 4A) and was not affected by phosphoramidon treatment (data not shown), although endogenous A accumulation by phosphoramidon-treated ECE-1-transfected cells was increased 1.5-2-fold during the same time period (Fig. 4B). 

Phrase: "After a 6-h incubation,"

Phrase: "removal of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015252:Removal [Therapeutic or Preventive Procedure]
   790   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "similar in the culture medium of vector-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "ECE-1-transfected CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by phosphoramidon treatment"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0039798:treatment [Functional Concept]
   770   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0001721:Affect [Mental Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "endogenous A accumulation by phosphoramidon-treated ECE-1-transfected cells"

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "1.5-2-fold during the same time period"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332462:Fold [Spatial Concept]
   742   C1880834:FOLD [Phenomenon or Process]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.205: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.206: 4.  

Phrase: "4."
Processing 00000000.tx.207: Removal of exogenous synthetic A by ECE-overexpressing CHO cells. 

Phrase: "Removal of exogenous synthetic A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "by ECE-overexpressing CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.208: A, synthetic human A40 (150pM) was added to confluent CHO cells stably transfected with ECE-1a, ECE-1b, or the control vector and incubated for 6and 24h. 

Phrase: "A,"

Phrase: "synthetic human A40"

Phrase: "(150pM"

Phrase: ")"

Phrase: "was"

Phrase: "added to confluent CHO cells stably"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0085080:CHO Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0205200:Confluent [Qualitative Concept]
   753   C1524062:Added [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1883712:Add [Functional Concept]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with ECE-1a,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450344:1A [Intellectual Product]
   770   C1414244:ECE [Gene or Genome]
   770   C1553633:1a [Medical Device]

Phrase: "ECE-1b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "or"

Phrase: "the control vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031249:control vector [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "incubated for 6and 24h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456696:/24h [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1442770:24H [Temporal Concept]
Processing 00000000.tx.209: Human A40 was measured at the indicated time points using the BAN50/BA27 sandwich ELISA, which does not detect endogenous CHO A. 

Phrase: "Human A40"

Phrase: "was"

Phrase: "measured at the indicated time points"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   756   C2348792:Time Point [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1444656:Indicated [Finding]
   753   C3541383:Time [Temporal Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BAN50/BA27 sandwich ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014441:ELISA [Laboratory Procedure]

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "endogenous CHO A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.210: Data shown represent the meanS.E. of triplicate wells that were incubated with synthetic A40. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanS.E."

Phrase: "of triplicate wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "that"

Phrase: "were"

Phrase: "incubated with synthetic A40."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1883254:synthetic [Activity]
Processing 00000000.tx.211: The concentration of A remaining after 24h is significantly lower in ECE-1a cells than in vector controls (p=0.0495,Mann-Whitney). 

Phrase: "The concentration of A remaining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "after 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "is"

Phrase: "significantly lower in ECE-1a cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in vector controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   966   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(p=0.0495,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Mann-Whitney"

Phrase: ")."
Processing 00000000.tx.212: The inset graph shows the percentage of exogenous A removed by ECE-1a and vector-transfected cells after 24h in the presence of phosphoramidon (34M). 

Phrase: "The inset graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681493:Graph [Intellectual Product]
   861   C2698021:Graph [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the percentage of exogenous A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "removed by ECE-1a"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0450344:1A [Intellectual Product]
   770   C0849355:Removed [Qualitative Concept]
   770   C1414244:ECE [Gene or Genome]
   770   C1553633:1a [Medical Device]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "vector-transfected cells after 24h"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(34M"

Phrase: ")."
Processing 00000000.tx.213: B, a second set of cells was incubated with or without phosphoramidon (34M) for the same time period to determine the accumulation of endogenous A. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "a second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "set of cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0007634:Set of cells [Cell]
           Cells set
           Cells
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "or without phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(34M"

Phrase: ")"

Phrase: "for the same time period to"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   861   C0439582:Time period [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   729 E C1632851:Times [Quantitative Concept]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "determine"

Phrase: "the accumulation of endogenous A."
Processing 00000000.tx.214: Endogenous A40 was measured at the indicated time points using the BNT77/BA27 sandwich ELISA. 

Phrase: "Endogenous A40"

Phrase: "was"

Phrase: "measured at the indicated time points"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   756   C2348792:Time Point [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1444656:Indicated [Finding]
   753   C3541383:Time [Temporal Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BNT77/BA27 sandwich ELISA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.215: Data are plotted as meanS.E. of triplicate wells. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "plotted as meanS.E. of triplicate wells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0205174:Triplicate [Quantitative Concept]
   748   C1704970:Means [Conceptual Entity]
   714   C0205170:Well [Qualitative Concept]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
   714   C3146287:Well [Manufactured Object]
Processing 00000000.tx.216: Given that BNT77 was raised against amino acids 11-28 of A, this assay can also detect amino truncated peptides and may lead to an overestimation of full-length A40. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that BNT77"

Phrase: "was"

Phrase: "raised against amino acids 11-28 of A,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0442818:Raised [Quantitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "this assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "can"

Phrase: "also"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "amino truncated peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "may"

Phrase: "lead to an overestimation of full-length A40."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0443225:Full [Qualitative Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1444754:Length [Quantitative Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1706316:LENGTH [Research Activity]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.217: Following a 24-h incubation, we did observe a significant increase (p=0.0495) in the removal of the spiked-in A in the medium of ECE-1a-transfected cells compared with the vector controls (Fig. 4A). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a 24-h incubation,"

Phrase: "we"

Phrase: "did"

Phrase: "observe"

Phrase: "a significant increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "(p=0.0495"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in the removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of the spiked-"

Phrase: "in A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "of ECE-1a-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "compared with the vector controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   781   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.218: No significant change in exogenous A removal was observed in cells expressing ECE-1b. 

Phrase: "No significant change in exogenous A removal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0442739:No change [Finding]
   774   C1548568:No change [Intellectual Product]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "observed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "ECE-1b."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]
Processing 00000000.tx.219: The ECE-1a-induced increase in A removal could be completely attenuated by phosphoramidon treatment, indicating that the effect was probably due to the enzymatic activity of ECE-1a (Fig. 4A, inset). 

Phrase: "The ECE-1a-induced increase in A removal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "attenuated by phosphoramidon treatment,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0039798:treatment [Functional Concept]
   770   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0332161:Attenuated [Qualitative Concept]
   770   C0599946:Attenuated [Activity]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "indicating"

Phrase: "that"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "probably due to the enzymatic activity of ECE-1a"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0678226:Due to [Functional Concept]
           due
   764   C2267219:Enzymatic Activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0450344:1A [Intellectual Product]
   742   C0750492:Probably [Idea or Concept]
   742   C1414244:ECE [Gene or Genome]
   742   C1553633:1a [Medical Device]
   742   C1561536:*Activity [Idea or Concept]
   742   C3146286:Due [Idea or Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.220: In the same ECE-1a cells, phosphoramidon treatment resulted in an ~600% increase in endogenous A accumulation at the 24-h time point (Fig. 4B). 

Phrase: "In the same ECE-1a cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "phosphoramidon treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in an ~600% increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442805:Increase [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in endogenous A accumulation"

Phrase: "at the 24-h time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C2348792:Time Point [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C1552961:Point [Quantitative Concept]
   812   C2347617:point [Quantitative Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.221: Partially Purified solECE-1 Degrades A in Vitro-- Recombinant, soluble forms of ECE-1 (solECE-1) lacking the intracellular and transmembrane domains have been reported to hydrolyze big ET-1 with activity comparable with that of membrane-bound ECE-1a (16, 36, 37). 

Phrase: "Partially Purified solECE-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1998793:Purified [Functional Concept]
   719 E C1947930:Cleanse [Activity]

Phrase: "Degrades"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in Vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "--"

Phrase: "Recombinant, soluble forms of ECE-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "(solECE-1"

Phrase: ")"

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "and"

Phrase: "transmembrane domains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C2752508:transmembrane [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "hydrolyze"

Phrase: "big ET-1 with activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1413561:BIG-1 [Gene or Genome]
   760   C0549177:Big [Quantitative Concept]

Phrase: "comparable with that of membrane-bound ECE-1a"

Phrase: "(16,"

Phrase: "36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.222: The soluble ECE-1 preparation described by Korth et al. 

Phrase: "The soluble ECE-1 preparation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0360722:Enzyme preparation [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0455052:Preparation [Health Care Activity]
   812   C1521827:Preparation [Functional Concept]

Phrase: "described by Korth et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.223: (37) was active in a broad pH range from 5to 7,with an optimum of pH 6.6-6.8 for big ET-1. 

Phrase: "(37"

Phrase: ")"

Phrase: "was"

Phrase: "active in a broad pH range"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205177:Active [Functional Concept]

Phrase: "from 5to 7,"

Phrase: "with an optimum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2698651:Optimum [Qualitative Concept]

Phrase: "of pH 6.6-6.8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0020283:[pH] [Quantitative Concept]
   804   C0450407:ph+ [Finding]
   804   C0450408:ph++ [Finding]
   804   C0450409:ph+++ [Finding]

Phrase: "for big ET-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1413561:BIG-1 [Gene or Genome]
   901   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0549177:Big [Quantitative Concept]
Processing 00000000.tx.224: Under the conditions assayed, Ahn et al. 

Phrase: "Under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: ","

Phrase: "Ahn et al."
Processing 00000000.tx.225: (36, 53) found that their soluble ECE-1 preparation had a somewhat narrower pH optimum, with an optimal pH for big ET-1 of 6.5.To examine whether ECE-1 is capable of direct catabolism of A, we generated a soluble ECE-1 similar to those previously described. 

Phrase: "(36,"

Phrase: "53"

Phrase: ")"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "their soluble ECE-1 preparation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0360722:Enzyme preparation [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0455052:Preparation [Health Care Activity]
   812   C1521827:Preparation [Functional Concept]

Phrase: "had"

Phrase: "a somewhat narrower pH optimum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2698651:Optimum [Qualitative Concept]

Phrase: "with an optimal pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "for big ET-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1413561:BIG-1 [Gene or Genome]
   901   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0549177:Big [Quantitative Concept]

Phrase: "of 6.5.To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0442749:6/5 [Finding]

Phrase: "examine"

Phrase: "whether"

Phrase: "ECE-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "capable of direct catabolism of A,"

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a soluble ECE-1 similar to those previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.226: Incubation of synthetic A40 and A42 with this enzyme resulted in a nearly complete loss of the full-length peptides as detected by sandwich ELISA (Fig. 5). 

Phrase: "Incubation of synthetic A40"

Phrase: "and"

Phrase: "A42 with this enzyme"

Phrase: "resulted in a nearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "loss of the full-length peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "as"

Phrase: "detected by sandwich ELISA (Fig. 5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0014441:ELISA [Laboratory Procedure]
   753   C0349966:Fig [Food]
   753   C0442726:Detected [Finding]
   753   C1337208:FIG [Food]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.227: This reduction was completely blocked by incubation with phosphoramidon and also with a more selective ECE-1 inhibitor, PD069185. 

Phrase: "This reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked by incubation"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "with phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "also with a more selective ECE-1 inhibitor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   767   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   767   C1418824:INHIBITOR 1 [Gene or Genome]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "PD069185."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0671712:PD069185 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.228: (This inhibitor, while very useful for in vitro studies, is not informative in cell-based studies due to its toxicity (38)). 

Phrase: "("

Phrase: "This inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "while"

Phrase: "very useful for in vitro studies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0869040:Use studies [Research Activity]

Phrase: "is"

Phrase: "not informative in cell-based studies due to its toxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C0947630:studies [Laboratory Procedure]
   706 E C0557651:Study [Manufactured Object]
   706 E C2603343:Study [Research Activity]

Phrase: "(38"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.229: To confirm that the loss of A was indeed due to A catabolism and not to A binding or some other phenomenon, we analyzed the effect of solECE-1 on A by HPLC with a radiolabeled A reporter molecule. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the loss of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "was"

Phrase: "indeed due to A catabolism"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0543484:catabolism [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0699900:Catabolism [Organism Function]
   760   C1516314:Catabolism [Physiologic Function]
   760   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "not to A binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0243122:binding [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1518422:Not [Functional Concept]

Phrase: "or"

Phrase: "some other phenomenon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the effect of solECE-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "with a radiolabeled A reporter molecule."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:Molecule [Substance]
   741 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.230: Incubation of 3H-labeled A40 with solECE-1 resulted in loss of the full-length peptide and formation of at least three novel peaks detected by reversed-phase chromatography (Fig. 6). 

Phrase: "Incubation of 3H-labeled A40"

Phrase: "with solECE-1"

Phrase: "resulted in loss of the full-length peptide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0443225:Full [Qualitative Concept]
   744   C1444754:Length [Quantitative Concept]
   744   C1517945:Loss [Quantitative Concept]
   744   C1706316:LENGTH [Research Activity]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "and"

Phrase: "formation of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0220781:formation [Biologic Function]
   833   C0439634:formation [Spatial Concept]
   833   C1522492:Formation [Functional Concept]

Phrase: "at least three novel peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0444505:peaks [Quantitative Concept]

Phrase: "detected by reversed-phase chromatography"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0597410:Reversed-Phase Chromatography [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726   C1555029:Reverse [Idea or Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.231: The formation of these peaks was completely blocked by treatment with PD069185. 

Phrase: "The formation of these peaks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked by treatment"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0028778:Blocked [Pathologic Function]
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0332206:Blocked [Functional Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C2983591:BLOCKED [Research Activity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "with PD069185."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0671712:PD069185 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.232: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.233: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.234: Degradation of synthetic A40 and A42 by soluble ECE-1. 

Phrase: "Degradation of synthetic A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "A42 by soluble ECE-1."
Processing 00000000.tx.235: Soluble ECE-1 (~6 nM), partially purified from transfected CHO cell medium, was incubated for 24h at 37C with 0.01M A40 (A) or A42 (B). 

Phrase: "Soluble ECE-1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(~6 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "partially"

Phrase: "purified from transfected CHO cell medium,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0085080:CHO cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1705217:Medium [Substance]
   753   C1948049:Cell [Spatial Concept]
   753   C1998793:Purified [Functional Concept]
   753   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "incubated for 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442770:24H [Temporal Concept]

Phrase: "at 37C"

Phrase: "with 0.01M A40"

Phrase: "(A"

Phrase: ")"

Phrase: "or"

Phrase: "A42"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.236: As a control, the enzyme was preincubated for 15min with the ECE inhibitor PD069185 (150M) or phosphoramidon (150M) prior to the addition of A40 or A42, respectively. 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "preincubated for 15min"

Phrase: "with the ECE inhibitor PD069185"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0671712:PD069185 [Organic Chemical,Pharmacologic Substance]

Phrase: "(150M"

Phrase: ")"

Phrase: "or"

Phrase: "phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(150M"

Phrase: ")"

Phrase: "prior to the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of A40"

Phrase: "or"

Phrase: "A42,"

Phrase: "respectively."
Processing 00000000.tx.237: Closed bars, ECE inhibitor; 

Phrase: "Closed bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "ECE inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.238: open bars, no inhibitor. 

Phrase: "open bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "no inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.239: Identical reactions were carried out with co-purifying proteins isolated from nontransfected CHO cells (Control). 

Phrase: "Identical reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0439787:Out [Spatial Concept]
   833   C0849355:Out [Qualitative Concept]

Phrase: "co-purifying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1998793:Purifying [Functional Concept]
   768 E C1947930:Cleanse [Activity]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "isolated from nontransfected CHO cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C0370215:Isolate [Substance]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.240: After the incubation, the remaining A was detected using the BAN50/BA27 and BAN50/BC05 sandwich ELISA systems, which detect full-length A40 or A42 peptides, respectively. 

Phrase: "After the incubation,"

Phrase: "the remaining A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BAN50/BA27"

Phrase: "and"

Phrase: "BAN50/BC05 sandwich ELISA systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   771   C0449913:System [Functional Concept]
   771   C1553451:System [Manufactured Object]
   771   C1704459:System [Medical Device]
   721 E C0205373:Systemic [Functional Concept]

Phrase: "which"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "full-length A40"

Phrase: "or"

Phrase: "A42 peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "respectively."
Processing 00000000.tx.241: Data are plotted as meanS.E. of triplicate reactions. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "plotted as meanS.E. of triplicate reactions."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0205174:Triplicate [Quantitative Concept]
   748   C1704970:Means [Conceptual Entity]
   714   C0443286:Reaction [Functional Concept]
   714 E C0444504:Mean [Quantitative Concept]
   714   C1114821:Reaction [Clinical Attribute]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.242: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.243: 6.  

Phrase: "6."
Processing 00000000.tx.244: HPLC analysis of 3H-labeled A40 degradation by soluble ECE-1. 

Phrase: "HPLC analysis of 3H-labeled A40 degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "by soluble ECE-1."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]
   743 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.245: Soluble ECE-1 (~6 nM) was incubated for 24h at 37C with 3H-labeled A40 (0.56M, 2104 dpm). 

Phrase: "Soluble ECE-1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(~6 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "was"

Phrase: "incubated for 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442770:24H [Temporal Concept]

Phrase: "at 37C"

Phrase: "with 3H-labeled A40"

Phrase: "(0.56M,"

Phrase: "2104 dpm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512024:DPM [Intellectual Product]
   861   C1634619:dpm [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.246: As a control, the enzyme was preincubated for 15min with the ECE inhibitor PD069185 (150M) prior to the addition of A. 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "preincubated for 15min"

Phrase: "with the ECE inhibitor PD069185"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0671712:PD069185 [Organic Chemical,Pharmacologic Substance]

Phrase: "(150M"

Phrase: ")"

Phrase: "prior to the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.247: The resulting peptides were separated by reversed-phase chromatography (C4 column). 

Phrase: "The resulting peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "separated by reversed-phase chromatography"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0597410:Reversed-Phase Chromatography [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0086972:Separated [Finding]
   760   C0205390:Phase [Temporal Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   726   C1555029:Reverse [Idea or Concept]

Phrase: "(C4 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.248: 1-min fractions were collected, and 3H dpm was determined by liquid scintillation counting. 

Phrase: "1-min fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "3H dpm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512024:DPM [Intellectual Product]
   861   C1634619:dpm [Quantitative Concept]

Phrase: "was"

Phrase: "determined by liquid scintillation counting."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726   C0750480:Count [Activity]
   726   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.249: For comparative purposes, synthetic A alone elutes as a single peak at fraction 21,identical to that observed for A incubated with solECE-1 in the presence of PD069185 (data not shown). 

Phrase: "For comparative purposes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285529:purposes [Functional Concept]

Phrase: "synthetic A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "elutes as a single peak"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0444505:Peak [Quantitative Concept]

Phrase: "at fraction 21,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "identical to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "observed for A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1441672:Observed [Functional Concept]

Phrase: "incubated with solECE-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of PD069185"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0671712:PD069185 [Organic Chemical,Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.250: Determination of Cleavage Sites of A40 by solECE-1-- Since ECE-1 has been shown to cleave a number of biologically active peptides on the amino side of hydrophobic residues (16), there are multiple potential ECE-1 cleavage sites within the A peptide. 

Phrase: "Determination of Cleavage Sites of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "by solECE-1"

Phrase: "-"

Phrase: "-"

Phrase: "Since"

Phrase: "ECE-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "a number of biologically active peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "on the amino side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "of hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "are"

Phrase: "multiple potential ECE-1 cleavage sites within the A peptide."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C0205145:Sites [Spatial Concept]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.251: To determine the sites of A40 cleavage, synthetic unlabeled peptide was digested with solECE-1, and the cleavage products were separated by reversed-phase HPLC. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the sites of A40 cleavage,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C2945843:Site of [Qualitative Concept]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "synthetic unlabeled peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "digested with solECE-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "the cleavage products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by reversed-phase HPLC."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0086972:Separated [Finding]
   760   C0205390:Phase [Temporal Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   726   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.252: Digestion of A40 in this experiment resulted in the formation of four major product peaks, similar to that which was observed with the 3H-labeled peptide. 

Phrase: "Digestion of A40"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0012238:Digestion [Organism Function]
   790   C2349986:Digestion [Research Activity]
   734 E C0443277:Peptic [Functional Concept]

Phrase: "in this experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "resulted in the formation of four major product peaks,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0205164:Major [Qualitative Concept]
   742   C0205450:Four [Quantitative Concept]
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C0444505:peaks [Quantitative Concept]
   742   C1514468:product [Entity]
   742   C1522492:Formation [Functional Concept]
   742   C1704444:Product [Quantitative Concept]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "observed with the 3H-labeled peptide."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1441672:Observed [Functional Concept]
   753   C1442460:3H [Temporal Concept]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.253: The major peaks were further analyzed by mass spectrometry and NH2-terminal sequencing, leading to the identification of three NH2-terminal fragments: A-(1-16), A-(1-17), and A-(1-19). 

Phrase: "The major peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed by mass spectrometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C0936012:Analyzed [Research Activity]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "NH2-terminal sequencing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]

Phrase: "leading to the identification of three NH2-terminal fragments"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   742   C0002508:NH2 [Organic Chemical]
   742   C0020792:Identification [Mental Process]
   742   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   742   C0205088:Terminal [Temporal Concept]
   742   C0205396:Identification [Qualitative Concept]
   742   C0205449:Three [Quantitative Concept]
   742   C0332152:Leading [Temporal Concept]
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   742   C1522538:Leading [Functional Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1708096:Fragment [Qualitative Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1-19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.254: Only one C-terminal fragment was observed, which corresponds to A-(20-40) (Fig. 7 and Table I). 

Phrase: "Only one C-terminal fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1707271:C-Terminal [Amino Acid Sequence]
   804   C0205088:Terminal [Temporal Concept]
   804   C0332255:fragment [Functional Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "corresponds to A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(20-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.255: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.256: 7.  

Phrase: "7."
Processing 00000000.tx.257: Determination of sites of A40 cleavage by solECE-1. 

Phrase: "Determination of sites of A40 cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "by solECE-1."
Processing 00000000.tx.258: A, unlabeled synthetic A40 (100M) was digested with solECE-1 (~20 nM) overnight at 37C. 

Phrase: "A,"

Phrase: "unlabeled synthetic A40"

Phrase: "(100M"

Phrase: ")"

Phrase: "was"

Phrase: "digested with solECE-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0868946:digested [Physiologic Function]

Phrase: "(~20 nM) overnight at 37C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]
Processing 00000000.tx.259: The cleavage products were separated by reversed-phase HPLC using a C4 column. 

Phrase: "The cleavage products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by reversed-phase HPLC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0086972:Separated [Finding]
   760   C0205390:Phase [Temporal Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   726   C1555029:Reverse [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a C4 column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
Processing 00000000.tx.260: Half-minute fractions were collected, and absorbance was monitored at 215nm. 

Phrase: "Half-minute fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1268822:Absorbance [Clinical Attribute]
  1000   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "monitored at 215nm."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.261: B, amino acid sequence of A40 showing principal solECE-1 cleavage sites. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "amino acid sequence of A40"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1519249:Sequence [Functional Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "principal solECE-1 cleavage sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0205145:Sites [Spatial Concept]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.262: The identities of HPLC peaks 1-5 were determined by mass spectrometry and NH2-terminal sequencing (see Table I). 

Phrase: "The identities of HPLC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0424215:identities [Mental Process]
   737 E C2003939:Identity [Finding]

Phrase: "peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "1-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "were"

Phrase: "determined by mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "NH2-terminal sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.263: The open arrows under the sequence indicate previously determined NEP cleavage sites (8).  

Phrase: "The open arrows under the sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "previously determined NEP cleavage sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0205145:Sites [Spatial Concept]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.264: View this table: [in this window] [in a new window]  Table I Identification of cleavage sites of A40 by solECE-1 Synthetic A40 was digested with solECE-1, and the resulting peptides were separated by HPLC as shown in Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Identification of cleavage sites of A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "by solECE-1 Synthetic A40"

Phrase: "was"

Phrase: "digested with solECE-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "the resulting peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "separated by HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.265: 7A. 

Phrase: "7A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.266: Peaks 1-5 were collected and further analyzed by mass spectrometry and NH2-terminal sequencing. 

Phrase: "Peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "1-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed by mass spectrometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C0936012:Analyzed [Research Activity]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "NH2-terminal sequencing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.267: Kinetic Analysis of A40 Cleavage by solECE-1-- SolECE-1 has been reported to hydrolyze big ET-1 with a Km of ~2-4 M (16, 36, 37) and bradykinin with a Km of 340M (16). 

Phrase: "Kinetic Analysis of A40 Cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "by solECE-1"

Phrase: "--"

Phrase: "SolECE-1"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "hydrolyze"

Phrase: "big ET-1 with a Km of ~2-4"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   784   C0913440:big ET-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0079282:ET-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0217843:ET-A [Amino Acid, Peptide, or Protein,Receptor]
   762   C1413561:BIG-1 [Gene or Genome]
   762   C1413562:BIG-2 [Gene or Genome]
   742   C0549177:Big [Quantitative Concept]

Phrase: "M ("

Phrase: "16,"

Phrase: "36,"

Phrase: "37"

Phrase: ")"

Phrase: "and"

Phrase: "bradykinin with a Km of 340M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   753   C1537501:bradykinin [Gene or Genome]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.268: Despite a much higher Km, the catalytic efficiency of bradykinin hydrolysis by solECE-1 actually exceeds that of big ET-1, with a second order rate constant of 6.6104 M1 s1 for bradykinin compared with 2.5104 M1 s1 for big ET-1 at pH 6.5(16). 

Phrase: "Despite a much higher Km,"

Phrase: "the catalytic efficiency of bradykinin hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013682:Efficiency [Quantitative Concept]

Phrase: "by solECE-1 actually"

Phrase: "exceeds"

Phrase: "that of big ET-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1413561:BIG-1 [Gene or Genome]
   760   C0549177:Big [Quantitative Concept]

Phrase: "with a second order rate constant"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   861   C2986811:Rate Constant [Quantitative Concept]
   812   C0205436:Second [Quantitative Concept]
   812   C0457385:Second [Temporal Concept]
   812   C0565930:/second [Quantitative Concept]
   812   C0871208:Rate [Activity]
   812   C1521828:Rate [Quantitative Concept]
   812   C1547014:*Constant [Quantitative Concept]
   812   C1561503:second [Idea or Concept]
   812   C1705175:Order [Intellectual Product]
   812   C1705176:Order [Qualitative Concept]
   812   C1705177:Order [Classification]
   812   C1705178:Order [Activity]
   812   C1705190:Second [Qualitative Concept]
   812   C1882348:Order [Qualitative Concept]
   812   C1948059:Constant [Qualitative Concept]
   741 E C0027627:secondary [Neoplastic Process]
   741 E C0175668:Secondary [Temporal Concept]

Phrase: "of 6.6104 M1 s1"

Phrase: "for bradykinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "compared with 2.5104 M1 s1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Compared [Activity]

Phrase: "for big ET-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1413561:BIG-1 [Gene or Genome]
   901   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0549177:Big [Quantitative Concept]

Phrase: "at pH 6.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.269: To attempt to determine the Km for A40 hydrolysis by solECE-1, we initially examined the rate of hydrolysis of A at various substrate concentrations up to 20M at the reported pH optimum for big ET-1 cleavage. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "attempt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the Km for A40 hydrolysis"

Phrase: "by solECE-1,"

Phrase: "we initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the rate of hydrolysis of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "at various substrate concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "up to 20M"

Phrase: "at the reported pH optimum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2698651:Optimum [Qualitative Concept]

Phrase: "for big ET-1 cleavage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]
   708   C1413561:BIG-1 [Gene or Genome]
Processing 00000000.tx.270: The rate of A hydrolysis was linear with respect to substrate concentration up to 20M (data not shown). 

Phrase: "The rate of A hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "linear with respect to substrate concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205132:Linear [Spatial Concept]

Phrase: "up to 20M"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.271: We were concerned that the use of significantly higher concentrations of A in these experiments would complicate the kinetic measurements, since A40 peptide is prone to aggregate and precipitate in the high micromolar range. 

Phrase: "We"

Phrase: "were"

Phrase: "concerned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "that"

Phrase: "the use of significantly higher concentrations of A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1524063:Use of [Functional Concept]
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C1947944:Use [Intellectual Product]

Phrase: "in these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "would"

Phrase: "complicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231242:complicate [Functional Concept]

Phrase: "the kinetic measurements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "since"

Phrase: "A40 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "prone to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033422:Prone [Spatial Concept]

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "precipitate in the high micromolar range."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1882443:PRECIPITATE [Phenomenon or Process]
Processing 00000000.tx.272: Thus, we were unable to determine the Km and Vmax. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "determine"

Phrase: "the Km"

Phrase: "and"

Phrase: "Vmax."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710637:Vmax [Phenomenon or Process]
Processing 00000000.tx.273: We were able, however, to calculate the kcat/Km by measuring the rate of A hydrolysis by solECE under second-order conditions. 

Phrase: "We"

Phrase: "were"

Phrase: "able, however,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the kcat/Km by measuring"

Phrase: "the rate of A hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "by solECE"

Phrase: "under second-order conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.274: Under these conditions, when the substrate concentration is well below Km, the rate of substrate hydrolysis is equal to the kcat/Km multiplied by the enzyme concentration (see "Experimental Procedures"). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "when"

Phrase: "the substrate concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "well below Km,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205170:Well [Qualitative Concept]
   790   C3146287:Well [Manufactured Object]

Phrase: "the rate of substrate hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "is"

Phrase: "equal to the kcat/Km"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0205163:Equal To [Qualitative Concept]
           Equal
   760   C1549782:Equal [Idea or Concept]

Phrase: "multiplied by the enzyme concentration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]
   726   C1719797:Multiply [Functional Concept]
   726   C2911648:Multiply [Quantitative Concept]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.275: Using this method, the kcat/Km for A40 hydrolysis by solECE-1 was determined to be (1.70.6)103 M1 s1 at pH 6.5.

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "the kcat/Km for A40 hydrolysis"

Phrase: "by solECE-1"

Phrase: "was"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be ("

Phrase: "1.70.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "103 M1 s1 at pH 6.5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   774   C1414297:S1-5 [Gene or Genome]
Processing 00000000.tx.276: This value is 15-fold lower than that for big ET-1 hydrolysis under the same conditions. 

Phrase: "This value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "15-fold lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "for big ET-1 hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020291:Hydrolysis [Natural Phenomenon or Process]
   708   C1413561:BIG-1 [Gene or Genome]

Phrase: "under the same conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.277: Intrigued by a recent report indicating that solECE-1 cleaves bradykinin and substance P with an acidic pH optimum of ~5.6 compared with the optimum of pH 6.5for big ET-1 (53), we next compared the efficiency of solECE-1 hydrolysis of A40 and big ET-1 at pH 5.6.

Phrase: "Intrigued by a recent report"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332185:Recent [Temporal Concept]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "indicating"

Phrase: "that solECE-1"

Phrase: "cleaves"

Phrase: "bradykinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "and"

Phrase: "substance P with an acidic pH optimum of ~5.6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0038585:Substance P [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C1420563:substance P [Gene or Genome]
   739   C0439861:Substance [Substance]

Phrase: "compared with the optimum of pH 6.5for big ET-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1413561:BIG-1 [Gene or Genome]
   738   C0020283:[pH] [Quantitative Concept]
   738   C0450407:ph+ [Finding]
   738   C0450408:ph++ [Finding]
   738   C0450409:ph+++ [Finding]
   738   C0549177:Big [Quantitative Concept]
   738   C1707455:Compared [Activity]
   738   C2698651:Optimum [Qualitative Concept]

Phrase: "(53"

Phrase: ")"

Phrase: ","

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the efficiency of solECE-1 hydrolysis of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0013682:Efficiency [Quantitative Concept]

Phrase: "and"

Phrase: "big ET-1 at pH 5.6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1413561:BIG-1 [Gene or Genome]
   748   C0549177:Big [Quantitative Concept]
Processing 00000000.tx.278: Similar to bradykinin and substance P, solECE-1 cleaves A40 more efficiently at pH 5.6,with a kcat/Km determined to be (2.00.5)104 M1 s1, ~12 times greater than the value determined at pH 6.5.

Phrase: "Similar to bradykinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "substance P,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038585:Substance P [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1420563:substance P [Gene or Genome]
   861   C0439861:Substance [Substance]

Phrase: "solECE-1"

Phrase: "cleaves"

Phrase: "A40 more efficiently at pH 5.6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0020283:[pH] [Quantitative Concept]
   748   C0450407:ph+ [Finding]
   748   C0450408:ph++ [Finding]
   748   C0450409:ph+++ [Finding]

Phrase: "with a kcat/Km"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be ("

Phrase: "2.00.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0450346:2 5 [Quantitative Concept]
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "104 M1 s1,"

Phrase: "~12 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "greater than the value"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "determined at pH 6.5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
Processing 00000000.tx.279: The kcat/Km for big ET-1 hydrolysis by our preparation of solECE-1 at pH 5.6under these conditions was determined to be ~6.1104 M1 s1 at pH 5.6,slightly greater than that determined at pH 6.5.

Phrase: "The kcat/Km for big ET-1 hydrolysis"

Phrase: "by our preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of solECE-1"

Phrase: "at pH 5.6under"

Phrase: "these conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "was"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be ~"

Phrase: "6.1104 M1 s1 at pH 5.6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C1414297:S1-5 [Gene or Genome]

Phrase: "slightly greater than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "determined at pH 6.5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
Processing 00000000.tx.280: This value of kcat/Km for big ET-1 hydrolysis at pH 5.6is only 3-fold greater than that for A40 at the same pH. 

Phrase: "This value of kcat/Km"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1522609:Value [Quantitative Concept]

Phrase: "for big ET-1 hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020291:Hydrolysis [Natural Phenomenon or Process]
   708   C1413561:BIG-1 [Gene or Genome]

Phrase: "at pH 5.6is only 3-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0332462:Fold [Spatial Concept]
   799   C1880834:FOLD [Phenomenon or Process]
   709   C0601906:PH 3 [Pharmacologic Substance]

Phrase: "greater than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "for A40"

Phrase: "at the same pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.281: It is important to note that the kcat/Km values reported here rely on a determination of enzyme concentration based on the reported kcat/Km of big ET-1 hydrolysis by solECE-1 at pH 6.5(see "Experimental Procedures"), and thus the absolute values may differ based on any differences in actual enzyme concentration from our estimates. 

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the kcat/Km values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "rely on a determination of enzyme concentration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0086045:Concentration [Mental Process]
   748   C1148554:determination [Laboratory Procedure]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "based on the reported kcat/Km of big ET-1 hydrolysis"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   756   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1413561:BIG-1 [Gene or Genome]
   738   C0020291:Hydrolysis [Natural Phenomenon or Process]
   738   C0549177:Big [Quantitative Concept]
   738   C0684224:Reported [Intellectual Product]
   738   C0700287:Reported [Health Care Activity]
   738   C1527178:Based [Functional Concept]
   738   C1705938:Based [Idea or Concept]
   738   C3496591:Reported [Clinical Attribute]
   704 E C0002055:base [Inorganic Chemical]
   704 E C0178499:Base [Chemical Viewed Functionally]
   704 E C1880279:Base [Biomedical or Dental Material]
   704 E C3273238:Report [Intellectual Product]

Phrase: "by solECE-1"

Phrase: "at pH 6.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "thus"

Phrase: "the absolute values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205344:Absolute Value [Qualitative Concept]
           Absolute
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "may"

Phrase: "differ"

Phrase: "based on any differences"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "in actual enzyme concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "from our estimates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:estimates [Quantitative Concept]
Processing 00000000.tx.282: However, the relative kcat/Km for A40 hydrolysis versus big ET-1 hydrolysis was determined in parallel experiments with the same enzyme and would not change even if the estimated concentration of enzyme were slightly different.  

Phrase: "However,"

Phrase: "the relative kcat/Km for A40 hydrolysis"

Phrase: "versus"

Phrase: "big ET-1 hydrolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020291:Hydrolysis [Natural Phenomenon or Process]
   708   C1413561:BIG-1 [Gene or Genome]

Phrase: "was"

Phrase: "determined"

Phrase: "in parallel experiments with the same enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "even"

Phrase: "if"

Phrase: "the estimated concentration of enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "slightly different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.283: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Recently, there has been considerable debate over the enzyme or enzymes that contribute most to A catabolism in the human brain. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "there"

Phrase: "has"

Phrase: "been"

Phrase: "considerable debate over the enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0870392:debate [Activity]

Phrase: "or"

Phrase: "enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "most to A catabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0205393:Most [Quantitative Concept]
   770   C0543484:catabolism [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0699900:Catabolism [Organism Function]
   770   C1516314:Catabolism [Physiologic Function]

Phrase: "in the human brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.284: Both insulin-degrading enzyme and neprilysin have been argued to be major proteases involved in the degradation of secreted A (5, 9). 

Phrase: "Both insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "argued"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "major proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "involved in the degradation of secreted A"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0243125:degradation [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0699900:Degradation [Organism Function]
   748   C1314939:Involved [Functional Concept]
   748   C1327616:Secreted [Cell Function]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.285: However, with the data available at this time, it is impossible to determine which, if any, of the identified proteases contributes most to A degradation in the intact brain. 

Phrase: "However,"

Phrase: "with the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "available at this time,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "impossible to"

Phrase: "determine"

Phrase: "which,"

Phrase: "if"

Phrase: "any,"

Phrase: "of the identified proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "most to A degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0205393:Most [Quantitative Concept]
   770   C0243125:degradation [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0699900:Degradation [Organism Function]

Phrase: "in the intact brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683213:intact brain [Organ or Tissue Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.286: It is likely that multiple proteases, both intracellular and extracellular, may play a role in determining A concentration. 

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that multiple proteases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "both intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "and"

Phrase: "extracellular,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521119:Extracellular [Cell Component]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in determining A concentration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.287: The relative contribution of A-degrading enzymes and other mechanisms of A removal may vary in different regions of the brain and may also differ for A40 and A42. 

Phrase: "The relative contribution of A-degrading enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "other mechanisms of A removal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "vary in different regions of the brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1273723:brain regions [Body Location or Region]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1705242:Different [Qualitative Concept]
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "may"

Phrase: "also"

Phrase: "differ for A40"

Phrase: "and"

Phrase: "A42."
Processing 00000000.tx.288: A decrease in the activity of any of these mechanisms, whether they are major or minor, may potentially result in increased A accumulation and the development of AD pathology. 

Phrase: "A decrease in the activity of any of these mechanisms,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0392756:Decrease [Qualitative Concept]
   739   C0547047:Decrease [Quantitative Concept]

Phrase: "whether"

Phrase: "they"

Phrase: "are"

Phrase: "major"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205164:Major [Qualitative Concept]

Phrase: "or"

Phrase: "minor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026193:Minor [Population Group]
  1000   C0205165:Minor [Qualitative Concept]

Phrase: "may"

Phrase: "potentially"

Phrase: "result in increased A accumulation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "and"

Phrase: "the development of AD pathology."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.289: Conversely, an increase in the activity of any enzyme capable of degrading A may result in decreased accumulation of the peptide, potentially reducing the risk for AD. 

Phrase: "Conversely,"

Phrase: "an increase in the activity of any enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "capable of degrading A"

Phrase: "may"

Phrase: "result in decreased accumulation of the peptide,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "potentially"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the risk for AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.290: Taken together, the data presented in this report indicate that ECE-1 activity can dramatically affect A concentration, probably by direct degradation of the peptide. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented in this report"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0449450:Presented [Idea or Concept]
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C3273238:Report [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "indicate"

Phrase: "that ECE-1 activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0243102:enzyme activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "dramatically"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "A concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "probably by direct degradation of the peptide."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C1523817:peptide degradation [Molecular Function]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0243125:degradation [Functional Concept]
   748   C0439851:Direct [Qualitative Concept]
   748   C0699900:Degradation [Organism Function]
   748   C0750492:Probably [Idea or Concept]
   748   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.291: Recombinant soluble ECE-1 has a substrate specificity in non-ET peptides similar to that of NEP, with preferential cleavage on the amino side of hydrophobic residues (16). 

Phrase: "Recombinant soluble ECE-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C1514798:recombinant [Organism]
   812   C1749467:soluble [Cell Component]
   812   C1948047:Soluble [Qualitative Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "a substrate specificity in non-ET peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0038592:Substrate Specificity [Quantitative Concept]
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]
   748   C1710236:Substrate [Manufactured Object]
   738   C0205370:Non-specific [Qualitative Concept]

Phrase: "similar to that of NEP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "with preferential cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "on the amino side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "of hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.292: In contrast to NEP, however, ECE-1 appears not to cleave peptides smaller than 6amino acids in length. 

Phrase: "In contrast to NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "however,"

Phrase: "ECE-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "cleave"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "smaller than 6amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0547044:Smaller [Qualitative Concept]
   770   C0700321:Smaller [Quantitative Concept]

Phrase: "in length."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]
Processing 00000000.tx.293: Given this specificity, there are ~13 potential ECE/NEP cleavage sites in the A40 peptide. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "this specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "there"

Phrase: "are ~"

Phrase: "13 potential ECE/NEP cleavage sites in the A40 peptide."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C0205145:Sites [Spatial Concept]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.294: At least five of these sites are reported to be cleaved by recombinant NEP in vitro (8). 

Phrase: "At least five"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205451:Five [Quantitative Concept]
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "of these sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cleaved by recombinant NEP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]
   770   C1366499:NEPRILYSIN [Gene or Genome]
   770   C1514798:recombinant [Organism]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.295: Using HPLC, mass spectrometry, and NH2-sequence analysis, we have determined that soluble ECE-1 cleaves synthetic A40 at least three sites, resulting in the formation of A fragments 1-16, 1-17, 1-19, and 20-40. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "mass spectrometry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "NH2-sequence analysis,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   901   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0936012:Analysis [Research Activity]
   827   C1519249:Sequence [Functional Concept]
   827   C1524024:analysis [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "determined"

Phrase: "that soluble ECE-1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "cleaves"

Phrase: "synthetic A40 at least three sites,"

Phrase: "resulting in the formation of A"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0332294:Resulting in [Functional Concept]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0678226:resulting [Functional Concept]
   753   C1522492:Formation [Functional Concept]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "1-16,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1-17,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1-19,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "20-40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.296: Consistent with the known substrate specificity of ECE-1, each of these observed cleavages by solECE-1 occurred on the amino side of hydrophobic residues (Leu17, Val18, and Phe20). 

Phrase: "Consistent with the known substrate specificity of ECE-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "each of these observed cleavages"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1441672:Observed [Functional Concept]
   760   C1457900:Each [Quantitative Concept]
   726   C0010813:cleavage [Cell Function]
   726   C0596311:Cleavage [Phenomenon or Process]
   726   C1330957:cleavage [Cell Function]

Phrase: "by solECE-1"

Phrase: "occurred on the amino side of hydrophobic residues"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0441987:Side [Spatial Concept]
   744   C0598629:Hydrophobic [Qualitative Concept]
   744   C1709305:Occurred [Activity]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]
   711 E C2745955:OCCUR [Temporal Concept]

Phrase: "(Leu17,"

Phrase: "Val18,"

Phrase: "and"

Phrase: "Phe20"

Phrase: ")."
Processing 00000000.tx.297: Given that ECE-2 is highly homologous to ECE-1 and shares similar catalytic activity (29), we hypothesize that ECE-2 may also be capable of degrading A. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "is"

Phrase: "highly homologous to ECE-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homologous [Gene or Genome]

Phrase: "and"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "similar catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0243102:catalytic activity [Molecular Function]
   901   C1264638:Catalytic activity [Functional Concept]
   901   C1547012:*Catalytic Activity [Quantitative Concept]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "hypothesize"

Phrase: "that ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "capable of degrading A."
Processing 00000000.tx.298: Since ECE-2 is abundantly expressed in the central nervous system, this activity may also potentially be relevant to the accumulation of A in the brain. 

Phrase: "Since"

Phrase: "ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "is"

Phrase: "abundantly"

Phrase: "expressed in the central nervous system,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0927232:Central Nervous System [Body System]
   833   C1269563:Central nervous system [Body System]
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0205099:Central [Spatial Concept]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1879652:Central - [Laboratory Procedure]
   734 E C0205494:Neurologic [Qualitative Concept]

Phrase: "this activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "also potentially"

Phrase: "be"

Phrase: "relevant to the accumulation of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevant [Qualitative Concept]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.299: ECE-1 activity is localized both intracellularly and on the cell surface in many cell types, with ECE-2 appearing to reside exclusively within the cell. 

Phrase: "ECE-1 activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0243102:enzyme activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "both intracellularly"

Phrase: "and on the cell surface"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1515981:And [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in many cell types,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "with ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "appearing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2982691:Reside [Activity]

Phrase: "exclusively within the cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.300: In CHO cells overexpressing human ECE-1a, we observed increased phosphoramidon-sensitive removal of exogenous A after 24h of incubation, indicating that ECE-1a may also contribute slightly to the extracellular degradation of the peptide. 

Phrase: "In CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "human ECE-1a,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "increased phosphoramidon-sensitive removal of exogenous A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015252:Removal [Therapeutic or Preventive Procedure]
   748   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "after 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "of incubation,"

Phrase: "indicating"

Phrase: "that ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "may"

Phrase: "also"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "slightly to the extracellular degradation of the peptide."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1523817:peptide degradation [Molecular Function]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0243125:degradation [Functional Concept]
   744   C0521119:Extracellular [Cell Component]
   744   C0699900:Degradation [Organism Function]
   744   C0750482:Slightly [Idea or Concept]
Processing 00000000.tx.301: In CHO cells overexpressing ECE-1b and in H4 neuroglioma cells expressing endogenous ECE, degradation of exogenous A was not sensitive to phosphoramidon. 

Phrase: "In CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "ECE-1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and in H4 neuroglioma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "endogenous ECE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1414244:ECE [Gene or Genome]

Phrase: "degradation of exogenous A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "not sensitive to phosphoramidon."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.302: These results raise the possibility that the dramatic increase in A accumulation by these cells in the presence of phosphoramidon may be due to inhibition of intracellular degradation of the peptide. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that"

Phrase: "the dramatic increase in A accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "by these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "may"

Phrase: "be due to inhibition of intracellular degradation of the peptide."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   760   C0678226:Due to [Functional Concept]
           due
   757   C1523817:peptide degradation [Molecular Function]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0175996:intracellular [Cell Component]
   739   C0178719:Intracellular [Spatial Concept]
   739   C0243125:degradation [Functional Concept]
   739   C0699900:Degradation [Organism Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C2987476:Be [Conceptual Entity]
   739   C3146286:Due [Idea or Concept]
   739   C3463820:Inhibition [Activity]
Processing 00000000.tx.303: Even in ECE-1a-expressing CHO cells, the dramatic increase in A concentration upon treatment with phosphoramidon does not appear to be accounted for by the modest increase in exogenous A degradation. 

Phrase: "Even in ECE-1a-expressing CHO cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0085080:CHO Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0450344:1A [Intellectual Product]
   748   C1414244:ECE [Gene or Genome]
   748   C1553633:1a [Medical Device]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "the dramatic increase in A concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "upon treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by the modest increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in exogenous A degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]
Processing 00000000.tx.304: We cannot, however, rule out the possibility of a local event at the cell surface upon secretion of endogenous A that might not be evident in our spike experiments, where the peptide is diluted directly into the culture medium. 

Phrase: "We"

Phrase: "cannot"

Phrase: ","

Phrase: "however,"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility of a local event"

Phrase: "at the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "upon secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "of endogenous A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "might"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "evident in our spike experiments,"

Phrase: "where"

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "directly into the culture medium."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C1947931:Directly [Qualitative Concept]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]
Processing 00000000.tx.305: While ECE-1a has been reported to be localized predominantly to the cell surface, this isoform has been shown to process big ET-1 intracellularly in CHO cells, most likely in secretory vesicles, as well as at the cell surface (54). 

Phrase: "While"

Phrase: "ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "predominantly to the cell surface,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "this isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "has"

Phrase: "been"

Phrase: "shown to process big ET-1 intracellularly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1413561:BIG-1 [Gene or Genome]
   748   C0549177:Big [Quantitative Concept]
   748   C1184743:Process [Body Part, Organ, or Organ Component]
   748   C1522240:Process [Phenomenon or Process]
   714   C1547282:Show [Intellectual Product]

Phrase: "in CHO cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "most likely in secretory vesicles,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0750501:most likely [Idea or Concept]
   760   C0332148:Likely [Qualitative Concept]
   760   C0750492:Likely [Idea or Concept]

Phrase: "as well as at the cell surface"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0699040:Cell surface [Cell Component]
   748   C0007634:Cell [Cell]
   748   C0205148:Surface [Spatial Concept]
   748   C0205170:Well [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3146287:Well [Manufactured Object]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.306: Therefore, ECE-1a may similarly degrade A intracellularly in CHO cells as it is being trafficked to the cell surface. 

Phrase: "Therefore,"

Phrase: "ECE-1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "may"

Phrase: "similarly"

Phrase: "degrade"

Phrase: "A intracellularly in CHO cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "it"

Phrase: "is"

Phrase: "being"

Phrase: "trafficked to the cell surface."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0599896:trafficked [Cell Function]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.307: While detailed co-localization studies have not been performed, separate studies indicate that ECE and A are present in the same cellular compartments. 

Phrase: "While"

Phrase: "detailed co-localization studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "separate studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that ECE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "present in the same cellular compartments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
Processing 00000000.tx.308: Human ECE-1b has been reported to be present in the TGN, a proposed site of A40 generation in neuronal cells (24, 55). 

Phrase: "Human ECE-1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450345:1B [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in the TGN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "a proposed site of A40 generation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "in neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(24,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.309: Interestingly, we found that solECE-1 hydrolyzed A40 more efficiently at pH 5.6than at pH 6.5,with a kcat/Km at pH 5.6only 3-fold lower than that for a known physiological substrate, big ET-1. 

Phrase: "Interestingly,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that solECE-1 hydrolyzed A40 more efficiently at pH 5.6than"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0020283:[pH] [Quantitative Concept]
   738   C0450407:ph+ [Finding]
   738   C0450408:ph++ [Finding]
   738   C0450409:ph+++ [Finding]

Phrase: "at pH 6.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with a kcat/Km"

Phrase: "at pH 5.6only 3-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]
   708   C0601906:PH 3 [Pharmacologic Substance]

Phrase: "lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "for a known physiological substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "big ET-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1413561:BIG-1 [Gene or Genome]
   901   C0079281:ET-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0549177:Big [Quantitative Concept]
Processing 00000000.tx.310: This result may be particularly relevant, since the TGN, where ECE-1b appears to be expressed, has an acidic pH. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "particularly relevant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "since"

Phrase: "the TGN,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "where ECE-1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450345:1B [Intellectual Product]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "expressed"

Phrase: ","

Phrase: "has"

Phrase: "an acidic pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.311: ECE-2 is also likely to be present in the TGN and vesicles of the constitutive secretory pathway (29, 31). 

Phrase: "ECE-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1567265:ECE-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414244:ECE [Gene or Genome]

Phrase: "is"

Phrase: "also likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "present in the TGN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "vesicles of the constitutive secretory pathway"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0886515:Secretory Vesicles [Cell Component]
   753   C0333262:VESICLES [Acquired Abnormality]
   719 E C1622418:vesicle [Cell Component]

Phrase: "(29,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.312: Consistent with the hypothesis that phosphoramidon may inhibit intracellular degradation of A, Fuller et al. 

Phrase: "Consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "may"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "intracellular degradation of A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "Fuller et al."
Processing 00000000.tx.313: (40) have reported that phosphoramidon treatment of SY5Y neuronal cells results in an increase in cell-associated A. 

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that phosphoramidon treatment of SY5Y neuronal cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "results in an increase in cell-associated A."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   770   C0699040:cell associated [Cell Component]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cell [Cell]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0332281:Associated [Qualitative Concept]
   744   C0442805:Increase [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1269647:Cell [Cell]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2825142:Result [Finding]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.314: Unfortunately, we have not been able to convincingly detect intracellular A in H4 cells either in the presence or absence of phosphoramidon, presumably due to rapid secretion of the peptide. 

Phrase: "Unfortunately,"

Phrase: "we"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "able to convincingly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "intracellular A in H4 cells either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of phosphoramidon,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "presumably due to rapid secretion of the peptide."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0678226:Due to [Functional Concept]
           due
   767   C1819802:peptide secretion [Cell Function]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0439831:Rapid [Qualitative Concept]
   744   C3146286:Due [Idea or Concept]
Processing 00000000.tx.315: However, the fact that removal of exogenous A by H4 cells is insensitive to phosphoramidon suggests that the compound may exert its effect on A through an intracellular event. 

Phrase: "However,"

Phrase: "the fact"

Phrase: "that removal of exogenous A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "by H4 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "insensitive to phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0237677:Insensitivity [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "may"

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "its effect on A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "through an intracellular event."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]
Processing 00000000.tx.316: Phosphoramidon itself has a polar structure that would appear to make it poorly cell-penetrant (56). 

Phrase: "Phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "itself"

Phrase: "has"

Phrase: "a polar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813983:polar [Quantitative Concept]

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "that"

Phrase: "would"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it poorly cell-penetrant"

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.317: However, this compound has been shown to be able to inhibit the intracellular conversion of big ET-1 to mature endothelin (17, 29, 57). 

Phrase: "However,"

Phrase: "this compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the intracellular conversion of big ET-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439836:Conversion [Functional Concept]

Phrase: "to mature endothelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(17,"

Phrase: "29,"

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.318: It is possible that phosphoramidon may elevate A accumulation through inhibition of intracellular ECE, cell surface ECE, or both, depending on the expression of cell surface and intracellular ECE in various cell types. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "may"

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "A accumulation through inhibition of intracellular ECE,"

Phrase: "cell surface ECE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1414244:ECE [Gene or Genome]
   734   C0699040:Cell surface [Cell Component]

Phrase: "or"

Phrase: "both,"

Phrase: "depending on the expression of cell surface"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0699040:Surface of cell [Cell Component]
           Cell surface
   748   C0007634:Cell [Cell]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205148:Surface [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714   C0725813:depend [Medical Device]

Phrase: "and"

Phrase: "intracellular ECE in various cell types."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1414244:ECE [Gene or Genome]
Processing 00000000.tx.319: The 2-3-fold increase in endogenous A accumulation by cell lines treated with phosphoramidon is as large as or larger than that seen in cells expressing most AD-causing mutations (2), suggesting that disruption of phosphoramidon-sensitive A degradation may be a significant risk factor for AD. 

Phrase: "The 2-3-fold increase in endogenous A accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "by cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "treated with phosphoramidon"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "is as large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0549177:Large [Quantitative Concept]

Phrase: "as"

Phrase: "or"

Phrase: "larger than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0443228:larger [Quantitative Concept]
   790   C0549177:Larger [Quantitative Concept]
   790   C1704243:Larger [Quantitative Concept]

Phrase: "seen in cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0205397:Seen [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C0042789:see [Organism Function]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1947903:See [Activity]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "most AD-causing mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that disruption of phosphoramidon-sensitive A degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:Disruption [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "a significant risk factor for AD."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035648:Risk factor [Quantitative Concept]
   783   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   783   C0960756:factor A [Organic Chemical]
   753   C0035647:Risk [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.320: While many factors in addition to ECE probably contribute to endothelin levels, and the results are controversial, it is noteworthy that decreases in endothelin levels have been reported in the cerebral spinal fluid of AD patients when compared with nondemented control individuals (58). 

Phrase: "While"

Phrase: "many factors in addition to ECE probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "contribute to endothelin levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "controversial,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "it"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that decreases in endothelin levels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0547047:decreases [Quantitative Concept]
   726 E C0392756:Decrease [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported in the cerebral spinal fluid of AD patients"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0007806:Cerebral Spinal Fluid [Body Substance]
           Spinal fluid
   745   C0747307:patients report [Intellectual Product]
   742   C0005889:FLUID [Body Substance]
   742   C0030705:Patients [Patient or Disabled Group]
   742   C0302908:fluid [Substance]
   742   C0444611:Fluid [Qualitative Concept]
   742   C0521329:Spinal [Spatial Concept]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C1704353:Fluid [Substance]
   742   C3496591:Reported [Clinical Attribute]
   708 E C3273238:Report [Intellectual Product]

Phrase: "when"

Phrase: "compared with nondemented control individuals"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.321: A reasonable test for the degree of involvement of ECE or any protease in the brain is to examine the effect of animals null for these enzymes. 

Phrase: "A reasonable test for the degree of involvement of ECE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0022885:Test [Laboratory Procedure]
   739   C0039593:Test [Functional Concept]
   739   C0392366:test [Intellectual Product]

Phrase: "or"

Phrase: "any protease in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1947941:Protease [Enzyme]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the effect of animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "null for these enzymes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456148:Null [Quantitative Concept]
Processing 00000000.tx.322: ECE-1 knockout mice have craniofacial and cardiac abnormalities resulting in embryonic lethality, while ECE-2 knockout mice develop normally and are viable (32, 59). 

Phrase: "ECE-1 knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "craniofacial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596392:craniofacial [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cardiac abnormalities"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0018798:Cardiac abnormalities [Congenital Abnormality]
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "resulting in embryonic lethality,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0013935:Embryonic [Embryonic Structure]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "while"

Phrase: "ECE-2 knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "develop"

Phrase: "normally"

Phrase: "and"

Phrase: "are"

Phrase: "viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:Viable [Qualitative Concept]

Phrase: "(32,"

Phrase: "59"

Phrase: ")."
Processing 00000000.tx.323: Surprisingly, large amounts of mature ET-1 peptide are detected in both lines. 

Phrase: "Surprisingly,"

Phrase: "large amounts of mature ET-1 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:amounts [Quantitative Concept]

Phrase: "are"

Phrase: "detected in both lines."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205132:lines [Spatial Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.324: In ECE-1/ECE-2 double knockout mice, the cardiac defects are even more severe; 

Phrase: "In ECE-1/ECE-2 double knockout mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0206745:Knock-out Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "the cardiac defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0741916:Cardiac defects [Disease or Syndrome]
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "are"

Phrase: "even more severe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205082:Severe [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.325: however, mature ET-1 peptides are still detected, indicating compensation by as yet unidentified proteases (32, 59). 

Phrase: "however,"

Phrase: "mature ET-1 peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "still"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "indicating"

Phrase: "compensation by"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0152057:Compensation [Mental Process]
   833   C0152058:Compensation [Physiologic Function]
   833   C0220808:Compensation [Quantitative Concept]

Phrase: "as yet unidentified proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Proteases [Enzyme]

Phrase: "(32,"

Phrase: "59"

Phrase: ")."
Processing 00000000.tx.326: The apparent redundancy of endothelin-converting enzyme activity may limit the utility of the knockouts to examine the contribution of ECE in A accumulation in vivo. 

Phrase: "The apparent redundancy of endothelin-converting enzyme activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1313915:Redundancy [Functional Concept]

Phrase: "may"

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "the utility of the knockouts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0582205:utility [Organization]

Phrase: "examine"

Phrase: "the contribution of ECE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "in A accumulation"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.327: Nonetheless, these experiments are under way and may provide additional insight into the role of ECE in endogenous A accumulation in the brain. 

Phrase: "Nonetheless,"

Phrase: "these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "under way"

Phrase: "and"

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "additional insight into the role of ECE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0233820:Insight [Mental Process]

Phrase: "in endogenous A accumulation"

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.328: Regardless of the extent of the in vivo role of ECE activity in the amount of A accumulation in the brain, these results are highly significant for several reasons. 

Phrase: "Regardless of the extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "of the in vivo role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "of ECE activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of A accumulation"

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "highly significant for several reasons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1299395:Highly significant [Qualitative Concept]
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.329: First, ECE inhibitors have received a large amount of pharmaceutical interest for their potential as anti-hypertension drugs (60). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "ECE inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "have"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "a large amount of pharmaceutical interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "for their potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]

Phrase: "as anti-hypertension drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.330: If degradation of A by ECE does, as we hypothesize, contribute to the extracellular concentration of the plaque-forming peptide in the brain, inhibiting this activity may lead to the development of AD and/or accelerate the disease in susceptible individuals. 

Phrase: "If"

Phrase: "degradation of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "by ECE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "does"

Phrase: ","

Phrase: "as"

Phrase: "we"

Phrase: "hypothesize"

Phrase: ","

Phrase: "contribute to the extracellular concentration of the plaque-forming peptide"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   739   C0011389:Plaque [Disease or Syndrome]
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0086045:Concentration [Mental Process]
   739   C0205431:Forming [Functional Concept]
   739   C0332461:Plaque [Finding]
   739   C0333463:plaque [Acquired Abnormality]
   739   C0521119:Extracellular [Cell Component]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1522492:Forming [Functional Concept]
   739   C1880177:Contribute [Activity]
   706 E C0348078:Form [Qualitative Concept]
   706 E C0376315:Form [Manufactured Object]

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "this activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "lead to the development of AD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1527148:Development [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the disease in susceptible individuals."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.331: Because most ECE and NEP inhibitors will inhibit both enzymes at certain concentrations, the use of these drugs may be particularly risky if ECE and NEP both play physiological roles in the degradation of A in the brain. 

Phrase: "Because"

Phrase: "most ECE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "and"

Phrase: "NEP inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "will"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "both enzymes at certain concentrations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]

Phrase: "the use of these drugs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1524063:Use of [Functional Concept]
   781   C0242510:drug use [Mental or Behavioral Dysfunction]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "particularly risky"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0035647:Risk [Qualitative Concept]

Phrase: "if"

Phrase: "ECE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "and"

Phrase: "NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "both"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "physiological roles in the degradation of A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0035820:Roles [Social Behavior]
   714 E C1705810:Role [Conceptual Entity]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.332: ET receptors may be a safer target for pharmacological interference with the endothelin system to reduce hypertension without the side effect of decreased A catabolism. 

Phrase: "ET receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "be"

Phrase: "a safer target for pharmacological interference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "with the endothelin system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "reduce"

Phrase: "hypertension without the side effect of decreased A catabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0020538:Hypertension [Disease or Syndrome]
   742   C1963138:Hypertension [Finding]
Processing 00000000.tx.333: Second, up-regulation of ECE activity may be useful therapeutically for the treatment of AD. 

Phrase: "Second, up-regulation of ECE activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "may"

Phrase: "be"

Phrase: "useful therapeutically for the treatment of AD."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]
   738   C1524063:Use of [Functional Concept]
Processing 00000000.tx.334: One obvious concern with this treatment method is that patients may become hypertensive. 

Phrase: "One obvious concern with this treatment method"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2699424:Concern [Idea or Concept]

Phrase: "is"

Phrase: "that patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "may"

Phrase: "become"

Phrase: "hypertensive."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0857121:hypertensive [Finding]
Processing 00000000.tx.335: Up-regulation of ECE activity in the periphery of mice injected with a construct to increase ECE expression, however, does not appear to result in increased circulating endothelin levels, indicating that ECE is not likely to be rate-limiting in the conversion of big ET to ET (61). 

Phrase: "Up-regulation of ECE activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in the periphery"

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "injected with a construct to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2827421:Construct [Classification]
   726   C1720154:Inject [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "ECE expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "however,"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in increased circulating endothelin levels,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0175630:Circulating [Functional Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "indicating"

Phrase: "that ECE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "is"

Phrase: "not likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "rate-limiting in the conversion of big ET"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   744   C0439801:limiting [Functional Concept]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]
   711 E C1549649:Limit [Idea or Concept]
   711 E C2349209:Limit [Conceptual Entity]

Phrase: "to ET (61"

Phrase: ")."
Processing 00000000.tx.336: Further, even if increased ECE activity does augment endothelin levels, endothelin receptor antagonists could be given in parallel to reduce or block any effect of increased endothelin levels. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "even"

Phrase: "if"

Phrase: "increased ECE activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0474395:increased activity [Finding]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "does"

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "endothelin levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "endothelin receptor antagonists"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C2266875:Endothelin Receptor Antagonists [Molecular Function]
   983 E C1134681:Endothelin receptor antagonist [Pharmacologic Substance]
   983 E C3537018:Endothelin Receptor Antagonist [Pharmacologic Substance]
   827   C0243076:antagonists [Chemical Viewed Functionally]
   793 E C0231491:Antagonist [Organ or Tissue Function]
   734   C0059285:Endothelin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   721 E C0680242:antagonism [Social Behavior]

Phrase: "could"

Phrase: "be"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "in parallel to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C2348042:Parallel [Qualitative Concept]
   827   C2826345:PARALLEL [Research Activity]

Phrase: "reduce"

Phrase: "or"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "any effect of increased endothelin levels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0595938:EFFECT INCREASED [Pathologic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.337: Third, mutations in ECE may be identified that are causative of Alzheimer's disease in certain individuals. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "mutations in ECE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "causative of Alzheimer's disease"

Phrase: "in certain individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.338: In this regard, it is worthwhile to note that the sib-pair analyses of genetic factors contributing to late onset AD have not excluded the region on chromosome 1where the ECE-1 gene is located (62). 

Phrase: "In this regard,"

Phrase: "it"

Phrase: "is"

Phrase: "worthwhile to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the sib-pair analyses of genetic factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0085801:Factor Analyses [Quantitative Concept]
   757   C0679560:genetic analysis [Laboratory Procedure]
   757   C0796344:Genetic Analysis [Laboratory Procedure]
   726   C2825412:Paired Analysis [Idea or Concept]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "contributing to late onset AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205087:Late [Temporal Concept]
   760   C0332162:Onset [Qualitative Concept]
   760   C1880177:Contributing [Activity]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "the region on chromosome 1where"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1953345:Chromosome region [Cell]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "the ECE-1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1333402:Enzyme Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "located"

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.339: Equally important, however, is the possibility that there may be individuals with normally high levels of ECE activity who are at a reduced risk for the disease. 

Phrase: "Equally important, however,"

Phrase: "is"

Phrase: "the possibility"

Phrase: "that there"

Phrase: "may"

Phrase: "be"

Phrase: "individuals with normally high levels of ECE activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0027361:Individual [Population Group]
   711   C0237401:Individual [Human]

Phrase: "who"

Phrase: "are at a reduced risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035647:Risk [Qualitative Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1551058:Are [Quantitative Concept]

Phrase: "for the disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.340: A careful analysis of ECE activity in AD and control individuals is necessary to determine the extent of the involvement of this enzyme family in the development of AD.  

Phrase: "A careful analysis of ECE activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0556570:Activity analysis [Therapeutic or Preventive Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in AD"

Phrase: "and"

Phrase: "control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "is"

Phrase: "necessary to"

Phrase: "determine"

Phrase: "the extent of the involvement of this enzyme family"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439792:Extent [Spatial Concept]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of AD."
Processing 00000000.tx.341: ACKNOWLEDGEMENTS We thank Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.342: Steven Younkin for continued support and critical evaluation of the manuscript. 

Phrase: "Steven Younkin for continued support"

Phrase: "and"

Phrase: "critical evaluation of the manuscript."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0220825:Evaluation [Functional Concept]
   760   C1261322:Evaluation [Health Care Activity]
Processing 00000000.tx.343: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.344: Terrone Rosenberry for help with kinetic analyses and for critical evaluation of the manuscript. 

Phrase: "Terrone Rosenberry for"

Phrase: "help with kinetic analyses"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0018896:Help [Social Behavior]
   770   C0022702:kinetic [Natural Phenomenon or Process]
   770   C1552861:help [Idea or Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]
   715 E C0026597:Motion [Natural Phenomenon or Process]
   715 E C0687704:Motions [Functional Concept]

Phrase: "and for critical evaluation of the manuscript."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0220825:Evaluation [Functional Concept]
   748   C0600659:Manuscript [Intellectual Product,Manufactured Object]
   748   C1261322:Evaluation [Health Care Activity]
   748   C1511545:Critical [Qualitative Concept]
   748   C1515981:And [Idea or Concept]
Processing 00000000.tx.345: We also thank Debra Yager and Dr. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Debra Yager"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.346: Cristian-Mihail Prada for expert technical assistance, Takeda Industries for anti-A antibodies, Dr. 

Phrase: "Cristian-Mihail Prada for expert technical assistance,"

Phrase: "Takeda Industries for anti-A antibodies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0021267:Industries [Occupational Activity]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.347: Abdul Fauq for synthesis of PD069185, and Dr. 

Phrase: "Abdul Fauq for synthesis of PD069185,"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.348: Kumar Sambamurti for critical evaluation of the manuscript. 

Phrase: "Kumar Sambamurti for critical evaluation of the manuscript."
Processing 00000000.tx.349: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.350: Masashi Yanagisawa for helpful discussions on the localization of ECE-1 isoforms.  

Phrase: "Masashi Yanagisawa for helpful discussions"

Phrase: "on the localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "of ECE-1 isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.351: FOOTNOTES * This work was supported by a Smith Fellowship (to C.E.), by a Bursak fellowship (to E.E.), and by the Mayo Foundation for Medical Education and Research.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a Smith Fellowship"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0015770:Fellowship [Educational Activity]
   760   C0554249:Smith [Professional or Occupational Group]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]

Phrase: "("

Phrase: "to C.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "by a Bursak fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015770:Fellowship [Educational Activity]

Phrase: "("

Phrase: "to E.E."

Phrase: ")"

Phrase: ","

Phrase: "and by the Mayo Foundation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0016617:Foundation [Organization]
   760   C0454788:Mayo [Geographic Area]
   760   C1077578:mayo [Plant]
   760   C1515981:And [Idea or Concept]

Phrase: "for Medical Education"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0013631:Education, Medical [Educational Activity]
   861   C0013621:Education [Educational Activity]
   861   C0013622:education [Classification]
   861   C0013658:Education, NOS [Finding]
   861   C0039401:Education [Educational Activity]
   789 E C1555905:Educational [Intellectual Product]

Phrase: "and"

Phrase: "Research."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]
Processing 00000000.tx.352: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.353: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.354: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.355: To whom correspondence should be addressed: Mayo Clinic Jacksonville, Birdsall Bldg. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Mayo Clinic Jacksonville,"

Phrase: "Birdsall Bldg."
Processing 00000000.tx.356: Rm. 

Phrase: "Rm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2951520:RM [Body Location or Region]
Processing 00000000.tx.357: 253,4500San Pablo Rd., Jacksonville, FL 32224.Tel.: 

Phrase: "253,"

Phrase: "4500San Pablo Rd.,"

Phrase: "Jacksonville,"

Phrase: "FL 32224.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.358: 904-953-2979; 

Phrase: "904-953-2979"

Phrase: ";"
Processing 00000000.tx.359: Fax: 904-953-7370; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "904-953-7370"

Phrase: ";"
Processing 00000000.tx.360: E-mail: Eckman@mayo.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Eckman@mayo.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.361: Published, JBC Papers in Press, May 3,2001,DOI 10.1074/jbc.M007579200 2 C. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "May 3,"

Phrase: "2001,"

Phrase: "DOI 10.1074/jbc.M007579200 2 C."
Processing 00000000.tx.362: B.Eckman, unpublished observation.  

Phrase: "B.Eckman,"

Phrase: "unpublished observation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.363: ABBREVIATIONS The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.364: A, -amyloid; 

Phrase: "A, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.365: ECE, endothelin-converting enzyme; 

Phrase: "ECE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "endothelin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.366: CHO, Chinese hamster ovary; 

Phrase: "CHO,"

Phrase: "Chinese hamster ovary"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.367: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.368: APP, -amyloid precursor protein; 

Phrase: "APP, -"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.369: sAPP, secreted amyloid precursor protein; 

Phrase: "sAPP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538722:APP [Laboratory Procedure]

Phrase: "secreted amyloid precursor protein"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1327616:Secreted [Cell Function]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.370: NEP, neprilysin; 

Phrase: "NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.371: ET, endothelin; 

Phrase: "ET, endothelin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.372: TGN, trans-Golgi network; 

Phrase: "TGN,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "trans-Golgi network"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.373: HUVEC, human umbilical vein endothelial cell; 

Phrase: "HUVEC,"

Phrase: "human umbilical vein endothelial cell"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   897   C0427861:human cell [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial cell [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cell [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1269647:Cell [Cell]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.374: solECE-1, soluble ECE-1; 

Phrase: "solECE-1,"

Phrase: "soluble ECE-1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.375: ACE, angiotensin-converting enzyme; 

Phrase: "ACE,"

Phrase: "angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.376: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.377: PMSF, phenylmethylsulfonyl fluoride; 

Phrase: "PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.378: Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; 

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ";"
Processing 00000000.tx.379: MES, 4-morpholineethanesulfonic acid; 

Phrase: "MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265215:MES [Congenital Abnormality]
  1000   C1417092:MES [Gene or Genome]

Phrase: "4-morpholineethanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.380: HPLC, high pressure liquid chromatography; 

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high pressure liquid chromatography"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0008562:Chromatography, High Pressure Liquid [Laboratory Procedure]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0033095:Pressure [Phenomenon or Process]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0460139:Pressure [Finding]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1306345:Pressure [Functional Concept]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.381: MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt.  

Phrase: "MTS,"

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(3-carboxymethoxyphenyl"

Phrase: ")-"

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(4-sulfophenyl"

Phrase: ")-"

Phrase: "2H-tetrazolium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039704:tetrazolium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "inner salt."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0036140:Salt [Chemical Viewed Structurally]
   861   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0206136:Salt [Food,Inorganic Chemical]
   789 E C1537053:salty [Qualitative Concept]
   761 E C0678584:saltiness [Qualitative Concept]
Processing 00000000.tx.382: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.383: Checler, F. 

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.384: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.385: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.386: 65, 1431-1444[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "1431-1444"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.387: Golde, T. 

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.388: E., Eckman, C. 

Phrase: "E.,"

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.389: B., and Younkin, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.390: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.391: (2000) Biochim. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.392: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.393: Acta 1502, 172-187[Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "Acta 1502,"

Phrase: "172-187"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.394: Kurochkin, I. 

Phrase: "Kurochkin,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.395: V., and Goto, S. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Goto,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.396: (1994) FEBS Lett. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.397: 345, 33-37[CrossRef][Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "345,"

Phrase: "33-37"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.398: Qiu, W. 

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.399: Q., Walsh, D. 

Phrase: "Q., Walsh,"

Phrase: "D."
Processing 00000000.tx.400: M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. 

Phrase: "M."

Phrase: ","

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.401: B., Rosner, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.402: R., Safavi, A., Hersh, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Safavi,"

Phrase: "A.,"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.403: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.404: J. 

Phrase: "J."
Processing 00000000.tx.405: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.406: Biol. 

Phrase: "Biol."
Processing 00000000.tx.407: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.408: 273, 32730-32738[Abstract/Free FullText] 5. 

Phrase: "273,"

Phrase: "32730-32738"

Phrase: "[Abstract/Free FullText"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.409: Vekrellis, K., Ye, Z., Qiu, W. 

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.410: Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. 

Phrase: "Q., Walsh,"

Phrase: "D."

Phrase: ","

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D."

Phrase: ","

Phrase: "Chesneau,"

Phrase: "V.,"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.411: R., and Selkoe, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.412: J. 

Phrase: "J."
Processing 00000000.tx.413: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.414: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.415: 20, 1657-1665[Abstract/Free FullText] 6. 

Phrase: "20,"

Phrase: "1657-1665"

Phrase: "[Abstract/Free FullText"

Phrase: "] 6."
Processing 00000000.tx.416: Perez, A., Morelli, L., Cresto, J. 

Phrase: "Perez,"

Phrase: "A.,"

Phrase: "Morelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cresto,"

Phrase: "J."
Processing 00000000.tx.417: C., and Castano, E. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Castano,"

Phrase: "E."
Processing 00000000.tx.418: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: (2000) Neurochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.420: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.421: 25, 247-255[CrossRef][Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "25,"

Phrase: "247-255"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.422: Chesneau, V., Vekrellis, K., Rosner, M. 

Phrase: "Chesneau,"

Phrase: "V.,"

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.423: R., and Selkoe, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.424: J. 

Phrase: "J."
Processing 00000000.tx.425: (2000) Biochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.426: J. 

Phrase: "J."
Processing 00000000.tx.427: 351, 509-516[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "351,"

Phrase: "509-516"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.428: Howell, S., Nalbantoglu, J., and Crine, P. 

Phrase: "Howell,"

Phrase: "S."

Phrase: ","

Phrase: "Nalbantoglu,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Crine,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.429: (1995) Peptides 16, 647-652[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Peptides 16,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "647-652"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.430: Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H. 

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Watanabe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sekiguchi,"

Phrase: "M."

Phrase: ","

Phrase: "Hosoki,"

Phrase: "E.,"

Phrase: "Kawashima-Morishima,"

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.431: J., Hama, E., Sekine-Aizawa, Y., and Saido, T. 

Phrase: "J.,"

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Sekine-Aizawa,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.432: C. 

Phrase: "C."
Processing 00000000.tx.433: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.434: Med. 

Phrase: "Med."
Processing 00000000.tx.435: 6, 143-150[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "6,"

Phrase: "143-150"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.436: Takaki, Y., Iwata, N., Tsubuki, S., Taniguchi, S., Toyoshima, S., Lu, B., Gerard, N. 

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Taniguchi,"

Phrase: "S."

Phrase: ","

Phrase: "Toyoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.437: P., Gerard, C., Lee, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gerard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.438: J., Shirotani, K., and Saido, T. 

Phrase: "J.,"

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.439: C. 

Phrase: "C."
Processing 00000000.tx.440: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.441: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.442: (Tokyo) 128, 897-902[Abstract] 11. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "128,"

Phrase: "897-902"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 11."
Processing 00000000.tx.443: Backstrom, J. 

Phrase: "Backstrom,"

Phrase: "J."
Processing 00000000.tx.444: R., Lim, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.445: P., Cullen, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cullen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1051267:Cullen [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.446: J., and Tokes, Z. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Tokes,"

Phrase: "Z."
Processing 00000000.tx.447: A. 

Phrase: "A."
Processing 00000000.tx.448: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.449: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.450: 16, 7910-7919[Abstract/Free FullText] 12. 

Phrase: "16,"

Phrase: "7910-7919"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.451: Yamin, R., Malgeri, E. 

Phrase: "Yamin,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Malgeri,"

Phrase: "E."
Processing 00000000.tx.452: G., Sloane, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sloane,"

Phrase: "J."
Processing 00000000.tx.453: A., McGraw, W. 

Phrase: "A.,"

Phrase: "McGraw,"

Phrase: "W."
Processing 00000000.tx.454: T., and Abraham, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.455: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.456: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.457: Biol. 

Phrase: "Biol."
Processing 00000000.tx.458: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.459: 274, 18777-18784[Abstract/Free FullText] 13. 

Phrase: "274,"

Phrase: "18777-18784"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.460: Qiu, W. 

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.461: Q., Borth, W., Ye, Z., Haass, C., Teplow, D. 

Phrase: "Q., Borth,"

Phrase: "W.,"

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.462: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.463: J. 

Phrase: "J."
Processing 00000000.tx.464: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.465: Biol. 

Phrase: "Biol."
Processing 00000000.tx.466: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.467: 271, 8443-8451[Abstract/Free FullText] 14. 

Phrase: "271,"

Phrase: "8443-8451"

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.468: Turner, A. 

Phrase: "Turner,"

Phrase: "A."
Processing 00000000.tx.469: J., and Murphy, L. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Murphy,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.470: J. 

Phrase: "J."
Processing 00000000.tx.471: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.472: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.473: 51, 91-102[CrossRef][Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "51,"

Phrase: "91-102"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.474: Hoang, M. 

Phrase: "Hoang,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.475: V., and Turner, A. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Turner,"

Phrase: "A."
Processing 00000000.tx.476: J. 

Phrase: "J."
Processing 00000000.tx.477: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.478: J. 

Phrase: "J."
Processing 00000000.tx.479: 327, 23-26[Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "327,"

Phrase: "23-26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.480: Johnson, G. 

Phrase: "Johnson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.481: D., Stevenson, T., and Ahn, K. 

Phrase: "D."

Phrase: ","

Phrase: "Stevenson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Ahn,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.482: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.483: Biol. 

Phrase: "Biol."
Processing 00000000.tx.484: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.485: 274, 4053-4058[Abstract/Free FullText] 17. 

Phrase: "274,"

Phrase: "4053-4058"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.486: Xu, D., Emoto, N., Giaid, A., Slaughter, C., Kaw, S., deWit, D., and Yanagisawa, M. 

Phrase: "Xu,"

Phrase: "D."

Phrase: ","

Phrase: "Emoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Giaid,"

Phrase: "A.,"

Phrase: "Slaughter,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kaw,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1551965:Kaw [Language]
  1000   C1555246:Kaw [Population Group]

Phrase: "S."

Phrase: ","

Phrase: "deWit,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Yanagisawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.487: (1994) Cell 78, 473-485[Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 78,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "473-485"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.488: Davenport, A. 

Phrase: "Davenport,"

Phrase: "A."
Processing 00000000.tx.489: P., Kuc, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kuc,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.490: E., Plumpton, C., Mockridge, J. 

Phrase: "E.,"

Phrase: "Plumpton,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mockridge,"

Phrase: "J."
Processing 00000000.tx.491: W., Barker, P. 

Phrase: "W., Barker,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.492: J., and Huskisson, N. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Huskisson,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.493: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.494: (1998) Histochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Histochem."
Processing 00000000.tx.495: J. 

Phrase: "J."
Processing 00000000.tx.496: 30, 359-374[CrossRef] 19. 

Phrase: "30,"

Phrase: "359-374"

Phrase: "[CrossRef"

Phrase: "] 19."
Processing 00000000.tx.497: Korth, P., Bohle, R. 

Phrase: "Korth,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bohle,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.498: M., Corvol, P., and Pinet, F. 

Phrase: "M."

Phrase: ","

Phrase: "Corvol,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Pinet,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.499: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.500: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.501: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.502: 47, 447-462[Abstract/Free FullText] 20. 

Phrase: "47,"

Phrase: "447-462"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.503: Barnes, K., Walkden, B. 

Phrase: "Barnes,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Walkden,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.504: J., Wilkinson, T. 

Phrase: "J.,"

Phrase: "Wilkinson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.505: C., and Turner, A. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Turner,"

Phrase: "A."
Processing 00000000.tx.506: J. 

Phrase: "J."
Processing 00000000.tx.507: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.508: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.509: 68, 570-577[Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "570-577"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.510: Valdenaire, O., Rohrbacher, E., and Mattei, M. 

Phrase: "Valdenaire,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Rohrbacher,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Mattei,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.511: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.512: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.513: Biol. 

Phrase: "Biol."
Processing 00000000.tx.514: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.515: 270, 29794-29798[Abstract/Free FullText] 22. 

Phrase: "270,"

Phrase: "29794-29798"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.516: Shimada, K., Takahashi, M., Ikeda, M., and Tanzawa, K. 

Phrase: "Shimada,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "M."

Phrase: ","

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Tanzawa,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.517: (1995) FEBS Lett. 

Phrase: "(1995"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.518: 371, 140-144[CrossRef][Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "371,"

Phrase: "140-144"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.519: Schmidt, M., Kroger, B., Jacob, E., Seulberger, H., Subkowski, T., Otter, R., Meyer, T., Schmalzing, G., and Hillen, H. 

Phrase: "Schmidt,"

Phrase: "M."

Phrase: ","

Phrase: "Kroger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1589613:Kroger [Pharmacologic Substance]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jacob,"

Phrase: "E.,"

Phrase: "Seulberger,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Subkowski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Otter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029903:Otter [Mammal]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Meyer,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schmalzing,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hillen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.520: (1994) FEBS Lett. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.521: 356, 238-243[CrossRef][Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "356,"

Phrase: "238-243"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.522: Schweizer, A., Valdenaire, O., Nelbock, P., Deuschle, U., Dumas Milne Edwards, J. 

Phrase: "Schweizer,"

Phrase: "A.,"

Phrase: "Valdenaire,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Nelbock,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Deuschle,"

Phrase: "U.,"

Phrase: "Dumas Milne Edwards,"

Phrase: "J."
Processing 00000000.tx.523: B., Stumpf, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Stumpf,"

Phrase: "J."
Processing 00000000.tx.524: G., and Loffler, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Loffler,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.525: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.526: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.527: J. 

Phrase: "J."
Processing 00000000.tx.528: 328, 871-877[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "328,"

Phrase: "871-877"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.529: Valdenaire, O., Lepailleur-Enouf, D., Egidy, G., Thouard, A., Barret, A., Vranckx, R., Tougard, C., and Michel, J. 

Phrase: "Valdenaire,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Lepailleur-Enouf,"

Phrase: "D."

Phrase: ","

Phrase: "Egidy,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thouard,"

Phrase: "A.,"

Phrase: "Barret,"

Phrase: "A.,"

Phrase: "Vranckx,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tougard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Michel,"

Phrase: "J."
Processing 00000000.tx.530: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.531: (1999) Eur. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.532: J.

Phrase: "J."
Processing 00000000.tx.533: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.534: 264, 341-349[Abstract/Free FullText] 26. 

Phrase: "264,"

Phrase: "341-349"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.535: Azarani, A., Boileau, G., and Crine, P. 

Phrase: "Azarani,"

Phrase: "A.,"

Phrase: "Boileau,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Crine,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.536: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.537: J. 

Phrase: "J."
Processing 00000000.tx.538: 333, 439-448[Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "333,"

Phrase: "439-448"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.539: Cailler, F., Zappulla, J. 

Phrase: "Cailler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Zappulla,"

Phrase: "J."
Processing 00000000.tx.540: P., Boileau, G., and Crine, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Boileau,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Crine,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.541: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.542: J. 

Phrase: "J."
Processing 00000000.tx.543: 341, 119-126[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "341,"

Phrase: "119-126"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.544: Emoto, N., Nurhantari, Y., Alimsardjono, H., Xie, J., Yamada, T., Yanagisawa, M., and Matsuo, M. 

Phrase: "Emoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Nurhantari,"

Phrase: "Y.,"

Phrase: "Alimsardjono,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Xie,"

Phrase: "J.,"

Phrase: "Yamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yanagisawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Matsuo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.545: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.546: Biol. 

Phrase: "Biol."
Processing 00000000.tx.547: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.548: 274, 1509-1518[Abstract/Free FullText] 29. 

Phrase: "274,"

Phrase: "1509-1518"

Phrase: "[Abstract/Free FullText"

Phrase: "] 29."
Processing 00000000.tx.549: Emoto, N., and Yanagisawa, M. 

Phrase: "Emoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Yanagisawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.550: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.551: Biol. 

Phrase: "Biol."
Processing 00000000.tx.552: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.553: 270, 15262-15268[Abstract/Free FullText] 30. 

Phrase: "270,"

Phrase: "15262-15268"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.554: Nagase, T., Ishikawa, K., Miyajima, N., Tanaka, A., Kotani, H., Nomura, N., and Ohara, O. 

Phrase: "Nagase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001057:NAGase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3538752:NAGASE [Laboratory Procedure]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ishikawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Miyajima,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tanaka,"

Phrase: "A.,"

Phrase: "Kotani,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nomura,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Ohara,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.555: (1998) DNA Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "DNA Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.556: 5, 31-39[Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "31-39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.557: Russell, F. 

Phrase: "Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.558: D., and Davenport, A. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Davenport,"

Phrase: "A."
Processing 00000000.tx.559: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.560: (1999) Circ. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Circ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332520:Circ [Quantitative Concept]
  1000   C2347774:circ [Quantitative Concept]
Processing 00000000.tx.561: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.562: 84, 891-896[Abstract/Free FullText] 32. 

Phrase: "84,"

Phrase: "891-896"

Phrase: "[Abstract/Free FullText"

Phrase: "] 32."
Processing 00000000.tx.563: Yanagisawa, H., Hammer, R. 

Phrase: "Yanagisawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hammer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0181107:Hammer [Manufactured Object]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.564: E., Richardson, J. 

Phrase: "E.,"

Phrase: "Richardson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443048:Richardson [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.565: A., Emoto, N., Williams, S. 

Phrase: "A.,"

Phrase: "Emoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Williams,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.566: C., Takeda, S., Clouthier, D. 

Phrase: "C., Takeda,"

Phrase: "S."

Phrase: ","

Phrase: "Clouthier,"

Phrase: "D."
Processing 00000000.tx.567: E., and Yanagisawa, M. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Yanagisawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.568: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.569: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.570: Invest. 

Phrase: "Invest."
Processing 00000000.tx.571: 105, 1373-1382[Abstract/Free FullText] 33. 

Phrase: "105,"

Phrase: "1373-1382"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.572: Hasegawa, H., Hiki, K., Sawamura, T., Aoyama, T., Okamoto, Y., Miwa, S., Shimohama, S., Kimura, J., and Masaki, T. 

Phrase: "Hasegawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hiki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sawamura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Aoyama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Okamoto,"

Phrase: "Y.,"

Phrase: "Miwa,"

Phrase: "S."

Phrase: ","

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Kimura,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Masaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1461631:masaki [Plant]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.573: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.574: 428, 304-308[CrossRef][Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "428,"

Phrase: "304-308"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.575: Suzuki, N., Cheung, T. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.576: T., Cai, X. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.577: D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.578: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.579: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.580: (1994) Science 264, 1336-1340[Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1336-1340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.581: Asami-Odaka, A., Ishibashi, Y., Kikuchi, T., Kitada, C., and Suzuki, N. 

Phrase: "Asami-Odaka,"

Phrase: "A.,"

Phrase: "Ishibashi,"

Phrase: "Y.,"

Phrase: "Kikuchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kitada,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.582: (1995) Biochemistry 34, 10272-10278[Medline] [OrderarticleviaInfotrieve] 36. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochemistry 34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "10272-10278"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 36."
Processing 00000000.tx.583: Ahn, K., Herman, S. 

Phrase: "Ahn,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Herman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.584: B., and Fahnoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Fahnoe,"

Phrase: "D."
Processing 00000000.tx.585: C. 

Phrase: "C."
Processing 00000000.tx.586: (1998) Arch. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.587: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.588: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.589: 359, 258-268[CrossRef][Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "359,"

Phrase: "258-268"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.590: Korth, P., Egidy, G., Parnot, C., LeMoullec, J. 

Phrase: "Korth,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Egidy,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Parnot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "LeMoullec,"

Phrase: "J."
Processing 00000000.tx.591: M., Corvol, P., and Pinet, F. 

Phrase: "M."

Phrase: ","

Phrase: "Corvol,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Pinet,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.592: (1997) FEBS Lett. 

Phrase: "(1997"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.593: 417, 365-370[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "417,"

Phrase: "365-370"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.594: Ahn, K., Sisneros, A. 

Phrase: "Ahn,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sisneros,"

Phrase: "A."
Processing 00000000.tx.595: M., Herman, S. 

Phrase: "M."

Phrase: ","

Phrase: "Herman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.596: B., Pan, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.597: M., Hupe, D., Lee, C., Nikam, S., Cheng, X. 

Phrase: "M."

Phrase: ","

Phrase: "Hupe,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nikam,"

Phrase: "S."

Phrase: ","

Phrase: "Cheng,"

Phrase: "X."
Processing 00000000.tx.598: M., Doherty, A. 

Phrase: "M."

Phrase: ","

Phrase: "Doherty,"

Phrase: "A."
Processing 00000000.tx.599: M., Schroeder, R. 

Phrase: "M."

Phrase: ","

Phrase: "Schroeder,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.600: L., Haleen, S. 

Phrase: "L., Haleen,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.601: J., Kaw, S., Emoto, N., and Yanagisawa, M. 

Phrase: "J.,"

Phrase: "Kaw,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1551965:Kaw [Language]
  1000   C1555246:Kaw [Population Group]

Phrase: "S."

Phrase: ","

Phrase: "Emoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Yanagisawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.602: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.603: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.604: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.605: Commun. 

Phrase: "Commun."
Processing 00000000.tx.606: 243, 184-190[CrossRef][Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "243,"

Phrase: "184-190"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.607: Eckman, C. 

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.608: B., Prada, C.-M., and Younkin, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Prada,"

Phrase: "C.-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.609: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.610: (1995) Society for Neuroscience , San Diego, CA 40. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Society for Neuroscience ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037455:society [Organization]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.611: Fuller, S. 

Phrase: "Fuller,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.612: J., Storey, E., Li, Q. 

Phrase: "J.,"

Phrase: "Storey,"

Phrase: "E.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Q."
Processing 00000000.tx.613: X., Smith, A. 

Phrase: "X.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.614: I., Beyreuther, K., and Masters, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.615: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.616: (1995) Biochemistry 34, 8091-8098[Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochemistry 34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "8091-8098"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.617: Kukkola, P. 

Phrase: "Kukkola,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.618: J., Savage, P., Sakane, Y., Berry, J. 

Phrase: "J.,"

Phrase: "Savage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331893:Savage [Health Care Related Organization]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sakane,"

Phrase: "Y.,"

Phrase: "Berry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005135:Berry [Food]
  1000   C0982158:BERRY [Food]
  1000   C3495134:BERRY [Organic Chemical,Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.619: C., Bilci, N. 

Phrase: "C., Bilci,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.620: A., Ghai, R. 

Phrase: "A.,"

Phrase: "Ghai,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.621: D., and Jeng, A. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Jeng,"

Phrase: "A."
Processing 00000000.tx.622: Y. 

Phrase: "Y."
Processing 00000000.tx.623: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.624: Cardiovasc. 

Phrase: "Cardiovasc."
Processing 00000000.tx.625: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.626: 26, S65-S68[Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "26,"

Phrase: "S65-S68"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.627: Ansorge, S., Bohley, P., Kirschke, H., Langner, J., and Wiederanders, B. 

Phrase: "Ansorge,"

Phrase: "S."

Phrase: ","

Phrase: "Bohley,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kirschke,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Langner,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Wiederanders,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.628: (1984) Biomed. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Biomed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332030:Biomed [Health Care Related Organization]
Processing 00000000.tx.629: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.630: Acta 43, 39-46[Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "Acta 43,"

Phrase: "39-46"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.631: Turner, A. 

Phrase: "Turner,"

Phrase: "A."
Processing 00000000.tx.632: J., and Tanzawa, K. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Tanzawa,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.633: (1997) FASEB J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.634: 11, 355-364[Abstract/Free FullText] 44. 

Phrase: "11,"

Phrase: "355-364"

Phrase: "[Abstract/Free FullText"

Phrase: "] 44."
Processing 00000000.tx.635: Corvol, P., Williams, T. 

Phrase: "Corvol,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Williams,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.636: A., and Soubrier, F. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Soubrier,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.637: (1995) Methods Enzymol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.638: 248, 283-305[Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "248,"

Phrase: "283-305"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.639: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.640: G., Sicuteri, F., Salmon, S., and Malfroy, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sicuteri,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Salmon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036110:Salmon [Fish]
  1000   C0327949:salmon [Fish]
  1000   C0459210:Salmon [Food]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Malfroy,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.641: (1990) Biochem. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.642: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.643: 39, 1353-1356[CrossRef][Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "39,"

Phrase: "1353-1356"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.644: Soleilhac, J. 

Phrase: "Soleilhac,"

Phrase: "J."
Processing 00000000.tx.645: M., Lafuma, C., Porcher, J. 

Phrase: "M."

Phrase: ","

Phrase: "Lafuma,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Porcher,"

Phrase: "J."
Processing 00000000.tx.646: M., Auburtin, G., and Roques, B. 

Phrase: "M."

Phrase: ","

Phrase: "Auburtin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Roques,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.647: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.648: (1996) Eur. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.649: J.Clin. 

Phrase: "J."

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.650: Invest. 

Phrase: "Invest."
Processing 00000000.tx.651: 26, 1011-1017[Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "26,"

Phrase: "1011-1017"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450317:1011 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.652: Ikeda, K., Emoto, N., Raharjo, S. 

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Emoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Raharjo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.653: B., Nurhantari, Y., Saiki, K., Yokoyama, M., and Matsuo, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Nurhantari,"

Phrase: "Y.,"

Phrase: "Saiki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yokoyama,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Matsuo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.654: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.655: Biol. 

Phrase: "Biol."
Processing 00000000.tx.656: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.657: 274, 32469-32477[Abstract/Free FullText] 48. 

Phrase: "274,"

Phrase: "32469-32477"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.658: Ghaddar, G., Ruchon, A. 

Phrase: "Ghaddar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ruchon,"

Phrase: "A."
Processing 00000000.tx.659: F., Carpentier, M., Marcinkiewicz, M., Seidah, N. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Carpentier,"

Phrase: "M."

Phrase: ","

Phrase: "Marcinkiewicz,"

Phrase: "M."

Phrase: ","

Phrase: "Seidah,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.660: G., Crine, P., Desgroseillers, L., and Boileau, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crine,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Desgroseillers,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Boileau,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.661: (2000) Biochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.662: J. 

Phrase: "J."
Processing 00000000.tx.663: 347, 419-429[CrossRef][Medline] [OrderarticleviaInfotrieve] 49. 

Phrase: "347,"

Phrase: "419-429"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 49."
Processing 00000000.tx.664: Tanja, O., Facchinetti, P., Rose, C., Bonhomme, M. 

Phrase: "Tanja,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Facchinetti,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bonhomme,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.665: C., Gros, C., and Schwartz, J. 

Phrase: "C., Gros,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1332652:GRO [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1705593:GRO [Gene or Genome]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Schwartz,"

Phrase: "J."
Processing 00000000.tx.666: C. 

Phrase: "C."
Processing 00000000.tx.667: (2000) Biochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.668: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.669: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.670: Commun. 

Phrase: "Commun."
Processing 00000000.tx.671: 271, 565-570[CrossRef][Medline] [OrderarticleviaInfotrieve] 50. 

Phrase: "271,"

Phrase: "565-570"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 50."
Processing 00000000.tx.672: Roques, B. 

Phrase: "Roques,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.673: P., and Beaumont, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Beaumont,"

Phrase: "A."
Processing 00000000.tx.674: (1990) Trends Pharmacol. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Pharmacol."
Processing 00000000.tx.675: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.676: 11, 245-249[Medline] [OrderarticleviaInfotrieve] 51. 

Phrase: "11,"

Phrase: "245-249"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 51."
Processing 00000000.tx.677: Gronhagen-Riska, C., and Fyhrquist, F. 

Phrase: "Gronhagen-Riska,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Fyhrquist,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.678: (1980) Scand. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Scand."
Processing 00000000.tx.679: J.Clin. 

Phrase: "J."

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.680: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.681: Invest. 

Phrase: "Invest."
Processing 00000000.tx.682: 40, 711-719[Medline] [OrderarticleviaInfotrieve] 52. 

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "711-719"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 52."
Processing 00000000.tx.683: Ahn, K., Pan, S., Beningo, K., and Hupe, D. 

Phrase: "Ahn,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "S."

Phrase: ","

Phrase: "Beningo,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hupe,"

Phrase: "D."
Processing 00000000.tx.684: (1995) Life Sci. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.685: 56, 2331-2341[CrossRef][Medline] [OrderarticleviaInfotrieve] 53. 

Phrase: "56,"

Phrase: "2331-2341"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 53."
Processing 00000000.tx.686: Fahnoe, D. 

Phrase: "Fahnoe,"

Phrase: "D."
Processing 00000000.tx.687: C., Knapp, J., Johnson, G. 

Phrase: "C., Knapp,"

Phrase: "J.,"

Phrase: "Johnson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.688: D., and Ahn, K. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Ahn,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.689: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.690: Cardiovasc. 

Phrase: "Cardiovasc."
Processing 00000000.tx.691: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.692: 36, S22-S25[Medline] [OrderarticleviaInfotrieve] 54. 

Phrase: "36,"

Phrase: "S22-S25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419727:S25 [Gene or Genome]
   861   C1549916:S25 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 54."
Processing 00000000.tx.693: Parnot, C., Le Moullec, J. 

Phrase: "Parnot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Le Moullec,"

Phrase: "J."
Processing 00000000.tx.694: M., Cousin, M. 

Phrase: "M."

Phrase: ","

Phrase: "Cousin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337580:Cousin [Family Group]
  1000   C1610173:cousin [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.695: A., Guedin, D., Corvol, P., and Pinet, F. 

Phrase: "A.,"

Phrase: "Guedin,"

Phrase: "D."

Phrase: ","

Phrase: "Corvol,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Pinet,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.696: (1997) Hypertension 30, 837-844[Abstract/Free FullText] 55. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Hypertension 30,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: "837-844"

Phrase: "[Abstract/Free FullText"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.697: Hartmann, T., Bieger, S. 

Phrase: "Hartmann,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bieger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.698: C., Bruhl, B., Tienari, P. 

Phrase: "C., Bruhl,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tienari,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.699: J., Ida, N., Allsop, D., Roberts, G. 

Phrase: "J.,"

Phrase: "Ida,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020789:IDA [Organic Chemical,Pharmacologic Substance]
  1000   C0063555:IdA [Organic Chemical,Pharmacologic Substance]
  1000   C2275731:Ida [Plant]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Allsop,"

Phrase: "D."

Phrase: ","

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.700: W., Masters, C. 

Phrase: "W., Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.701: L., Dotti, C. 

Phrase: "L., Dotti,"

Phrase: "C."
Processing 00000000.tx.702: G., Unsicker, K., and Beyreuther, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Unsicker,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.703: (1997) Nat. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.704: Med. 

Phrase: "Med."
Processing 00000000.tx.705: 3, 1016-1020[Medline] [OrderarticleviaInfotrieve] 56. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "1016-1020"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 56."
Processing 00000000.tx.706: Umezawa, S., Tatsuta, K., Izawa, O., and Tsuchiya, T. 

Phrase: "Umezawa,"

Phrase: "S."

Phrase: ","

Phrase: "Tatsuta,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Izawa,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Tsuchiya,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.707: (1972) Tetrahedron Lett. 

Phrase: "(1972"

Phrase: ")"

Phrase: "Tetrahedron Lett."
Processing 00000000.tx.708: 1, 97-100 57. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "97-100 57."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439073:97 [Intellectual Product]
   827   C0439082:>97 [Quantitative Concept]
Processing 00000000.tx.709: Sawamura, T., Kasuya, Y., Matsushita, Y., Suzuki, N., Shinmi, O., Kishi, N., Sugita, Y., Yanagisawa, M., Goto, K., Masaki, T., and Kimura, S. 

Phrase: "Sawamura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kasuya,"

Phrase: "Y.,"

Phrase: "Matsushita,"

Phrase: "Y.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Shinmi,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kishi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Sugita,"

Phrase: "Y.,"

Phrase: "Yanagisawa,"

Phrase: "M."

Phrase: ","

Phrase: "Goto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1461631:masaki [Plant]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kimura,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.710: (1991) Biochem. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.711: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.712: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.713: Commun. 

Phrase: "Commun."
Processing 00000000.tx.714: 174, 779-784[Medline] [OrderarticleviaInfotrieve] 58. 

Phrase: "174,"

Phrase: "779-784"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 58."
Processing 00000000.tx.715: Yoshizawa, T., Iwamoto, H., Mizusawa, H., Suzuki, N., Matsumoto, H., and Kanazawa, I. 

Phrase: "Yoshizawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwamoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mizusawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.716: (1992) Neuropeptides 22, 85-88[Medline] [OrderarticleviaInfotrieve] 59. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Neuropeptides 22,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "85-88"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 59."
Processing 00000000.tx.717: Yanagisawa, H., Yanagisawa, M., Kapur, R. 

Phrase: "Yanagisawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yanagisawa,"

Phrase: "M."

Phrase: ","

Phrase: "Kapur,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1024808:kapur [Plant]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.718: P., Richardson, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Richardson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443048:Richardson [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.719: A., Williams, S. 

Phrase: "A.,"

Phrase: "Williams,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.720: C., Clouthier, D. 

Phrase: "C., Clouthier,"

Phrase: "D."
Processing 00000000.tx.721: E., de Wit, D., Emoto, N., and Hammer, R. 

Phrase: "E.,"

Phrase: "de Wit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043197:Wit [Idea or Concept]

Phrase: "D."

Phrase: ","

Phrase: "Emoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Hammer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0181107:Hammer [Manufactured Object]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.722: E. 

Phrase: "E."
Processing 00000000.tx.723: (1998) Development 125, 825-836[Abstract/Free FullText] 60. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Development 125,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "825-836"

Phrase: "[Abstract/Free FullText"

Phrase: "] 60."
Processing 00000000.tx.724: Gray, G. 

Phrase: "Gray,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.725: A., and Webb, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Webb,"

Phrase: "D."
Processing 00000000.tx.726: J. 

Phrase: "J."
Processing 00000000.tx.727: (1996) Pharmacol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Pharmacol."
Processing 00000000.tx.728: Ther. 

Phrase: "Ther."
Processing 00000000.tx.729: 72, 109-148[CrossRef][Medline] [OrderarticleviaInfotrieve] 61. 

Phrase: "72,"

Phrase: "109-148"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 61."
Processing 00000000.tx.730: Telemaque, S., Emoto, N., deWit, D., and Yanagisawa, M. 

Phrase: "Telemaque,"

Phrase: "S."

Phrase: ","

Phrase: "Emoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "deWit,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Yanagisawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.731: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.732: Cardiovasc. 

Phrase: "Cardiovasc."
Processing 00000000.tx.733: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.734: 31, S548-S550[CrossRef][Medline] [OrderarticleviaInfotrieve] 62. 

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "S548-S550"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 62."
Processing 00000000.tx.735: Kehoe, P., Wavrant-De Vrieze, F., Crook, R., Wu, W. 

Phrase: "Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wavrant-De Vrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "W."
Processing 00000000.tx.736: S., Holmans, P., Fenton, I., Spurlock, G., Norton, N., Williams, H., Williams, N., Lovestone, S., Perez-Tur, J., Hutton, M., Chartier-Harlin, M. 

Phrase: "S."

Phrase: ","

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fenton,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Spurlock,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Norton,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Williams,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Williams,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lovestone,"

Phrase: "S."

Phrase: ","

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Chartier-Harlin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.737: C., Shears, S., Roehl, K., Booth, J., Van Voorst, W., Ramic, D., Williams, J., Goate, A., Hardy, J., and Owen, M. 

Phrase: "C., Shears,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0175735:shears [Medical Device]
   827 E C0205013:shear [Therapeutic or Preventive Procedure]

Phrase: "S."

Phrase: ","

Phrase: "Roehl,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Booth,"

Phrase: "J.,"

Phrase: "Van Voorst,"

Phrase: "W.,"

Phrase: "Ramic,"

Phrase: "D."

Phrase: ","

Phrase: "Williams,"

Phrase: "J.,"

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Owen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.738: J. 

Phrase: "J."
Processing 00000000.tx.739: (1999) Hum. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.740: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.741: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.742: 8, 237-245[Abstract/Free FullText] Copyright  2001 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "8,"

Phrase: "237-245"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  2001 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

